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ABSTRACT 
The linear chromosomes ends in eukaryotes are protected by telomeres, a 
nucleoprotein structure that contains telomeric DNA with repetitive sequence and 
associated proteins. Telomerase is an RNA-dependent DNA polymerase that adds 
telomeric DNA repeats to the 3'-ends of chromosomes to offset the loss of terminal 
DNA repeats during DNA replication. It consists of two core components: a 
telomerase reverse transcriptase (TERT) and a telomerase RNA (TR). Telomerase 
uses a short sequence in its integral RNA component as template to add multiple 
DNA repeats in a processive manner. However, it remains unclear how the telomerase 
utilizes the short RNA template accurately and efficiently during DNA repeat 
synthesis. As previously reported human telomerase nucleotide synthesis arrests upon 
reaching the end of its RNA template by a unique template-embedded pause signal. In 
this study, I demonstrate pause signal remains active following template regeneration 
and inhibits the intrinsic processivity and rate of telomerase repeat addition. 
Furthermore, I have found that the human telomerase catalytic cycle comprises a 
crucial and slow incorporation of the first nucleotide after template translocation. This 
slow nucleotide incorporation step drastically limits repeat addition processivity and 
rate, which is alleviated with elevated concentrations of dGTP. Additionally, 
molecular mechanism of the disease mutants on telomerase specific motif T, K570N, 
have been explored. Finally, I studied how telomerase selective inhibitor BIBR 1532 
reduce telomerase repeat addition processivity by function assay. Together, these 
results shed new light on telomerase catalytic cycle and the importance of telomerase 
for biomedicine.  
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CHAPTER 1 
INTRODUCTION 
1.1 History of telomerase research 
Linear chromosomes in eukaryotic organisms require capping structures to 
maintain chromosomal termini during successive DNA replication (McClintock, 
1941; Muller, 1938). These unique DNA sequences along with capping protein 
structures were termed ‘telomeres’ (McClintock, 1941). After 40 years, Elizabeth 
Blackburn reported the first telomeric sequece from the ciliate Tetrahymena 
thermophila (Blackburn & Gall, 1978). Telomere nucleoprotein complexes are 
composed of a vast array of short, highly repetitive DNA sequences (repetitive T2G4 
in Tetrahymena). The guanosine rich strand was named ‘G-strand’ due to its high 
guanosine content compared to the complementary ‘C-strand’ for the high frequency 
of cytosine. Similar to T. thermophila, human telomeres are also composed of short, 
repetitive DNA sequences ‘TTAGGG’ (Moyzis et al, 1988). The sequence of 
telomeric DNA is conserved among vertebrate species, including humans as well as 
numerous marine invertebrates, fungi, plants, and protozoans (Meyne et al, 1989; 
Podlevsky et al, 2008). This indicates ‘TTAGGG’ as the common ancestral telomeric 
DNA sequence throughout major eukaryote lineages.   
Following the discovery that the material of inheritance is DNA replicates 
semi-conservatively, the ‘end-replication problem’ was recognized (Lingner et al, 
1995; Olovnikov, 1973; Watson, 1972). This problem arises due to the inability of 
conventional DNA polymerases to completely replicate linear chromosomal ends. 
DNA polymerases synthesize daughter DNA strand in a 5’-to-3’ direction and require 
a free 3’-hydroxyl group for the nucleotide addition. The RNA primers that provided 
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the free 3’-hydroxyl group for DNA synthesis will be degraded. At the very end of the 
chromosome, RNA primer cannot be filled with DNA and the daughter lagging strand 
will be shorter than the parental strand as the result. It has been found linear 
chromosome ends in eukaryotes have 3’single stranded DNA overhangs (Makarov et 
al, 1997).  The exonucleases Apollo and Exo1 act upon and resect blunt-ended DNA 
produced by leading strand synthesis (Sfeir et al, 2005). The resection decreases the 
length of parental DNA in the leading strand and the daughter strand in the lagging 
strand (Huffman et al, 2000). Due to the end-replication problem, progressive loss of 
chromosome termini occurs and upon reaching critical lengths, which leads to 
genomic instability ensues followed by cellular senescence and apoptosis (de Lange, 
2009). (Figure 1.1) 
The biochemical activity to maintain telomeres from progressive loss of 
telomeric DNA was found to be from a specialized ribonucleoprotein complex named 
telomerase (Greider & Blackburn, 1985; Greider & Blackburn, 1987). Telomerase can 
synthesize short DNA repeats to the ends of chromosomes to offset the loss of 
telomere length following each round of DNA replication (Shippen-Lentz & 
Blackburn, 1990). (Figure 1.2) Unlike traditional reverse transcriptases, the 
telomerase enzyme is a ribonucleoprotein (RNP) consisting of two essential 
components for activity: the telomerase reverse transcriptase (TERT) protein and the 
integral telomerase RNA (TR) (Greider & Blackburn, 1987; Greider & Blackburn, 
1989). The TERT protein is the catalytic subunit while the TR harbors a small region 
that provides the template for repeat addition. The TERT and TR form the minimal 
catalytic core of telomerase with accessory proteins for proper biogenesis, 
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localization, and regulation of telomerase (Egan & Collins, 2010; Fu & Collins, 2003; 
Kiss et al, 2010; Venteicher & Artandi, 2009).  
Telomere length homeostasis is crucial for cell survival while mis-regulation 
leads to disorders and diseases in humans and other species. The expression of 
telomerase in human cells is tightly regulated. In most somatic cells, telomerase 
activity is undetectable while stem and germ-line cells show significant activity 
(Hiyama & Hiyama, 2007). Telomerase acts like a molecular clock for somatic cells, 
which limits their replicative capability. As a result, somatic cells will enter a stage of 
senescence and eventually death following a defined number of replications (Hayflick 
& Moorhead, 1961). Models such as protein counting and replication fork have been 
established to elucidate the telomere length regulation by telomerase (Greider, 2016; 
Marcand et al, 1997; Wellinger & Zakian, 2012). Mutations in telomerase or its 
accessory proteins that reduce telomerase activity can cause short telomere syndromes 
and a range of associated age-related disease (Armanios, 2009; Podlevsky & Chen, 
2012; Sarek et al, 2015). On the contrary, with upgraded telomerase activity, cancer 
cells are able to maintain or even elongate telomeres and escape senescence allowing 
immortal growth. Nearly 90% of human cancers shown an up-regulation of 
telomerase, which make it a promising target for cancer therapy (Arndt & MacKenzie, 
2016; Chen & Zhang, 2016; Kim et al, 1994). The importance of telomerase is 
evidenced by the Nobel Prize in Physiology or Medicine awarded to Elizabeth 
Blackburn, Carol Greider and Jack Szostak for their pioneering work in the discovery 
of how chromosomes are protected by telomeres and telomerase. 
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1.2 Telomerase reverse transcriptase 
The TERT protein is the catalytic subunit of the telomerase enzyme, which is 
used for the synthesis of telomeric DNA using the hTR template. The TERT protein is 
composed of four highly conserved domains: the telomerase essential N-terminal 
(TEN) domain, the telomerase RNA binding domain (TRBD), the reverse 
transcriptase (RT) domain, and the C-terminal extension (CTE). (Figure 1.3A) The 
TEN and TRBD domains are TERT specific while RT and CTE domains share 
similar motifs with other DNA polymerases and reverse transcriptases (Lingner et al, 
1997). The TRBD–RT–CTE domains of TERT form a ring like structure with a 
centralized active site to hold the RNA/DNA duplex during extension (Gillis et al, 
2008). (Figure 1.3B) 
The TEN domain of TERT binds TR and single-stranded telomeric DNA. The 
TEN domain contains a DNA ‘anchor’ site specifically binding single-stranded 
telomeric DNA, which is essential for processive telomeric DNA repeat synthesis. 
(Finger & Bryan, 2008; Jacobs et al, 2006; Lue & Li, 2007; Romi et al, 2007; Sealey 
et al, 2010). This binding can prevent complete release of the DNA substrate from the 
active site of enzyme and increases repeat addition processivity (Wyatt et al, 2010). It 
has been found that a conserved leucine residue outside of the DNA anchor site is 
reported to increase telomeric repeat addition processivity, whereas no homologous 
residues yet discovered in the TEN domains of human or yeast. Apart from the DNA 
anchor site and that leucine residue, the TEN domain contains a low-affinity RNA-
binding site for the TR pseudoknot region. (Lai et al, 2001; Moriarty et al, 2004; 
Podlevsky & Chen, 2012). However, the mechanism of the interaction of TERT-
pseudoknot unclear. Thought the TEN domain contains processivity-increasing 
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elements and a low-affinity RNA binding site, it is not indispensable for telomerase 
activity (Eckert & Collins, 2012). Insect species, such as Tribolium castaneum, has 
been reported without the TEN domain entirely in the telomerase (Gillis et al, 2008; 
Mitchell et al, 2010).  
TRBD is a prevalently conserved domain of TERT, which contributes to the 
majority interaction between TERT and TR (Bley et al, 2011; Huang et al, 2014; 
Jansson et al, 2015; Moriarty et al, 2004). The TRBD consists three universally 
conserved motifs: CP, QFP, and T.  These three motifs form a major RNA binding 
pocket with a highly helical structure in both T. thermophila and T. castaneum crystal 
structures (Gillis et al, 2008; Rouda & Skordalakes, 2007). The TERT specific motif 
T contains a highly conserved "FYXTE" sequence forming a hairpin structure. Motif 
T has been reported to interact with the RNA backbone of the RNA/DNA duplex and 
involved in repeat addition processivity (Drosopoulos & Prasad, 2010; Mitchell et al, 
2010). There are also other TR binding elements such as vertebrate-specific region 
(VSR) and ciliate counterpart (CP2) present in TRBD (Harley, 2002; Moriarty et al, 
2002). 
The RT and CTE domains of TERT protein share motifs with other 
conventional reverse transcriptases, contain a right hand with finger, palm and thumb 
subdomains (Gillis et al, 2008; Mitchell et al, 2010; Nakamura et al, 1997). The RT 
domain consists of a structural and functional homolog of the “fingers”, “palm” 
domains and other seven conserved motifs: 1, 2 and A, B, C, D, and E (Figure 1.3). 
The finger domain (motifs 1 and 2) is responsible for binding incoming nucleotides as 
well as positioning the RNA template and the palm domain (motifs A, B, C, D, and 
E). It is constituting the catalytic site for polymerization (Bosoy & Lue, 2001). Within 
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the palm domain of the TERT protein, there are three invariant aspartic acids 
consistently conserved among all DNA polymerases (Lingner et al, 1997). These 
aspartic acids coordinate the positioning of two magnesium atoms. Mutation in any 
one of these three conserved aspartic acids will result in inactive telomerase in vitro 
and telomere shortening in vivo (Bryan et al, 2000; Counter et al, 1997; Harrington et 
al, 1997; Nakayama et al, 1998; Weinrich et al, 1997; Wyatt et al, 2010). 
Additionally, TERT contains an invariantly conserved lysine residue in motif D, 
which is believed to activate the pyrophosphate leaving group generated from the 
nucleotide addition. The mutation of this lysine in TERT compromises telomerase 
activity severely (Bryan et al, 2000; Miller et al, 2000; Sekaran et al, 2010). It has 
been reported that motif E functions in positioning the single strand DNA in the 
TERT palm domain (Peng et al, 2001; Wyatt et al, 2007). This is further supported by 
the TERT crystal structure in Tribolium castaneum, in which a coiled loop is close to 
the end of the DNA primer (Mitchell et al, 2010).  
While the RT domain of TERT shares conserved motifs with conventional 
RTs, it also has several telomerase unique motifs to perform telomerase-specific 
functions.  Mutagenesis studies of insertion in fingers domain (IFD), a large insertion 
found in the finger domain, have identified its important role in telomerase repeat 
addition processivity and telomere maintenance (Lue et al, 2003). According to the 
structural data, this domain, instead of direct contact with the DNA or RNA appears 
to be crucial for protein arrangement (Gillis et al, 2008; Mitchell et al, 2010). Motif 3, 
another telomerase-specific motif named due to its location following motif 2, is 
directly involved in repeat addition processivity (Xie et al, 2010). Specific residues 
within this motif have been shown to influence repeat addition rate independent of 
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altering repeat addition processivity of telomeric repeat synthesis. Motif 3 contains a 
helix-coil-helix structure close to the RNA/DNA duplex bound to the active site 
(Gillis et al, 2008; Mitchell et al, 2010). 
The C-terminus of the TERT protein, called the C-terminal extension (CTE), 
contains little sequence homology to conventional RTs. The overall structure and 
function of CTE, however, is similar to the ‘thumb’ domain of retroviral RTs, such as 
HIV1 RT (Gillis et al, 2008; Mitchell et al, 2010; Nakamura et al, 1997). Structurally, 
it is close to the ring structure based on the Tribolium castaneum TERT, and it has 
been proposed that the CTE might interact with TR, when bound to the TRBD (Bley 
et al, 2011). Functionally, the CTE has been reported to have influence on telomeric 
DNA binding, telomerase activity and processivity (Hossain et al, 2002).  
1.3 Telomerase RNA 
In contrast to conventional RTs, telomerase contains an integral RNA 
component indispensable for enzymatic activity. Unlike the TERT protein, which is 
conserved, the TR is significantly divergent among different species. Despite the 
variation, there are two universally conserved motifs of TR: the template pseudoknot 
domain and distal stem-loop moiety or three-way junction (Blackburn & Collins, 
2010; Brown et al, 2007; Chen & Greider, 2004; Chen et al, 2002; Chen et al, 2000; 
Lin et al, 2004). (Figure 1.4) These two TR elements are necessary for reconstituting 
telomerase activity in vitro when added in trans with the TERT (Mitchell & Collins, 
2000; Tesmer et al, 1999). 
The hTR pseudoknot domain contains a triple helix structure consist with 
Hoogsteen base-pairings to a Watson-Crick base-paired helix in human (Theimer et 
al, 2005). Several other species have also been shown or predicted to have a similar 
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triple helix pseudoknot in their respective TRs (Qiao & Cech, 2008; Shefer et al, 
2007). Biochemical and structural studies have shown that the pseudoknot with a 
conserved triple helix is essential for proper telomerase activity (Chen & Greider, 
2005; Ly et al, 2003; Qiao & Cech, 2008; Shefer et al, 2007; Theimer et al, 2005). 
However, the exact function of the structure remains unclear. The pseudoknot is 
distant from the template sequence in the primary sequence, but they are close to each 
other in the secondary structure. Therefore, the pseudoknot has been postulated to 
function in template positioning or retention near the active site. NMR structures have 
revealed that there is a sharp kink between the triple helix and the template, which 
could be responsible for the positioning of the template (Zhang et al, 2011; Zhang et 
al, 2010). In the template region of the TR, the 5' end is used as the template for 
synthesis of telomeric DNA repeats and a non-templating region at the 3' end is a 
realignment region for annealing of the extended DNA at beginning of each repeat 
synthesis. Mutations in the TR template demonstrate that the sequence plays a key 
role in regulating telomerase activity and telomere length. Meanwhile, it contains a 
unique pausing signal for self-regulation of human telomerase (Brown et al, 2014; 
Drosopoulos et al, 2005. The upstream region of the TR template is known as the 
Template boundary element (TBE) and it defines the 5’ boundary of the template. The 
TBE consists of the P1b helix and the single stranded RNA between the 5' end of the 
template in vertebrates (Chen & Greider, 2003). (Figure 1.4) Structurally, TBE bound 
to TRBD establishes the template boundary. Being localized at the correct distance 
from the active site, TBE prohibit copying of non-template nucleotides in 
Tetrahymena. (Jansson et al, 2015) Mutations that alter the length or disrupt P1b have 
been shown to affect the telomere repeat sequence (Chen & Greider, 2003; Theimer & 
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Feigon, 2006). The upstream region of the template/pseudoknot domain in hTR exists 
a guanosine-rich region, which may form a G-quadruplex structure. The G-
quadruplex structure in association with the HEXH box RNA helicase RHAU has 
been reported to increase TR accumulation within cells (Lattmann et al, 2011; Sexton 
& Collins, 2011). 
Another conserved region of telomerase RNA crucial for proper enzymatic 
activity is a stem-loop moiety located downstream of the pseudoknot region. This 
element has been termed as conserved region 4/5 (CR4/5) in vertebrates, three-way-
junction (TWJ) in yeasts as well as helix IV in ciliates (Blackburn & Collins, 2010; 
Brown et al, 2007; Chen et al, 2000; Chen et al, 2002; Qi et al, 2013). In vertebrates, 
the CR4/5 domain contains a three-way junction three conserved stems P5, P6, and 
P6.1 (Blackburn & Collins, 2010; Brown et al, 2007; Chen et al, 2002; Chen et al, 
2000). (Figure 1.4) This structure is indispensable for telomerase activity both in vivo 
and in vitro in major eukaryotic clades. Disruptions or mutations of two conserved 
residues in P6.1 can abolish telomerase activity (Bley et al, 2011; Chen et al, 2002). 
Cross-linking studies mapped the CR4/5 binding site onto TRBD and the binding 
surface was elucidated by an RNA-protein co-crystal structure (Bley et al, 2011; 
Huang et al, 2014). In yeast, a three-way junction structure similar to the CR4/5 
domain of vertebrates has also been shown to be necessary for telomerase activity 
(Brown et al, 2007; Zappulla et al, 2005). Moreover, in the fission yeast 
Schizosaccharomyces pombe and filamentous fungi Neurospora crassa, a structure 
that is similar to CR4/5 in fungal termed P6/6.1 has been reported. The P6/6.1 of the 
filamentous fungal TR, like CR4/5 in vertebrate, is necessary for telomerase activity 
(Qi et al, 2013).  Ciliate TRs has a conserved Helix IV instead of a three-way junction 
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structure, which is functionally analogous to helix P6.1 of the vertebrate CR4/5. Helix 
IV interacts with TERT and is required for telomerase function (Blackburn & Collins, 
2010).   
Other than the conserved pseudoknot domain and stem-loop moiety, the hTR 
contains another major structurally conserved domain known as the H/ACA domain. 
This H/ACA domain contains two stem-loops separated by box H and ACA moieties 
(Jády et al, 2004; Mitchell et al, 1999). (Figure 1.4) This domain is homologous to 
small nucleolar (sno-) and small cajal body-specific (sca-) RNAs. Two copies of the 
dyskerin complex binds to the H/ACA domain of hTR (Egan & Collins, 2010). The 
dyskerin complex contains four proteins: dyskerin, NOP10, NHP2, and GAR1 and is 
essential for the proper RNA maturation and RNP biogenesis (Cheng & Roberts, 
2001; Girard et al, 1993; Hamma et al, 2005; Hockemeyer & Collins, 2015; Maiorano 
et al, 1999; Pogacić et al, 2000).   
A number of human telomerase-mediated diseases are due to TR mutations, 
such as Aplastic Anemia, Idiopathic Pulmonary Fibrosis and Dyskeratosis Congenita 
(Alder et al, 2008; Alder et al, 2011; Armanios et al, 2007; Dokal, 2003; Du et al, 
2009; Fogarty et al, 2003; Marrone et al, 2004; Tsakiri et al, 2007; Vulliamy, 2002; 
Vulliamy et al, 2006; Yamaguchi et al, 2003). These disorders occur due to the haplo-
insufficiency of a single functional TR allele, which leads to insufficient TR 
accumulation, reduced telomerase levels and telomere shortening (Armanios et al, 
2005). Disease mutations in template-pseudoknot, CR4/5, and H/ACA domains of 
hTR can disrupt RNA base-pairing, RNA secondary structure that is essential for 
enzymatic activity or RNA processing and accumulation (Podlevsky et al, 2008).  
Telomerase activity reduction or impaired RNA accumulation levels have been 
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reported for some disease mutations (Alder et al, 2008; Alder et al, 2011; Armanios et 
al, 2007; Cristofari et al, 2007; Fu & Collins, 2003; Ly et al, 2005; Theimer et al, 
2003; Theimer et al, 2007).  
1.4 Telomerase Mechanism 
 Contrary to conventional RTs which use a long RNA template and bind pre-
annealed DNA/RNA duplex to synthesize DNA, telomerase uses single stranded 
DNA as its substrate and contains an internal short template in the TR to add multiple 
repeats of DNA sequence in a processive manner. Like many polymerases, telomerase 
catalyzes the addition of incoming nucleotides to the 3' hydroxyl group of substrate 
primer, forming a product–template duplex. The mechanism of polymerization is 
same as other RTs employing a metal-dependent chemistry of nucleotide addition 
(Steitz, 1999). Incoming nucleotides are bound by the binding pocket between the 
fingers and the palm domain of the TERT protein and three conserved aspartic acid 
residues in the palm domain of TERT coordinate two Mg2+ ions in the active site 
(Gillis et al, 2008). The DNA/RNA duplex is placed in the active site and interacts 
with many regions of TERT including motif T, motif 3, the fingers domain and the 
CTE (Gillis et al, 2008; Mitchell et al, 2010; Wu et al, 2017; Xie et al, 2010). Once 
polymerization begins, the DNA/RNA duplex will be moved through the cavity of 
TERT’s ring like structure to position the 3’ end of newly synthesized DNA into the 
active site. It has been shown the length of the extended DNA/RNA duplex is 
maintained at a length of five to seven base pairs by concomitantly unpairing base 
pairs at the 5’ end of the DNA for additional base pairs made at the 3’ end 
(Förstemann & Lingner, 2005; Qi et al, 2012).  Structurally, the central cavity of the 
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protein is only sufficient to harbor a duplex of seven to eight base pairs in T. 
castaneum (Gillis et al, 2008).  
 A highly unique property of telomerase compared to other polymerases is 
"repeat addition", which is the repetitive synthesis of a long telomeric DNA without 
complete dissociation of the telomerase enzyme by using the short template in TR 
(Greider, 1991). While the exact process remains unclear, several working models for 
telomerase catalytic cycle have been proposed. A repeat addition cycle may contain 
several major steps: nucleotide addition, duplex disassociation, strand unpairing, 
template realignment, and duplex binding.  
 Accurate template use requires DNA synthesis to stop at the 5' end of the 
template. Once telomerase reaches the 5' end of its boundary, the duplex should 
dissociate from the active site to regenerate the template. The 5' end of the template is 
determined by the spacing from an adjacent RNA–protein and/or an RNA–RNA 
interaction (Podlevsky & Chen, 2016). Interestingly, in human telomerase the pause 
signal embedded in the sequence of template–product duplex makes the dominant 
contribution to prevent template read through (Brown et al, 2014). Then telomerase 
dissociates from the extended substrate regenerating the internal template. To achieve 
this, the two strands of the duplex need to be separated, followed by realignment at 
the beginning of the template for a next round of repeat addition. Template unpairing 
and repositioning require significant conformational changes compared to nucleotide 
addition (Wu et al, 2017). To explain the thermodynamic driver of duplex melting, 
there are several models have been proposed. For instance, DNA/RNA duplex could 
release together and reposition outside the active site (Qi et al, 2012); the TR template 
flanking elements serve to position the template for nucleotide addition while the 
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DNA remain bound to the active site (Berman et al, 2011); or product DNA forms a 
hairpin structure while still bound to telomerase (Yang & Lee, 2015).  
 Biochemical data support that the active site of telomerase becomes accessible 
and unoccupied to a short external DNA/RNA duplex during repeat synthesis (Qi et 
al, 2012). This indicates full dissociation of the DNA/RNA duplex from the active site 
during template translocation. Using a comparison between the crystal structures of 
TERT in T. castaneum with and without a duplex bound to the active site, it could be 
predicted that the duplex melting in the active site would not be feasible. It requires a 
drastic conformation altering to disrupt not only the hydrogen bonds of the duplex, 
but also the protein-nucleic acid contacts which hold the duplex in the active site. It 
has been reported in several species that the sequence of the primer determines the 
binding affinity to the telomerase instead of base pairing between the DNA primer 
and RNA template (Finger & Bryan, 2008; Hammond & Cech, 1998; Wallweber et al, 
2003). This indicates that protein nucleic acid interactions play an essential role in 
stabilizing the DNA/RNA duplex. 
 Another working model proposes that during repeat synthesis progression, the 
template 5' loop could reel into the active site while the 3' end of the template could 
be extruded from it. A 3' loop formed by complete repeat synthesis could make an 
RNA–RNA or RNA–protein interaction (Wu et al, 2017). Protein remodeling is 
required to dissociate the product–template duplex, thus promoting template 
translocation and default positioning of template. The single-stranded DNA retention 
surface (SRS) retains some interactions between DNA and TERT protein that were 
formed during repeat synthesis. The DNA unpaired from the TR template remains 
bound to TERT at SRS (Wu et al, 2017). Single-stranded DNA could thread passively 
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across the TERT surface and bring the template’s 3' end closer to the 3' end of the 
DNA for base pairing. A single-molecule FRET study that monitors telomere DNA 
structure and dynamics during the telomerase catalytic cycle indicates that template 
translocation is a rapid process.  There could be a second slow conformational change 
repositioning the DNA/RNA hybrid into the telomerase active site that drives the 
extrusion of the 5' end of the DNA primer out from the enzyme complex (Parks & 
Stone, 2014). 
 During template translocation, the telomeric DNA remains bound to the TEN 
domain of TERT even while upon dissociation from the central cavity near the active 
site (Finger & Bryan, 2008; Jacobs et al, 2006; Wyatt et al, 2007; Zaug et al, 2008). 
This interaction tethers the telomeric DNA to the TERT protein to increase the 
translocation efficiency because the DNA must dissociate from the active site for 
repeat synthesis. Additionally, at the TEN domain anchor site two telomerase 
accessory proteins, POT1 and TPP1, have been shown to play a significant role in 
decreasing the probability of DNA dissociation by direct interactions with both the 
single stranded DNA and TERT protein (Latrick & Cech, 2010; Wang et al, 2007). 
While the DNA is still bound to the TERT, the 3’ end of the substrate can find the 
free RNA template and anneal to the template realignment region. Proper positioning 
of DNA and realignment region to prevent reannealing to the 5' end of templating 
region is driven by steric forces of the TR scaffold, which stretch and compress in the 
template flanking regions (Berman et al, 2011).  Or duplex formation could be a cause 
or consequence of reversing the structural change that released the template 5' end 
from the active site (Wu et al, 2017). The length of complementary sequence in the 
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realignment region could be responsible for the efficiency for longer sequences 
producing more processive enzymes (Chen & Greider, 2003).   
 After forming the DNA/RNA duplex, it is then free to bind to the active site 
for next round of repeat addition. The newly formed duplex is very short because of 
the length of the alignment region (five nucleotides in humans), it could be unstable at 
37°C. To stabilize the binding of the duplex, the protein-nucleic acid interaction 
would be crucial for efficient template translocation. It has been proven both duplex 
substrates and short eight nucleotide primers, which lack upstream nucleic acid to 
from additional protein interactions to hold TERT during translocation, showed an 
obvious correlation between the binding affinity of the substrates and the repeat 
addition processivity of various TERT mutants (Qi et al, 2012; Xie et al, 2010). This 
indicates that the duplex binding affinity of TERT is important for repeat addition 
processivity. Repeat addition processivity can be stimulated by higher concentration 
of dGTP by enhancing the rate of addition as in human or the translocation efficiency 
for telomerase from Chinese hamster ovary (CHO) (Maine et al, 1999; Sun et al, 
1999). It has also been shown this dGTP dependent processivity could be due to a 
secondary allosetric binding site for the deoxyguanosine moiety in T. thermophila 
(Hardy et al, 2001).  
1.5 Project 
 The telomerase reaction is a highly orchestrated but poorly understood 
catalytic cycle to regenerate the short RNA template for synthesis of multiple 
telomeric DNA repeats. There are many independent subunits of telomerase that must 
coorperate to perform its function completely. Even though it has been studied for 
many years, there are many unanswered questions and numerous phenomena that 
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have not been explained. This study aims to identify and explore the mechanism of 
intrinsic and extrinsic factors that affect the telomerase catalytic function, including 
hTR template sequence, specific motif of hTERT, nucleotide concentration as well as 
telomerase inhibitor. 
In chapter 2, characteristics of the template embedded pausing signal are 
identified in human telomerase. After investigating the pausing signal, we explored 
telomerase activity with a series of distinct lengths of DNA/RNA duplex in the 
template free telomerase system. The 5’ DNA overhang can alleviate the pausing 
signal but not the 3’ RNA overhang. No effect on pausing signal by the RNA 5’ end 
flanking sequence indicates its existence is before and after template translocation. 
Further, the competition assay with circular permutated duplexes showed sequence 
dependent pausing is attributed to catalytic deficiency. 
In chapter 3, the mechanism of dGTP dependent stimulation of telomerase 
activity is explored. Employing template free system, the apparent KM of nucleotide 
addition for each position on the hTR template is measured. The KM of the first 
nucleotide after pausing signal is significantly higher, and it requires higher 
concentrations of the respective nucleotide for incorporation. To address why dGTP 
stimulates accumulation of longer DNA products, we applied bound-release and 
pulse-chase assays to quantify the repeat addition processivity and repeat addition rate 
of telomerase. We observed that higher concentration of dGTP cause the increase 
both repeat addition processivity and rate which can be explained that it is the first 
nucleotide added after translocation. Furthermore, the dGTP failed to stimulate the 
repeat addition processivity after disrupting the pausing signal. Additionally, we also 
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explored the usage of deoxynucleoside diphosphates for telomerase as well as other 
RTs and DNA polymerases. 
In chapter 4, the postulated mechanism of how the disease-causing K570 
residue mutation in TERT affects telomerase activity will be described. To determine 
its defects in processivity, alanine screening was done to determine the role of K570 
residue in telomerase processivity. Moreover, we explore the essentiality of charge 
and position of this residue by additional mutagenesis experiments. Next, the apparent 
KM value for K570A mutant is determined to test the deficiency of nucleotide 
incorporation. Additionally, the mutant shows binding defects with its DNA substrate 
as well as DNA/RNA duplex in template free system. 
In chapter 5, the mechanism of telomerase inhibitor BIBR 1532 is 
investigated. We tested the inhibition of human telomerase activity with titration of 
BIBR 1532, following exploration of its function in TERT expression, RNP 
reconstitution and enzymatic reaction. Without influencing TERT expression or RNP 
reconstitution, BIBR 1532 shows no effect in nucleotide addition or on the apparent 
KM value. Taken together, all above studies provided a novel understanding of human 
telomerase function and further refining the working model of the telomerase catalytic 
cycle.  
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Figure 1.1.  The end-replication problem is the critical loss of chromosomal ends 
with each replication cycle.  Conventional DNA polymerases are unable to fully 
replicate the ends of linear chromosomes leading to shorter DNA products (light blue) 
than the parental DNA strands (dark blue).  The end-most lagging strand RNA primer 
(green) cannot be replaced with DNA resulting in a slightly shorter DNA strand (light 
blue).  Leading strand synthesis generates a blunt-end, which is then processed by the 
exonucleases Apollo and Exo1 to generate a far shorter DNA product (dark blue). 
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Figure 1.2. The telomerase catalytic cycle. Telomerase acts as a conventional 
reverse transcriptase by extending single-stranded telomeric DNA primer (blue) or 
onto the ends of telomeric DNA utilizing an intrinsic RNA template (green). Different 
from conventional polymerases, after reaching the end of the template, telomerase can 
regenerate the template by template translocation for an additional round of 
nucleotide addition. This leads to the generation of longer telomeric DNA products. 
After each round of DNA synthesis, unsuccessful template translocation can terminate 
additional repeat addition leading to product release. 
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Figure 1.3.  Structure of the catalytic TERT protein subunit.  (A) TERT consists 
of four structural domains: telomerase essential N-terminal (TEN, yellow) domain, 
telomerase RNA-binding domain (TRBD, blue), reverse transcriptase (RT, red), and 
the C-terminal extension (CTE, orange).  The TEN and TRBD are telomerase-
specific, essential for template translocation. Important motifs within each domain are 
colored similarly. (B) The Tribolium castaneum TERT crystal structure demonstrates 
that TRBD, RT, and CTE domains form a ring like structure, unseen in other 
polymerases. TRBD contains the crucial TR binding site (dashed line) within TERT. 
The TERT active site (purple), motif 3 (dark red) and motif IFD (red-orange) in the 
RT domain are denoted. 
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Figure 1.4.  Secondary structure of vertebrate TR. Two major structural elements 
are common to all known TRs: a template proximal pseudoknot (red) and template-
distal three-helical junction CR4/5 in vertebrates (orange). Additionally, there is a 
template boundary element (TBE, blue) which defines the boundary of the TR 
template. Vertebrate TRs contain a CR4/5 domain (red) essential for activity and a 
distal H/ACA domain with a CAB box (green) for TR biogenesis and localization. 
Vertebrate TRs contain a CR4/5 domain (orange) composed of P6 and P6.1. The 3’-
proximal H/ACA domain with a CAB box in the apical loop (green) is crucial for TR 
biogenesis and telomerase localization.  
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Figure 1.5. A working model for the telomerase catalytic cycle. Schematic of 
human telomerase bound to a telomeric DNA primer (blue). The TR alignment region 
(green) is base-paired with the 3’-end of the telomeric DNA primer (blue) to form 5 
base pairs adjacent to the active site (purple arrow). TERT (gray) catalyzes the 
addition of six deoxyribonucleotides to the 3’ end of the DNA primer by reverse 
transcribing the TR template sequence. After nucleotide addition, a new repeat is 
generated which retains only 5-6 base pairs. After reaching the end of the template, 
the nucleotide addition is arrested by the pausing signal (red) along with the 
restriction imposed by the physical boundary. The duplex dissociates from the active 
site. Outside the active site, the DNA/RNA duplex undergoes template translocation 
(yellow box) involving strand separation and template realignment to reform 5 base 
pairs. Further nucleotide addition can proceed with the regenerated template. 
Unsuccessful realignment of the DNA primer to the RNA template eventually results 
in complete dissociation of the DNA product from the enzyme. Strand separation and 
template realignment are postulated as reversible, with multiple binding/separation 
steps possible. 
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CHAPTER 2 
IDENTIFICATION OF THE PROPERTIES OF TEMPLATE-EMBEDDED PAUSE 
SIGNAL 
Reproductions with permission in part from: 
Brown, A. F., Qi, X., Podlevsky, J. D., Chen, Y., Mingyi, X., & Chen, J. J.-L. (2014). 
A Self-Regulating Template in Human Telomerase. Proc. Natl Acad. Sci. USA, 111, 
11311-11316.  
2.1 Abstract 
Telomerase is a special reverse transcriptase (RT) containing an intrinsic 
telomerase RNA (TR) component. It synthesizes single strand telomeric DNA repeats 
reiteratively by copying a precisely defined, short template sequence from the integral 
TR. The mechanism of how the telomerase accurately and efficiently uses this short 
template region during processive DNA repeat synthesis is unclear. The human TR 
template, in addition to specifying the DNA repeat sequence, is embedded with a 
single-nucleotide signal enabling the pause of DNA repeat synthesis. This pause site 
coincides precisely with the physical template boundary, and it precludes the 
incorporation of non-telomeric nucleotides from the hTR template flanking region. To 
characterize the sequence-defined pausing mechanism, we employed template-free 
telomerase system and found the pausing signal following template translocation also 
has a similar influence on the incoming nucleotide incorporation. Additionally, the 
pausing signal is attributed to the inefficient catalysis for the duplex instead of 
binding affinity defect. The processive addition of DNA repeats by native telomerase 
could be explained by the comprehensive interaction of the telomerase core enzyme 
with telomeric DNA substrate. The 5’ end overhang of DNA, designed to imitate the 
24 
 
intermediate products of a native telomerase reaction, is able to alleviate the pausing 
signal. In this study, the identified properties of pausing signal provide essential clues 
to understand the accurate synthesis of the GGTTAG repeats as well as the 
catalytically regulatory function of telomerase. 
2.2 Introduction 
The ends of human chromosomes are composed of precise repetitions of a 6-
nucleotide sequence synthesized by the specialized reverse transcriptase (RT) --- 
telomerase (Meyne et al, 1989; Moyzis et al, 1988). The telomerase core enzyme is 
composed of the catalytic telomerase reverse transcriptase (TERT) and the integral 
telomerase RNA (TR). Human TR (hTR) is a 451-nt RNA containing a very short 11-
nt template which encodes for the telomeric DNA repeat “GGTTAG”. The shelterin 
complex is bound to the highly repetitive tract of DNA a sequence-specific manner to 
protect natural chromosome termini from end-to-end fusions and other DNA damage 
responses (Palm & de Lange, 2008; Sfeir & de Lange, 2012). High fidelity synthesis 
of telomeric DNA repeats by telomerase is critical for maintaining telomere function 
and chromosome stability. The TR template itself is highly conserved, even though 
TR sequences are highly divergent across species (Chen et al, 2000; Xie et al, 2008). 
In vertebrates, the template sequence is conserved as a specific register with the 5’ 
boundary defined physically by a long-ranged based-paired region known as helix P1 
(Chen & Greider, 2003). It has been proven the importance of the specific TR 
template sequence for the telomerase enzymatic function, whereby alterations in the 
template or realignment sequence affect the rate and processivity of telomeric DNA 
repeat synthesis (Drosopoulos et al, 2005; Förstemann et al, 2003; Gilley & 
Blackburn, 1996; Gilley et al, 1995; Qi et al, 2012). Additionally, telomerase has been 
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shown to exhibit differential activity toward telomeric DNA primers with permuted 
sequences (Maine et al, 1999; Wallweber et al, 2003). 
 During telomere repeat synthesis, telomerase catalyzes nucleotide 
incorporation to the DNA primer with the RNA template which forms a duplex in the 
active site (Qi et al, 2012). After each nucleotide addition, it would become a different 
RNA/DNA duplex sequence inside the binding pocket of the catalytic TERT subunit. 
Human telomerase lacking the template region from hTR (TF telomerase) has been 
tested with pre-annealed six permuted RNA/DNA duplexes as substrates for the 
activity (Figure 2.1). TF telomerase exhibited distinct extension patterns and diverse 
activities with each permuted duplex. Further studies demonstrated that the first rA:dT 
base pair formed in the duplex inducing a pausing signal in the telomeric DNA 
synthesis following the incorporation of three additional base pairs. A single-
nucleotide signal embedded in hTR to pause nucleotide addition at an exact position 
to safeguarding the 5’ boundary of the template region. In this study, I investigated 
the properties of the pausing signal in the role of telomerase DNA synthesis and 
catalytic cycle. By employing a telomerase-free telomerase system and specific assay 
conditions the sequence-defined pausing signal is essential for not only the accurate 
synthesis the GGTTAG repeats but also regulating the catalytic function of 
telomerase. 
2.3 Material and Methods 
Oligonucleotides and RNA/DNA hybrid substrates  
All DNA and RNA oligonucleotides were purchased from Integrated DNA 
Technologies (IDT). The specific sequences of oligonucleotides used in each 
experiment are shown in the text or figures. The RNA/DNA duplexes were prepared 
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by adding the RNA and DNA oligos at a final concentration of 200 μM in 1x 
annealing buffer (100mM Tris–HCl pH 7.5, 500mM NaCl and 50mM EDTA). 
Duplex formation was facilitated by incubation at 65°C for 5 min, followed by slowly 
cooling to room temperature.  
Reconstitution of telomerase  
Reconstitution of human telomerase in vitro was carried out in RRL as previously 
described (Xie et al, 2010). Briefly, hTERT was expressed from pN-FLAG-hTERT 
using the TnT® T7 Quick coupled transcription/translation kit (Promega) according 
to the manufacturer’s instruction. The hTR fragments, TF-PK (nt 64–184) and CR4/5 
(nt 239–328), were transcribed in vitro, gel purified and added at a final concentration 
of 1 μM to assemble with hTERT in RRL. For quantification, hTERT was 
synthesized in the presence of 35S-Methionine (>1000 Ci/mmol, 10.2 mCi/ml, Perkin-
Elmer) and analyzed by SDS–PAGE.  
Telomerase activity assay  
For analyzing TF telomerase, 1 μl in vitro reconstituted TF telomerase was 
assayed in a 10 μl reaction containing 1x duplex reaction buffer (50 mM Tris- HCl, 
pH8.0, 50 mM KCl, 3 mM MgCl2, 2 mM DTT and 1 mM spermidine), 40 μM pre-
annealed RNA/DNA duplex, specified dNTPs and 0.165 μM of the denoted α-32P-
dNTP. The reaction was incubated at 20°C for 60 min followed by 55 °C for 5 min 
with the addition of 10 μg of RNase A and terminated by phenol/chloroform 
extraction, followed by ethanol precipitation. The DNA products were resolved on a 
15% polyacrylamide/8 M urea denaturing gel, dried, exposed to a phosphorstorage 
screen and imaged on a Bio-Rad FX-Pro phosphorimager. The AMV RT duplex assay 
was identical to the TF telomerase duplex assays with the exception of substituting TF 
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telomerase with 0.5 unit of AMV RT enzyme (Promega) and the products were 
analyzed directly by denaturing polyacrylamide gel electrophoresis. The size markers 
for the template free duplex assay were prepared in a 10 μl reaction containing 1x 
reaction buffer (100 mM sodium cacodylate, pH 6.8, 1 mM CoCl2 and 0.1 mM DTT), 
10 μM oligonucleotide as indicated, 10 units of terminal deoxynucleotidyl transferase 
(TdT, Affymetrix) and 0.165 μM α-32P-dGTP (3000 Ci/mmol, 10 mCi/ml, Perkin-
Elmer). The reaction was incubated at 30°C for 5 seconds and terminated by the 
addition of 10 μl 2x formamide loading buffer (10 mM Tris-HCl, pH 8.0, 80% 
formamide, 2 mM EDTA, 0.08% bromophenol blue and 0.08% xylene cyanol).  
Duplex Competitive Inhibition Assay.  
 One microliter of in vitro reconstituted template-free telomerase was assayed 
in a 10 μL reaction containing 1x duplex reaction buffer, 40 μM non-telomeric duplex 
as substrate, 5 μM or 20 μM nonreactive telomeric duplex as competitor, 2 μM dGTP, 
and 0.165 μM [α-32P]dGTP (3,000 Ci/mmol, 10 mCi/mL; Perkin-Elmer). The reaction 
was incubated at 20 °C for 60 min followed by 55 °C for 5 min with the addition of 
10 μg of RNase A and terminated by phenol/chloroform extraction followed by 
ethanol precipitation. The DNA products were resolved on a 15% (wt/vol) 
polyacrylamide/8 M urea denaturing gel, dried, exposed to a phosphorstorage screen, 
and imaged on an FX-Pro phosphorimager (Bio-Rad). 
2.4 Results 
The pause site was retained before or following template translocation.  
 When the DNA substrate extended to the end of the template, the pausing 
signal together with TBE prevents the usage of the flanking region of the template. 
According to the telomerase working model, template translocation is required for 
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regenerating the short hTR template. After template translocation, the telomeric DNA 
substrate and hTR alignment region will form the duplex with the same sequence. To 
explore the sequence-dependent pausing signal after translocation, I tested the 
function of the 5’ end of RNA template flanking sequence. I employed two RNA 
sequences, UGUU and CCAA with an overhang at 5’ end, which represents the hTR 
template 5’ regions flanking the RNA/DNA duplex prior to or following template 
translocation (Figure 2.2). Regardless of the flanking sequence, both duplexes stopped 
after incorporation of three nucleotides on a template dependent manner which is 
under the control of the pausing signal. It indicates the pause site was retained with 
each of these two duplexes and independent from 5’ end of the RNA template. 
A DNA overhang alleviates nucleotide addition pausing.  
 In the native telomerase, interactions between the DNA primer, TR template, 
and TERT anchor sites collectively contribute to nucleotide addition processivity 
(Berman et al, 2011; Qi et al, 2012). Therefore, the D4 and D6 duplexes appended 
with either DNA or RNA overhangs to imitate the intermediate products of a native 
telomerase reaction were tested for nucleotide addition activity. (Figure 2.3). While 
D4 containing an effective pausing signal represents a post-pause signal extended 
duplex, D6, without pausing site, is the negative control. The results demonstrate it is 
the DNA 5’ overhang instead of RNA 3’ overhang allowing partial bypass of the 
sequence-defined pause site for the D4 duplex (Figure 2.3). The P6 duplex, lacking 
the pause signal, also exhibited a higher nucleotide addition processivity in 
comparison to the DNA 5’ overhang (Figure 2.3). In the presence of [α-32P] dGTP, 
the DNA primers from all duplex substrates were extended to the end of each RNA 
template regardless of the duplex sequence in avian myeloblastosis virus (AMV) RT.  
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 Additionally, various lengths of DNA overhangs or base-pair region of D4 
substrates have been assayed. It displayed a similar partial bypass of the pause signal 
with a different length of DNA 5’ overhang, and longer DNA 5’ end overhang 
slightly increases nucleotide addition. And the shorter DNA/RNA duplex, 6 or 7 bp 
duplex, showed relative higher activity which consistent with the previous results that 
the proximal anchor site is could actively maintain a constant 5-6 bp DNA/RNA 
hybrid by breaking a single base pair in the duplex when a new base pair is formed 
(Qi et al, 2012). But the length of the duplex did not affect pause signal (Figure 2.4) 
The protein-DNA interactions between TERT anchor sites and the DNA 5’ overhang 
presumably facilitated duplex translocation and thus increased nucleotide addition 
processivity. TERT binding with the DNA primer, and not the RNA strand, appears to 
promote nucleotide addition processivity and lessen the sequence-defined pausing.  
P5 inactivity results from catalysis deficiency.  
 In addition to the distinct extension patterns, the six permuted RNA/DNA 
duplexes also exhibited markedly different activities with TF-telomerase (Figure 
2.5A). Among the six duplexes, D5 displayed little activity even in the presence of a 
DNA 5’ overhang. This is consistent with a previous report that Chinese hamster 
telomerase failed to react with a DNA primer ending in the exact register as D5, 
GGTTAG (Maine et al, 1999). The inactivity of the D5 duplex with TF telomerase 
presumably results from the inability of telomerase to either bind the D5 duplex or 
catalyze nucleotide addition onto this substrate. To discern the relative binding 
affinity of D5 to the telomerase active site, we performed a competitive inhibition 
assay with the six permuted telomeric duplexes as inhibitors competition against a 
non-telomeric duplex substrate for binding to the telomerase active site (Figure 2.5B). 
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The RNA template for these telomeric duplex inhibitors was blocked with an rG 
residue, preventing incorporation of dGTP and therefore could not be extended when 
bound to the telomerase active site. Thus, the inhibition of telomerase activity with 
the non-telomeric substrate correlates with a telomerase binding affinity for the 
duplex inhibitors. At 5 or 20 μM, the D4, D5 and D6 duplex inhibitors had similar 
levels of inhibition with the non-telomeric substrate, indicating comparable binding 
affinities to the active site (Figure 2.5B). Thus, P5 inactivity would appear to result 
from inefficient catalysis, such as improper positioning of DNA 3’-OH within the 
catalytic site. 
2.5 Discussion 
 Telomeric DNA repeats were synthesized by telomerase iteratively copying 
the intended template sequence from an integral RNA component. The template 
region from the larger TR must be precisely defined to prevent incorporation 
nucleotides from the template flanking region. The sequence-defined pausing 
mechanism identified in human telomerase provides new insights into the template 
boundary definition mechanism for vertebrate telomerase. In our current working 
model of the telomerase catalytic cycle, the single-residue sequence-defined pause 
signal functions together with the structure defined template boundary. Following the 
processive addition of six nucleotides to the DNA primer, the first rA:dT base pair in 
the duplex signals a pause in DNA synthesis at the end of the template region. This 
pausing permits DNA/RNA duplex dissociation from the active site.  
In a processive telomerase reaction, DNA/RNA duplexes formed immediately 
prior to and following template translocation have the sequence register GGTTAG, 
which is identical to the D5 duplex. In the context of TF telomerase, the D5 duplex is 
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inactive, despite the presence of a DNA 5’ overhang (Figure 2.5A).  The sequence of 
the single stranded RNA region flanking the duplex fails to alter sequence-defined 
pausing with TF telomerase (Figure 2.2). It indicates after template translocation the 
pausing signal still has an influential effect on the incoming nucleotide incorporation. 
We proposed that the incorporation of the first nucleotide after template translocation 
onto the D5 duplex is the rate limiting step for processive telomeric DNA repeat 
synthesis which is under the control of the pausing signal. This is also supported by 
the recently published single molecular FRET data that showed the realignment of 
DNA/RNA duplex is fast process, while the conformational rearrangement for next 
round nucleotide addition is slower during template translocation (Parks & Stone, 
2014).  
In the processive human telomerase reaction, DNA/RNA duplexes formed 
immediately before or following template translocation have the sequence register 
GGTTAG, identical to the D5 duplex. However, the processive addition of DNA 
repeats by native telomerase requires extension of the D5 duplex formed post-
template translocation. When comparing TF and template-containing telomerase, the 
principal difference is the tethering of the RNA template to the core enzyme. In the 
native telomerase, the DNA primer could interact with TR template as well as TERT 
anchor sites corporately for nucleotide addition processivity (Berman et al, 2011; Qi 
et al, 2012). The 5’ end overhang of DNA, which imitate the intermediate products of 
a native telomerase reaction, can alleviate the pausing signal. It demonstrates the 
processive addition of DNA repeats by native telomerase, the D5 duplex formed after 
template translocation as well as the native telomerase is active for all six template 
circular permutations of primers. Meanwhile, the inefficient nucleotide addition onto 
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the D5 duplex post-template translocation is responsible for the low repeat addition 
rate and processivity of human telomerase core enzyme. In the context of native 
telomerase, the detail mechanism of extending the D5 duplex following template 
translocation remains unknown. 
These findings are supportive of the conservation of the vertebrate TR 
template for synthesizing the specific GGTTAG sequence register and the acutely 
deleterious effects of template mutations that impair the sequence-defined pausing 
mechanism (Chen et al, 2000; Drosopoulos et al, 2005; Stohr et al, 2010). The fidelity 
of telomeric repeat synthesis by telomerase is crucial for telomere function and 
genome stability in the germ line, stem cells and cancer cell. The sequence-defined 
pausing is a novel attribute of human telomerase to self-define the template region 
from adjacent sequences. This study sheds light on the mechanism of the repetitive 
synthesis of telomeric DNA substrate, and therefore informative for exploring the 
check point of the telomerase template translocation. 
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Figure 2.1. A single nucleotide in the RNA/DNA duplex signals a pause in 
nucleotide addition with template-free telomerase. (A) In vitro assembly of 
template-free (TF), telomerase was reconstituted by assembling in vitro expressed 
human TERT protein with the two essential hTR fragments, CR4/5 and the 
pseudoknot (PK) that had the template region excised. The pre-annealed DNA primer 
and RNA template are the substrates used for the TF telomerase activity assay. (B 
left) Sequences of circular permuted telomeric RNA/DNA duplexes D1-D6. (B right) 
Summarize the results of an activity assay of in vitro reconstituted TF telomerase with 
D1-D6 duplex. 
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Figure 2.2. Sequence-defined pausing is retained for duplexes with different 
RNA 5′ flanking sequences. (A) Schematic comparing duplexes of TR template and 
DNA primer before and post-template translocation. (B) The sequences of the duplex 
D2 substrates, D2-CCAg and D2-UGUU, are shown (top). The sequence-defined 
pause site is denoted (white triangles). Activity assay of the D2 duplexes with in vitro 
reconstituted TF telomerase is shown (bottom). Substrates were extended by the 
enzyme with [α-32P]dTTP in the presence (+) or absence (−) of 0.5mM dATP, dGTP, 
or dCTP as denoted above the gel. A 32P end-labeled 7-mer oligonucleotide was 
included as a recovery control (r.c.).  
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Figure 2.3. Functional assays of DNA/RNA duplex variants for sequence-defined 
pausing and binding affinity to TF telomerase. Activity assay of duplex substrates 
with various overhangs. Sequences of duplexes P4 and P6 appended either a 3’ RNA 
or 5’ DNA overhang. The sequence-defined pausing site is denoted (white triangles). 
Activity assay of duplex substrates with various overhangs (left). In vitro reconstituted 
TF telomerase (right upper panel) or AMV RT (right lower panel) was assayed with 
RNA/DNA duplexes and α -32P-dGTP in the presence (+) or absence (-) of 0.5 mM 
dATP as denoted above the gel. A 32P end-labeled 7-mer oligonucleotide is used as a 
recovery control (r.c.). The DNA primer TAGGGTTA extended by one α -32P-dGTP 
with TdT was included as a size marker (M). 
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Figure 2.4. Effect of DNA 5’ overhang length on nucleotide addition processivity 
and the sequence-defined pause site. (A and B, Upper) Sequences of duplexes with 
variable DNA 5’ overhang length and variable duplex length. (A and B, Lower) 
Activity assay of in vitro reconstituted TF telomerase with various duplex substrates. 
Substrates were extended by the enzyme with [α-32P]dGTP in the presence (+) or 
absence (−) of 0.5 mM dATP as denoted above the gel. A 32P end- labeled 7-mer 
oligonucleotide was included as a recovery control (r.c.). 
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Figure 2.5. TF telomerase is inactive with the P5 duplex that contains a DNA 5’ 
overhang. (A) Activity assay of in vitro reconstituted TF telomerase (top panel) and 
AMV RT (bottom panel) with duplex substrate variants (D1-D6) appended with DNA 
5’ overhangs. Substrates were extended by the enzyme with α-32P-dGTP. A 32P end-
labeled 7-mer oligonucleotide was used as a recovery control (r.c.). (B) Competitive 
inhibition assay of telomeric duplex competitors against a non-telomeric duplex 
substrate. In vitro reconstituted TF telomerase (upper panels) and AMV RT (lower 
panels) were assayed with 40 μM non-telomeric substrate and 5 or 20 μM telomeric 
competitors (D1-D6 with a 5’ DNA overhang) with α-32PdGTP. The substrate is 
extended by two nucleotides with the addition of 0.2 mM dTTP (+TTP). A 32P end-
labeled 7-mer oligonucleotide was used as a recovery control (r.c.). Quantitation of 
the relative activity in the presence of competitor is displayed below the gel. 
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CHAPTER 3 
A SINGLE NUCLEOTIDE INCORPORATION STEP LIMITS HUMAN 
TELOMERASE REPEAT-ADDITION ACTIVITY 
Reproductions with permission in part from: 
Chen, Y., J.D. Podlevsky, D. Logeswaran and J.J.-L. Chen (2018).  
A single nucleotide incorporation step limits human telomerase repeat addition 
activity. EMBO J. 37:e97953, DOI 10.15252/emboj.201797953. 
3.1 Abstract 
 Human telomerase synthesizes telomeric DNA repeats (GGTTAG)n onto 
chromosome ends using a short template from its integral telomerase RNA (hTR). 
However, telomerase is markedly slow for processive DNA synthesis among DNA 
polymerases. We report here that the unique template-embedded pause-signal restricts 
the first nucleotide incorporation for each repeat synthesized, imparting a significantly 
greater KM. This slow nucleotide incorporation step drastically limits repeat addition 
processivity and rate under physiological conditions, which is alleviated with 
augmented concentrations of dGTP or dGDP, and not with dGMP nor other 
nucleotides. The activity stimulation by dGDP is due to nucleoside diphosphates 
functioning as substrates for telomerase. Converting the first nucleotide of the repeat 
synthesized from dG to dA through the telomerase template mutation, hTR-51U, 
correspondingly shifts telomerase repeat addition activity stimulation to dATP-
dependent. In accordance, telomerase without the pause-signal synthesizes DNA 
repeats with extremely high efficiency under low dGTP concentrations and lacks 
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dGTP stimulation. Thus, the first nucleotide incorporation step of the telomerase 
catalytic cycle is a potential target for therapeutic enhancement of telomerase activity. 
3.2 Introduction 
 The ends of linear eukaryotic chromosomes are capped by telomeres, an array 
of short DNA repeats bound by specific telomeric proteins (Arnoult & Karlseder, 
2015). Telomere length is crucial for chromosome integrity and maintained by the 
unique cellular reverse transcriptase, telomerase, that adds telomeric DNA repeats 
(GGTTAG)n processively onto chromosome ends (Wu et al, 2017). Human 
telomerase utilizes a short 11-nt template from the long non-coding 451-nt telomerase 
RNA (TR) for DNA repeat synthesis catalyzed by the telomerase reverse transcriptase 
(TERT) subunit (Hockemeyer & Collins, 2015; Podlevsky & Chen, 2012). The 5’ 
boundary of the TR template prevents non-template usage to ensure telomeric DNA 
synthesis fidelity and is physically safeguarded in different species by divergent 
structural elements: a distal RNA helix and single-stranded nucleotide span in 
vertebrates (Chen & Greider, 2003), TERT-binding TR elements in ciliates (Jansson 
et al, 2015; Jiang et al, 2015), or a template-adjacent RNA helix in fungi (Qi et al, 
2013; Seto et al, 2003; Tzfati et al, 2000). The human TR (hTR) template 5' boundary 
is further protected by the template-embedded pause signal, the first dT:rA base-pair 
in the DNA product/RNA template hybrid, that restricts DNA synthesis beyond the 5' 
boundary (Brown et al, 2014). Upon completing synthesis of a DNA repeat and 
reaching the 5' template boundary, telomerase regenerates the RNA template for 
subsequent repeat synthesis (Wu et al, 2017). There have been identified telomerase 
mutations which impair specifically repeat addition processivity and not catalytic 
activity, yet result in stem cell defects that manifest as a spectrum of short telomere 
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syndromes (Alder et al, 2011; Gramatges et al, 2013; Robart & Collins, 2010; Zaug et 
al, 2013). 
 Telomerase repeat addition processivity relies on a highly complex and unique 
catalytic reaction cycle that comprises two distinct phases: (i) synthesis of a single 
telomeric repeat with six consecutive nucleotide incorporation steps and (ii) 
regeneration of the template for additional telomeric repeat synthesis (Podlevsky & 
Chen, 2012). Telomerase catalyzes the nucleotide incorporation reaction with an 
active site that comprises a triad of invariant aspartic acids universally conserved in 
DNA polymerases (Lingner et al, 1997). The template regeneration phase is unique to 
telomerase and is accomplished by a ‘template translocation’ mechanism whereby the 
template dissociates from and then realigns with the newly extended DNA product 
(Autexier & Lue, 2006). Recent findings indicate that template translocation is a rapid 
process (Parks and Stone 2014), although the precise mechanism remains enigmatic. 
Telomerase-synthesized DNA products are predominantly released from the enzyme 
between two consecutive cycles of repeat synthesis, which generates the characteristic 
6-nt ladder banding pattern of the products (Greider, 1991). However, the specific 
steps that promote product release and limit processive repeat synthesis during 
telomerase catalytic cycle remain elusive. 
 Several intrinsic enzymatic determinants or reaction conditions that affect 
specifically repeat addition processivity have been identified. These reaction 
conditions include high dGTP concentration that stimulate telomerase repeat addition 
activity through an unknown mechanism (Hammond & Cech, 1997; Hardy et al, 
2001; Maine et al, 1999; Sun et al, 1999; Wu et al, 2017). Herein, we report that 
human telomerase exhibits lower kinetics specifically for the incorporation of the first 
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nucleotide, a dG residue, of each telomeric repeat synthesized. This lower 
incorporation kinetic is mediated by the template-embedded pause signal that arrests 
nucleotide synthesis at the end of the template and remains active following template 
translocation, therefore impairing processive repeat synthesis. Elevated dGTP 
concentrations increase the incorporation efficiency of the first nucleotide for each 
repeat synthesis and consequently stimulates both processivity and rate of telomerase 
repeat addition. These results reveal a critical step in the telomerase catalytic cycle 
that underlies the dGTP stimulation of human telomerase repeat addition. 
3.3 Materials and methods 
In vitro reconstitution of TF human telomerase.  
 Human TERT protein was expressed in rabbit reticulocyte lysate (RRL) from 
the pNFLAG-hTERT plasmid DNA using the TnT T7 Quick Coupled 
transcription/translation kit (Promega) following manufacturer's instructions (Xie et 
al, 2010). The hTR pseudoknot (residues 64–184) and CR4/5 (residues 239–328) 
fragments were in vitro transcribed, gel purified, and assembled together with the 
TERT protein in RRL for 30 min at 30°C at a final concentration of 1.0 μM (Brown et 
al, 2014; Qi et al, 2012). 
In vivo reconstitution of wild-type human telomerase.  
 HEK 293FT cells were grown in DMEM medium (Corning) supplemented 
with 10% FBS (Atlanta Biological), 1X Penicillin-Streptomycin-Amphotericin B mix 
(Lonza) and 5% CO2 at 37°C to 80–90% confluency. Cells in a 6-well plate were 
transfected with 0.4 μg of pcDNA-NFLAG-hTERT, 1.6 μg of pBS-U1-hTR wildtype 
or template mutants and 6 μL of Fugene HD transfection reagent (Promega) following 
manufacturer’s instruction. Cells were harvested 48 hours post transfection, 
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homogenized in HEPES lysis buffer (20 mM HEPES-KOH, pH 7.9, 400 mM NaCl, 
0.2 mM EGTA, 2 mM MgCl2, 10% glycerol, 5 mM -mercaptoethanol and 1X 
complete protease inhibitor cocktail (Roche), 1 mM PMSF), incubated on ice for 30 
min and the lysate clarified by centrifugation. Two hundred microliters of cell lysate 
were combined with 30 μL Anti-FLAG® M2 Beads (Sigma) pre-washed with 1X 
TBS buffer (50 mM Tris-HCl, pH 7.4 and 150 mM NaCl) and incubated at 4°C with 
gentle rotation for 1 hour. The beads were washed three times with 100 μL of 1X TBS 
buffer and once with 50 μL 1X telomerase reaction buffer (50 mM Tris-HCl, pH 7.5, 
3 mM MgCl2, 50 mM KCl, 2 mM DTT and 1 mM spermidine), followed by activity 
assay. 
KM measurement using TF telomerase.  
 One microliter of RRL reconstituted TF telomerase enzyme was assayed in a 
10 μL reaction containing 1X telomerase reaction buffer, 40 μM pre-annealed 
DNA/RNA duplex, specified dNTPs and 0.165 μM of the denoted α-32P-dNTP. For 
measuring the KM values, the activity assays were performed with nucleotide 
concentrations varying from 0 to 200 µM, or up to 1 mM for high KM measurement. 
Reactions were incubated at 30°C for 60 min and terminated by phenol/chloroform 
extraction, followed by ethanol precipitation. The DNA products were resolved on a 
15% (wt/vol) polyacrylamide/8 M urea denaturing gel, dried, exposed to a 
phosphorstorage screen and imaged on a Bio-Rad FX-Pro phosphorimager. The 
intensities of specific products were normalized to the total product intensity and 
plotted against the nucleotide concentrations with the Michaelis-Menten equation, 
Y=Vmax*X/(Km+X), used to fit the nonlinear curve to determine the KM (Prism 5, 
Graphpad Software). 
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Activity assay for dNDP and dNMP incorporation.  
 One microliter of RRL reconstituted telomerase enzyme, 1 unit of AMV RT 
(Promega), 0.5 units of Taq DNA pol III (NEB), 1 unit of T4 DNA pol (Fermentas), 
or 0.5 units of Klenow fragment of DNA pol I (Invitrogen) were assayed in 10 μL 
reactions containing 1X telomerase reaction buffer, 40 μM of denoted pre-annealed 
DNA/RNA or DNA/DNA hybrid substrates, 100 μM dGTP, dGDP, or dGMP, and 
0.165 μM α-32P-dATP. The assay with TGIRT III group II intron RT (InGex) 
contained 50 units of enzyme, 1X reaction buffer (20 mM Tris-HCl, pH 7.5, 5 mM 
MgCl2, 0.45 M NaCl, 5 mM DTT) and 10 μM dGTP, dGDP, or dGMP, and 0.165 μM 
α-32P-dATP. Reactions were incubated at 30°C for 60 min and terminated by 
phenol/chloroform extraction, followed by ethanol precipitation. The size marker was 
prepared in a 10 μL reaction containing 1X reaction buffer (100 mM sodium 
cacodylate, pH 6.8, 1 mM CoCl2, and 0.1 mM DTT), 10 μM oligonucleotide as 
indicated, 10 units of terminal deoxynucleotidyl transferase (TdT, Affymetrix), and 
0.165 μM α-32P-dATP (3,000 Ci/mmol, 10 mCi/mL; Perkin-Elmer). The reaction was 
incubated at 30°C for 5 seconds and terminated by addition of 10 μL 2× formamide 
loading buffer [10 mM Tris·HCl, pH 8.0, 80% (vol/vol) formamide, 2 mM EDTA, 
0.08% bromophenol blue, and 0.08% xylene cyanol]. The DNA products were 
resolved on a 15% (wt/vol) polyacrylamide/8 M urea denaturing gel, dried, exposed to 
a phosphorstorage screen and imaged on a Bio-Rad FX-Pro phosphorimager. 
Telomerase direct primer-extension assay.  
 Twenty microliters of immuno-purified in vivo reconstituted telomerase 
enzyme on beads was assayed in a 10 μL reaction containing 1X telomerase reaction 
buffer, 1 μM DNA primer, specified dNTPs and 0.165 μM of the denoted α-32P-
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dNTP. Reactions were incubated at 30°C for 60 min and terminated by 
phenol/chloroform extraction, followed by ethanol precipitation. The DNA products 
were resolved on a 10% (wt/vol) polyacrylamide/8 M urea denaturing gel, dried, 
exposed to a phosphorstorage screen and imaged on a Bio-Rad FX-Pro 
phosphorimager. Repeat addition efficiency was estimated as the ratio of the high 
M.W. DNA products (>6 repeats added) over the low M.W. DNA products (1-6 
repeats added). The cutoff at 6 repeats was arbitrarily chosen to divide the gel into 
approximately two even sections. The relative High/Low ratios of reactions with 
varying nucleotide concentrations were determined through normalization to the ratio 
from the low nucleotide concentration reaction. 
Telomerase product release assay for repeat addition processivity determination. 
 Twenty microliters of immuno-purified in vivo reconstituted telomerase 
enzyme on beads was assayed in a 10 μL reaction containing 1X telomerase reaction 
buffer, 1 μM DNA primer, a range of dNTPs and 0.165 μM of the denoted α-32P-
dNTP. Reactions were incubated at 30°C for 60 min and the DNA products in the 
supernatant was separated from the DNA products bound to the telomerase enzyme 
immobilized on the beads. Following ethanol precipitation, the DNA products were 
resolved on a 10% (wt/vol) polyacrylamide/8 M urea denaturing gel, dried, exposed to 
a phosphorstorage screen and imaged on a Bio-Rad FX-Pro phosphorimager. Repeat 
addition processivity was calculated using the equation: 𝑃𝑟𝑜𝑐𝑒𝑠𝑠𝑖𝑣𝑖𝑡𝑦 =  
−𝑙𝑛2
2.303𝑘
 
(Latrick & Cech, 2010). The slope, k, was determined by plotting the intensity of each 
major band, normalized to the intensity of the first band, over the repeat number. 
Pulse-chase time course assay.  
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 Twenty microliters of immuno-purified in vivo reconstituted telomerase 
enzyme on beads was initially pulsed with 0.165 μM α-32P-dTTP for 5 min and then 
chased with 100 μM dTTP and denoted concentrations of dATP and dGTP. Aliquots 
of the reactions were terminated by phenol/chloroform extraction at denoted time 
points, followed by ethanol precipitation. The DNA products were resolved on a 10 
(wt/vol) polyacrylamide/8 M urea denaturing gel, dried, exposed to a phosphorstorage 
screen and imaged on a Bio-Rad FX-Pro phosphorimager. To determine the rate of 
repeat addition, the longest DNA products with the highest intensity above initial 
pulse product bands were used to deduce a ‘modal band’ to calculate the extension 
rate as previously described (Drosopoulos et al, 2005).  
3.4 Results 
Human telomerase template-embedded pause signal mediates high KM for nucleotide 
incorporation.s 
 Telomerase synthesizes DNA at an exceedingly lower rate than most DNA 
polymerases (Hwang et al, 2014), which is presumably due to the unique telomerase 
catalytic cycle for processive short DNA repeat synthesis. During each of the 
reiterated cycles, telomerase catalyzes the incorporation of six consecutive 
deoxynucleotides, dG1, dG2, dT3, dT4, dA5 and dG6, onto the 3' hydroxyl of the 
DNA primer (Figure 3.1A), followed by template translocation to regenerate the 
template for the next cycle of repeat synthesis. With template translocation having 
been reported to be a rapid process (Parks & Stone, 2014), we investigated whether 
any of the six nucleotide incorporations limit overall telomerase repeat addition 
activity, especially as specific TR template residue mutations have been shown to 
affect telomerase enzymatic function (Brown et al, 2014; Drosopoulos et al, 2005; 
46 
 
Gilley & Blackburn, 1996; Gilley et al, 1995). The kinetics of the individual 
nucleotide incorporation steps have not been previously assessed due to technical 
complications associated with analyzing processive telomerase enzymes. To 
overcome this technical difficulty, we employed template-free (TF) human telomerase 
(Qi et al, 2012) that catalyzes a non-processive DNA synthesis reaction using RNA 
templates supplied in trans, which permits a simplified and defined primer-extension 
assay for determining the nucleotide incorporation efficiency at each individual 
position across the hTR template. Human TF telomerase was reconstituted by 
assembling in vitro expressed human TERT protein in rabbit reticulocyte lysate with 
the two essential hTR fragments, CR4/5 and a template-free pseudoknot fragment 
lacking the template sequence (Figures 3.1B and 3.2). This TF telomerase was 
assayed for nucleotide incorporation with a series of DNA/RNA duplex substrates 
comprising a DNA primer and an RNA oligo serving as the template (Figure 3.3). The 
preassembled DNA/RNA hybrid substrates were specifically designed with permuted 
telomeric sequences and a short RNA template for measuring the KM of nucleotide 
incorporation specifically for dG1, dT3, dA5 and dG6, corresponding to positions 1, 
3, 5 and 6 in the hTR template (Figures 3.1A and 3.3). The KM measurements used 
extremely low concentrations of TF telomerase enzyme and excess nucleotide 
substrates ranging from 2 to 200 µM. With either 2 or 200 µM nucleotide substrate, 
the product formation over the incubation time remained linear indicating that the 
initial velocity of the reaction was measured (Figure 3.4). Remarkably, the KM for 
incorporating dG1 was approximately 120 µM, exceptionally higher than the KM for 
incorporating dT3, dA5 and dG6 that ranged from 3 to 31 µM (Figure 3.1C). To 
further investigate whether this was a result of nucleotide identity or the incorporation 
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position within the template sequence, we altered the identity of the nucleotide 
incorporated at positions 1, 5 and 6 to dA1, dT1, dG5 and dT6 (Figure 3.3). Altering 
the identity of the nucleotide incorporated at these positions did not substantially 
change the high KM for nucleotide incorporation at position 1, nor the low KM at other 
positions measured (Figure 3.1C). Interestingly, the dG-to-dT transversion at 
positions 1 and 6 noticeably increased KM from 120 to 400 µM and from 5 to 14 µM, 
respectively (Figure 3.1C). This is consistent with results reported for Tetrahymena 
telomerase, where the KM for incorporating dT was slightly higher than for dG 
(Collins & Greider, 1995; Lee & Blackburn, 1993). Overall, these results suggest that 
the high KM of the first nucleotide incorporation is position-specific relative to the 
template sequence and independent of the identity of the nucleotide incorporated. 
 The incorporation of the first nucleotide, dG1, perfectly coincides with the 
DNA synthesis pause site governed by the pause signal embedded in the hTR 
template sequence (Figure 3.1C). The template-embedded pause signal dT:rA base-
pair forms with the incorporation of dT3 and mediates DNA synthesis arrest after the 
incorporation of the three subsequent nucleotides, dT4, dA5 and dG6 (Brown et al, 
2014). We hypothesized that the pause signal arresting DNA synthesis through an 
elevated KM for nucleotide incorporation at the pause site would be mitigated with 
increased dGTP concentrations. To test this hypothesis, we designed a DNA/RNA 
hybrid substrate with a dT:rA pause signal embedded within and a single-stranded 
RNA template that allows for the incorporation of four nucleotides, corresponding to 
dA5, dG6, dG1, and a non-telomeric dC2 (Figure 3.1D). The pause signal would 
arrest DNA synthesis at the pause site following the incorporation of 32P-dA5 and 
dG6. In the presence of only 32P-dATP, a single 32P-dA5 residue was incorporated to 
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the DNA primer, generating a single band (Figure 3.1D, lane 1). The inclusion of 5 
µM dGTP in the reaction permitted the incorporation of dG6, while the subsequent 
dG1 incorporation was inhibited by the pause signal (Figure 3.1D, lane 2). Increasing 
the dGTP concentration to 20 or 50 µM increasingly overcame this DNA synthesis 
arrest and resulted in the dG1 incorporation, generating a pronounced third band 
(Figure 3.1D, lanes 3 and 4). These nucleotide incorporations were template-
dependent as the fourth band corresponding to a dC2 incorporation was generated 
only in the presence of dCTP (Figure 3.1D, lane 5). These results reveal that elevated 
dGTP concentrations effectively overcome the DNA synthesis arrest at the pause site 
which is governed by the pause-signal and mediated through the high KM of the dG1 
incorporation. 
 To further explore the connection between the pause signal and the high KM 
for dG1 nucleotide incorporation, we eliminated the pause signal from the DNA/RNA 
hybrid substrate by mutating the base-pair dT:rA to dA:rU and then measured KM for 
the dG1 nucleotide incorporation (Figures 3.1E and 3.5). This transversion mutation 
has previously been shown to effectively inactivate the pause signal and permit DNA 
synthesis beyond the pause site (Brown et al, 2014). As expected, the removal of the 
pause signal significantly reduced the KM for dG1 incorporation from 120 to 22 µM 
(Figures 3.1E and 3.5). In contrast, the loss of the pause signal in the DNA/RNA 
duplex did not affect the KM for incorporating dG6 (Figures 3.1C and 3.1E). We thus 
conclude that the template-embedded pause signal has an inhibitory effect specifically 
on the dG1 nucleotide incorporation, mediated through a high KM exclusively for this 
nucleotide incorporation. 
dGTP stimulates telomerase repeat addition processivity and rate. 
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 It has been previously proposed that the template-embedded pause signal may 
have dual functions (Brown et al, 2014): arresting DNA synthesis at the end of the 
template and inhibiting the first nucleotide incorporation after template translocation 
(Figure 3.6A). Processive repeat addition by telomerase necessitates reiterated cycles 
of nucleotide addition. The inhibitory effect of the pause signal on the first nucleotide 
dG1 incorporation would impair initiating synthesis of each repeat, negatively 
affecting processive telomerase repeat addition. As high dGTP concentrations can 
effectively overcome the pause signal mediated inhibition of dG1 incorporation 
(Figure 3.1D), we hypothesized that high dGTP concentrations would facilitate 
progression into subsequent catalytic cycles and in turn promote telomerase repeat 
addition activity, generating more high molecular weight (M.W.) DNA products. In 
fact, dGTP-dependent stimulation of repeat addition activity has been previously 
reported for human and ciliate telomerases (Hammond & Cech, 1997; Hardy et al, 
2001; Maine et al, 1999; Sun et al, 1999). However, the underlying mechanism for 
dGTP-stimulation of telomerase repeat addition remained unclear. To ascertain that 
this previously reported nucleotide stimulation of human telomerase is specific to 
dGTP, and not dATP or dTTP, we reconstituted wild-type human telomerase with 
full-length, template-bearing hTR in human HEK293 cells and assayed the immuno-
purified telomerase enzyme for repeat addition activity with a telomeric DNA primer 
(TTAGGG)3 (Figure 3.6B-C). To determine the effects of dGTP and dATP 
concentrations on telomerase repeat addition, we performed the conventional 
telomerase primer-extension assay in the presence of 32P-dTTP with increasing 
concentrations (10, 50 and 200 µM) of dGTP or dATP individually (Figure 3.6B). 
Elevated dGTP concentrations at 50 or 200 µM significantly increased the relative 
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ratio of high over low M.W. products by approximately 1.5-fold (Figure 3.6B, lanes 
1, 4 and 5), while varying the concentration of dATP had no significant effect on 
repeat addition (Figure 3.6B, lanes 1-3). To examine the effects of dTTP, a similar 
assay was performed in the presence of 32P-dATP. Similarly, increased dGTP 
concentrations increased repeat addition efficiency by approximately 1.5-fold (Figure 
3.6C, lanes 1, 4 and 5), while elevated dTTP did not significantly increase repeat 
addition efficiency, but seemed to slightly increase the length of the highest M.W. 
products (Figure 3.6C, lanes 1-3). The slight increase of the highest M.W. products 
with elevated dTTP is consistent with a previous report (Drosopoulos & Prasad, 
2010). Additionally, increasing nucleotide concentrations from 10 to 100 µM did not 
appear to alter single repeat synthesis, as nucleotide incorporation efficiency was 
saturated at 10 µM (Figure 3.7). These data clearly demonstrate that human 
telomerase repeat addition was stimulated specifically by increased concentrations of 
dGTP, and not dATP or dTTP. The increased ratio of higher over lower M.W. 
products could arise from an increase in the processivity and/or the rate of repeat 
addition, two independent attributes of the telomerase enzyme (Drosopoulos et al, 
2005; Xie et al, 2010). To investigate the underlying mechanism for dGTP-
stimulation of telomerase repeat addition, we employed two specific telomerase 
activity assays to measure separately processivity from rate of repeat addition in the 
presence of elevated dGTP concentrations. 
 To specifically measure the processivity of telomerase repeat addition, we 
designed a telomerase product release assay that quantitates repeat addition 
processivity based on the distribution of DNA products released from the enzyme 
(Figure 3.8A). Enzyme-bound DNA products are still undergoing additional rounds of 
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repeat addition and the inclusion of these premature intermediates would influence the 
measurement of telomerase repeat addition processivity. For this assay, human 
telomerase was reconstituted in HEK 293FT cells and the immuno-purified enzyme 
bound to beads was incubated with the telomeric DNA primer (TTAGGG)3 in the 
presence of different concentrations of dGTP or dATP. The DNA products released 
from the immobilized telomerase enzyme were isolated from the supernatant and 
analyzed to determine the probability of each successive DNA repeat addition. This 
probability was calculated from the slope of ‘products left behind’ (Latrick & Cech, 
2010) by plotting the intensity of major DNA products with the number of repeats (3-
12) added (Figure 3.8A and 3.8B). The slope of the plot corresponds to the repeat 
addition processivity and was used to compare the relative repeat addition 
processivity across different assay conditions (Figure 3.8B). The results of this 
product release assay found that increasing dGTP concentration from 10 to 100 µM 
resulted in a 2-fold increase in processivity, while increasing dATP concentrations to 
100 µM had no significant effect on processivity (Figure 3.8C). Thus, high dGTP 
concentration effectively stimulates the processivity of human telomerase repeat 
addition. 
 We next investigated the effects of elevated dGTP concentrations on the rate 
of repeat addition. To specifically measure repeat addition rate, we employed a pulse-
chase time course assay to track the increasing size of the DNA products undergoing 
processive repeat addition over time (Figure 3.8D). For this pulse-chase assay, 
immuno-purified telomerase was initially incubated exclusively with 32P-dTTP to 
radioactively label the DNA primer and this pulsed reaction was chased with cold 
nucleotides to track the processive enzyme-DNA complexes over time. The repeat 
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addition rate was 0.86 repeat/min measured under the chase condition with 10 µM 
dGTP and 100 µM of dTTP and dATP. However, when chased with the dGTP 
concentration increased to 100 µM, the repeat addition rate nearly doubled to 1.45 
repeat/min (Figure 3.8E, left panel). In contrast, when the reaction was chased with 
either 10 or 100 µM dATP, in the presence of 100 µM dGTP and dTTP, the repeat 
addition rate remained unchanged at 1.21 or 1.27 repeat/min, respectively (Figure 
3.8E, right panel). Thus, dGTP concentration is a crucial determinant for the rate, in 
addition to processivity, of human telomerase repeat addition. 
First nucleotide incorporation following template translocation mediates nucleotide-
specific stimulation of telomerase repeat addition. 
 The synthesis of a telomeric DNA repeat comprises three dG incorporations: 
dG1, dG2 and dG6 (Figure 3.9A). We hypothesized that the high dGTP concentration 
stimulated telomerase repeat addition by overcoming the high KM for dG
1 
incorporation. To determine whether the dG1 incorporation is specifically responsible 
for the dGTP-stimulation of telomerase repeat addition, we generated three hTR 
template mutants hTR-51U, -50U and -46/52U that individually altered the three dG 
nucleotide incorporations to dA1, dA2 and dA6, respectively. We reconstituted these 
telomerase template mutants in human HEK293 cells and assayed the immuno-
purified enzyme by conventional telomerase primer-extension assay in the presence of 
32P-dTTP with either 10 or 100 µM of dGTP or dATP. Remarkably, of these three 
mutants, only the hTR-51U mutant had a pronounced increase of the higher M.W. 
products with increased dATP (Figure 3.9B, lanes 4 and 5), and was unaffected by 
increased dGTP (Figure 3.9B, lanes 4 and 6). Similar to wild-type, the hTR-50U and -
46/52U mutant telomerases had increased repeat addition efficiencies with increased 
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dGTP, and were unaffected by increased dATP (Figure 3.9B, lanes 6-12). It is 
interesting to note that the hTR-46/52U mutant telomerase had significantly lower 
repeat addition efficiency, producing less high M.W. products (Figure 3.9B, lanes 1 
and 10). This was likely due to the less stable dA:rU base-pairing located at the end of 
the primer/template duplex, which would negatively impact primer realignment 
efficiency during template translocation. Noticeably, the hTR-51U and -50U mutant 
telomerases generated DNA products with altered banding profiles (Figure 3.9B). 
This is seeming due to the substitution of a dA instead of a dG residue at the specified 
template positions affecting nucleotide incorporation efficiency, as it has been 
reported that telomerase is sensitive to the template sequence alterations (Drosopoulos 
et al, 2005; Gilley et al, 1995). The template mutant hTR-50U appeared to have a 
lower incorporation efficiency for dG6 residue, resulting accumulation of the DNA 
product after dA5 incorporation visible as an additional band (Figure 3.9B, lanes 7 and 
8), which was effectively alleviated by high dGTP (Figure 3.9B, lane 9). Nonetheless, 
by changing the nucleotide incorporation from dG1 to dA1 with the hTR-51U template 
mutation, we effectively changed the stimulation of human telomerase repeat addition 
from dGTP to dATP-dependent. This further supports the hypothesis that the dG1 
nucleotide incorporation is a critical step for human telomerase repeat addition. 
 We next sought to determine whether the dATP-dependent stimulation of 
hTR-U51 mutant telomerase affects specifically the processivity and/or the rate of 
repeat addition. We examined the repeat addition processivity of the hTR-51U mutant 
with our product release assay (Figure 3.10A). As expected, the hTR-51U mutant had 
a 35% increase of telomerase repeat addition processivity in the presence of 100 µM 
dATP and no effect with 100 µM dGTP (Figure 3.10A-C). This result indicates that 
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the first nucleotide incorporation in the telomerase catalytic cycle is an important 
determinant for repeat addition processivity. Following this, we then examined the 
contribution of the first nucleotide incorporation efficiency on the repeat addition rate. 
We performed a pulse-chase time course assay with the hTR-51U mutant to measure 
the repeat addition rate in the presence of either 10 or 100 µM of dATP or dGTP 
(Figure 3.10D). When the reactions were chased with 100 µM dATP, the repeat 
addition rate was dramatically increased to 3.15 repeat/min from 1.27 repeat/min with 
10 µM dATP—a near 2-fold increase (Figure 3.10E). In contrast, increasing dGTP 
from 10 to 100 µM did not increase the repeat addition rate of hTR-51U mutant which 
remained similar from 2.99 to 2.95 repeat/min (Figure 3.10E). Our data indicate that 
the concentration of the nucleotide incorporated as the first residue of a telomeric 
DNA repeat is crucial for the processivity as well as the rate of human telomerase 
repeat addition. 
Telomerase can incorporate deoxynucleoside diphosphates as substrate 
 It was previously reported that Tetrahymena telomerase accumulates high 
M.W. DNA products in the presence of elevated dGTP, dGDP, or even dGMP, 
leading to the hypothesis that a secondary guanosine binding site was responsible for 
the dGTP-dependent repeat addition stimulation (Hardy et al, 2001). However, our 
hTR51U telomerase mutant exhibited dATP-dependent stimulation of repeat addition 
processivity, opposing a secondary guanosine binding site in human telomerase. To 
investigate the possibility of a more general purine nucleoside binding site for repeat 
addition stimulation, we examined whether dGMP or dGDP stimulates human 
telomerase repeat addition. Our result showed that dGMP, at either 10 or 100 µM, 
failed to stimulate telomerase repeat addition in a reaction containing 10 µM dGTP, 
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10 µM dTTP and 100 µM dATP (Figure 3.11A, lanes 1 and 2). Interestingly, 
increasing dGDP concentrations from 10 to 100 µM generated a noticeable increase 
in telomerase repeat addition efficiency (Figure 3.11A, lanes 3 and 4). To investigate 
this dGDP-dependent stimulation of repeat addition, we examined whether dGDP 
functions as a substrate for nucleotide incorporation by telomerase. By replacing 
dGTP with either dGDP or dGMP in the telomerase reaction, we showed that human 
telomerase can effectively incorporate dGDP as substrate for telomeric DNA 
synthesis (Figure 3.11A, lanes 8-9), and not dGMP (Figure 3.11A, lanes 6-7). We 
further examined telomerase for utilizing dADP as substrate. Similarly, human 
telomerase can effectively incorporate dADP, and not dAMP (Figure 3.12A-B). To 
eliminate the possibility of -phosphate transfer from dATP in the reaction to dGDP, 
we performed a telomerase reaction lacking any nucleoside triphosphates using a 32P-
end labeled DNA primer with exclusively deoxynucleoside diphosphates: dGDP, 
dADP and dTDP as substrates (Figure 3.12C). This deoxynucleoside diphosphates-
only telomerase reaction generated a significant level of repeat addition activity 
(Figure 3.12D, lanes 1-2) which however was consistently lower than the activity 
from the deoxynucleoside triphosphates reaction (Figure 3.12D, lanes 3-4). These 
results suggest that deoxynucleoside diphosphates are sufficient substrates, yet less 
effective than deoxynucleoside triphosphates for human telomerase DNA synthesis. 
 We sought to assess the pervasiveness of DNA polymerases for utilizing 
deoxynucleoside diphosphates for DNA synthesis. In addition to telomerase examined 
in this study, it has been previously reported that the HIV RT and a bacteriophage 
DNA polymerase are capable of using deoxynucleoside diphosphates as substrate 
(Garforth et al, 2008; Yang et al, 2002). We examined three RTs: TF telomerase, 
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AMV and TGIRT III group II intron RTs, and three DNA-dependent DNA 
polymerases: Taq, T4 and the Klenow fragment, for incorporating dGDP into DNA 
products using corresponding DNA/RNA or DNA/DNA duplex substrates and 
labeling 32P-dATP (Figures 3.11B-C and 3.11). Except for the T4 DNA polymerase 
(Figure 3.13, lane 7), all other examined enzymes showed significant incorporation of 
dGDP and not dGMP as substrate (Figure 3.11B, lane 4 and 8; Figure 3.11C, lanes 3; 
and 7; Figure 3.13, lane 3). All enzymes analyzed showed template-directed 
nucleotide incorporations lacking non-specific terminal transferase activities. 
Therefore, the utilization of deoxynucleoside diphosphate as substrate for DNA 
synthesis is ubiquitous amongst DNA polymerases. Moreover, the dGDP-dependent 
stimulation of human telomerase repeat addition is likely from active incorporation of 
dGDP as substrate rather than secondary-site binding. 
Removal of the template-embedded pause signal eliminates dGTP-specific stimulation 
of human telomerase repeat addition. 
 With our TF telomerase system, we showed that the template-embedded pause 
signal is responsible for the high KM of the dG
1 incorporation (Figure 3.1E), a crucial 
determinant for repeat addition processivity and rate (Figure 3.8). To assess whether 
the pause signal limits repeat addition in a processive telomerase reaction, we 
generated a human telomerase template mutant, termed ∆pause, that lacks the pause 
signal by mutating the four rA residues (nt positions 48, 49, 54 and 55) in the template 
to rU residues (Figure 3.14A). Our previous study indicated that each of the rA 
residues in the TR template must be altered to completely eliminate the pause signal 
(Brown et al, 2014). We reconstituted wild-type and the Δpause mutant human 
telomerase in HEK293 cells and assayed the immuno-purified enzyme with 
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corresponding DNA primers and a titration of dGTP from 10 to 50 µM (Figure 
3.14B). In sharp contrast to the wild-type telomerase that had the expected dGTP-
dependent stimulation of repeat addition activity (Figure 3.14B, lanes 1-3), the 
Δpause mutant had strikingly high repeat addition activity with only 10 µM dGTP, 
which remained unchanged with 100 µM dGTP (Figure 3.14B, lanes 4-6). 
Interestingly, the Δpause template mutant had an altered major banding pattern 
compared with the wild-type enzyme, which was presumably due to a shift of the 
limiting nucleotide incorporation from dG1 to the three dA residues for the mutant 
enzyme (Figure 3.14B, lane 4). We then analyzed the Δpause mutant for repeat 
addition processivity and rate separately (Figure 3.15). The Δpause mutant had an 
approximately 1-fold greater processivity at either 10 or 100 µM dGTP compared to 
the wild-type enzyme at 10 µM dGTP (Figure 3.15A-C). The repeat addition rate of 
the Δpause mutant was found to be 1.70 repeat/min at 10 µM dGTP and 1.65 
repeat/min with 100 µM dGTP (Figure 3.15D-E), which is significantly higher than 
the 0.7 and 1.3 repeat/min of the wild-type enzyme at 10 and 100 µM dGTP, 
respectively (Figure 3.8D-E). These results strongly support the pause signal is 
responsible for the intrinsically low processivity and rate, as well as the dGTP-
specific stimulation of human telomerase repeat addition. 
dGTP-specific processivity stimulation is mediated by the sequence-defined pause and 
not template translocation.  
 Template translocation efficiency has long been viewed as the key determinant 
of telomerase repeat addition processivity (Lue, 2004). This was supported by the 
assumption that failed template translocation was responsible for DNA product 
release giving rise to the characteristic six-nucleotide ladder banding pattern of 
58 
 
telomerase activity (Greider, 1991). The physical template boundary alone does not 
prevent mis-incorporations using the template flanking non-telomeric residues in the 
hTR-T6 template permutation mutant (Figure 3.16). The contribution, and even the 
existence, of the hTR template-embedded pause signal was obscured by the precise 
overlap of the pause site with the physical template boundary and the position for 
template translocation (Figure. 3.17A). Thus, the sequence-defined pause site would 
need to be separated from the template physical boundary and the ensuing template 
translocation. To determine the individual contributions of (1) template translocation 
efficacy compared to (2) the sequence-defined pausing for telomerase processivity, 
we uncoupled the pause site from the physical boundary defined by TR structural 
elements (Chen & Greider, 2003). We generated the hTR template mutant T6 with a 
permuted template sequence, 3’-CCAAUCCCAAU-5’, one-residue offset from the 
wild-type sequence 3’-CAAUCCCAAUC-5’ (Figure 3.17A). The hTR-T6 template 
permutation delays the sequence-defined pause of DNA synthesis, resulting in 
template translocation occurring at the physical boundary and reaching the pause site 
after a single nucleotide addition (Figure 3.17B). This uncoupling separates the dG 
residue incorporated immediately following template translocation from a distinct dG 
residue incorporated immediately following the pause site. To discern amongst these 
two dG residues, we introduced mutations, T6-51U and T6-50U, into the hTR-T6 
permuted template sequence to alter individually one of the two dG residues to dA 
(Figure 3.17C). We then reconstituted hTR-T6 mutant telomerases for processivity 
stimulation analysis with 32P-dTTP and increased dGTP or dATP concentrations. 
Similar to the wild-type enzyme, the telomerase hTR-T6 template permutation mutant 
exhibited dGTP-specific processivity stimulation (Figure 3.17D and 3.17E). 
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Strikingly, the T6-51U mutant retained dGTP-specific processivity stimulation, 
suggesting that the first nucleotide incorporated following template translocation was 
not responsible for processivity stimulation. In contrast, the T6-50U mutant showed 
dATP-specific stimulation, demonstrating that the first nucleotide incorporated 
following the pause site was critical for processivity stimulation (Figure 3.17D and 
3.17E). Interestingly, the hTR-T6 template permutation mutants generated products 
with banding patterns identical to the wild-type telomerase, suggesting that the 
telomeric DNA products were released at the sequenced-defined pause site and not at 
the physical template boundary (Figures 3.9B and 3.17D).  
3.5 Discussion 
 Telomerase is an RNA-dependent DNA polymerase specialized in adding 
telomeric DNA repeats onto chromosome ends (Podlevsky & Chen, 2016). Apart 
from other DNA polymerases, telomerase employs a highly orchestrated, yet poorly 
understood, catalytic cycle to regenerate the RNA template for processive synthesis of 
multiple telomeric DNA repeats (Wu et al, 2017). The total number of DNA repeats 
added by a given telomerase enzyme in a single turnover is determined by the two 
tangibly separate attributes of the telomerase enzyme: the processivity and the rate of 
repeat addition (Podlevsky & Chen, 2012; Schmidt & Cech, 2015). The processivity 
of telomerase repeat addition corresponds to the probability of continuous DNA 
repeat synthesis over complete product release following each catalytic cycle of six 
nucleotide incorporations. Distinct from processivity, the rate of repeat addition 
corresponds to the number of telomeric repeat synthesized per unit time. The repeat 
addition rate is contributed by: (i) the rate of individual nucleotide additions to the 
primer and (ii) the rate of template regeneration by template translocation. In this 
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work, we discovered a previously unknown role of the telomerase template-embedded 
pause signal for inhibiting the dG1 incorporation step, the first nucleotide of each 
telomeric DNA repeat. This slow dG1 incorporation is a decisive step that affects the 
rate of the telomerase reaction. Failure to incorporate the dG1 residue prevents 
processive additional cycles of repeat synthesis, which prompts complete DNA 
product release and terminates the reaction (Figure. 3.18). 
 As depicted in our working model of the telomerase catalytic cycle (Figure 
3.18), each repeat synthesis comprises the addition of six nucleotides to the 3' 
hydroxyl of the DNA primer and then arrested at the 5' end of the hTR template by 
the physical boundary element (Chen & Greider, 2003) and the unique template-
embedded pause signal (Brown et al, 2014). Following each repeat synthesis, 
telomerase regenerates the template through a template translocation step, which has 
recently been shown to be a rapid process (Parks & Stone, 2014) with a rate about 
100-fold faster than the overall repeat addition rate measured (Latrick & Cech, 2010). 
Thus, the template translocation step is unlikely a major determinant for the rate of 
repeat addition (Figure 3.18). Moreover, the high repeat addition activity and the lack 
of product release after the dG6 incorporation with the Δpause mutant suggest that 
template translocation is efficient (Figure 3.14B, lane 4). Recently, two models have 
been proposed for the mechanism of template translocation: single-stranded DNA 
retention by DNA-protein interactions (Wu et al, 2017) and DNA hairpin formation 
(Yang & Lee, 2015). Each of these models are possible for template translocation, yet 
additional work is necessary to establish the definitive mechanism. The data presented 
herein centers on DNA synthesis post template translocation and neither supports nor 
negates these proposed models. However, mutations across the template that alter the 
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telomeric DNA sequence do not affect the functionality of the pause signal (Brown 
2014), which would imply that the putative DNA hairpin is largely unaffected by the 
DNA sequence or is not critical for pause-signal mediated arrest of DNA synthesis. A 
myriad of intrinsic and extrinsic factors contribute synergistically to template 
translocation efficiency and repeat addition processivity. These intrinsic factors 
include the template length that affects template/primer realignment (Chen & Greider, 
2003), TERT anchor sites that bind DNA to prevent complete DNA dissociation 
(Akiyama et al, 2015; Finger & Bryan, 2008; Jacobs et al, 2006; Wyatt et al, 2007; 
Zaug et al, 2008), or TERT motifs that enable stable retention of the realigned 
DNA/RNA hybrid in the active site (Huard et al, 2003; Lue et al, 2003; Qi et al, 2012; 
Wu et al, 2017; Xie et al, 2010). Moreover, telomerase accessory proteins, POT1 
(Protection Of Telomeres 1) and TPP1 (TIN2 and POT1-interacting Protein 1), have 
been found to increase processivity by delaying product release through DNA-protein 
interactions (Latrick & Cech, 2010; Lingner et al, 1997). These DNA-protein 
interactions promote progression into the next cycle of repeat synthesis and augments 
telomerase repeat addition processivity (Figure 3.18). In addition to the intrinsic 
factors, extrinsic factor such as ionic strength, temperature, nucleotide and primer 
concentrations (Sun et al, 1999). The sheer number of distinct factors that affect 
telomerase repeat addition processivity underlie the excessive complexity of template 
translocation. 
 After a successful template translocation event, the template is regenerated 
and ready for further nucleotide addition (Figure 3.18). Nevertheless, the pause signal 
remains effective following template translocation and inhibits the incorporation of 
the dG1 residue through an excessively high KM for this incorporation (Figure 3.1C). 
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Our KM measurements for nucleotide incorporation at specific positions across 
template were only feasible by using the non-processive TF telomerase (Qi et al, 
2012) and specifically designed DNA/RNA hybrid substrates with permuted 
sequences (Figure 3.3); these measurements were otherwise challenging and complex 
with a processive telomerase enzyme. By measuring individual nucleotide 
incorporation efficiencies with the TF telomerase, we found that removing the pause 
signal in the DNA/RNA hybrid effectively lowers the high KM of the dG
1 
incorporation to a value comparable to other positions across template, suggesting that 
the pause signal is responsible for this inhibitory effect (Figures 3.1E and 3.5). For the 
processive wild-type telomerase enzyme, the removal of the pause signal from the 
hTR template dramatically increases repeat addition activity even in the presence of 
low dGTP concentration at 10 µM (Figure 3.14B). This suggests that the dG1 
incorporation is no longer the limiting step for processive repeat addition. The 
template mutations introduced in the Δpause mutants modified the sequence of the 
DNA products, which may affect DNA-protein interactions with TERT anchor sites 
or accessory proteins. While altering DNA-enzyme binding affinity has the potential 
to augment repeat addition processivity, it is unlikely that this would simultaneously 
enhance the rate of repeat addition (Figure 3.15). Therefore, it is more feasible that 
the increased rate of repeat addition with the Δpause mutant was caused by the lower 
KM of the dG
1 incorporation. Under saturating dGTP concentrations, the Δpause 
mutant and wild-type telomerases had equally high repeat addition activity 
(Drosopoulos et al, 2005), supporting our hypothesis that the dramatically high repeat 
addition activity of the Δpause mutant at low dGTP was mainly due to the alleviated 
dG1 incorporation. Moreover, the loss of the pause signal noticeably altered the 
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banding pattern of DNA products, which was presumably from new limiting 
nucleotide incorporations at other template positions and premature product releases.  
 Upon recognition of the pause signal in the DNA/RNA hybrid, telomerase 
stalls DNA synthesis precisely at the pause site by the elevated KM for nucleotide 
incorporation (Figure 3.1C). While the underlying mechanism for pause-signal 
recognition requires further investigation, we speculate that pause-signal recognition 
induces a subtle conformational change in the DNA/RNA hybrid binding site and/or 
the catalytic site within the TERT protein that manifests as the elevated KM for 
nucleotide incorporation. Supporting this hypothesis, previous structural and 
biochemical studies suggest that telomerase undergoes conformational changes at 
distinct steps of catalytic cycle (Mitchell et al, 2010; Parks et al, 2017; Tomlinson et 
al, 2015). However, determining the exact mechanism for pause-signal mediated 
arrest of DNA synthesis would require high-resolution structures of the telomerase 
enzyme complexed with various DNA/RNA hybrids and even the incoming 
nucleotide bound within the active site. 
 Beyond compensating for the high KM of the dG
1 incorporation, high dGTP 
concentrations have no exotic stimulatory effects on human telomerase. Our results 
demonstrate that altering the dG1 incorporation to dA1 effectively shifted the 
stimulation of repeat addition processivity and rate from dGTP- to dATP-dependent 
for human telomerase (Figures 3.9 and 3.10). However, the ciliate Tetrahymena 
thermophila telomerase has been reported to have repeat addition processivity 
stimulated by high concentrations of dGTP, dGDP or even dGMP (Hardy et al, 2001). 
In contrast, our assays with human telomerase failed to show dGMP-dependent 
stimulation of repeat addition activity (Figure 3.11A). Thus, the effects of elevated 
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dGTP concentrations on ciliate telomerases appear esoteric with an underlying 
mechanism distinct from human telomerase. It was interesting to observe that, in 
addition to dGTP, elevated dGDP also stimulates telomerase repeat addition (Figure 
3.11A, lane 3). Rather than an allosteric effect from a secondary guanosine binding 
site, dGDP was directly utilized as substrate and effectively increased overall 
nucleotide concentrations (Figure 3.11A, lanes 8-9). Furthermore, telomerase assayed 
with solely deoxynucleoside diphosphates generated a significant amount of DNA 
products (Figure 3.12D, lane 2), eliminating the possibility of phosphate transfer from 
deoxynucleoside triphosphates to diphosphates. Nonetheless, deoxynucleoside 
diphosphates are a poorer substrate to telomerase with 5-10-fold lower concentrations 
in cells than deoxynucleoside triphosphates (Bradshaw & Samuels, 2005). Thus, we 
do not expect telomerase to utilize deoxynucleoside diphosphates as substrate under 
cellular conditions. In addition to telomerase, all other RTs and most DNA-dependent 
DNA-polymerases examined in this study are capable to incorporate dGDP into DNA 
products (Figures 3.11B-C and 3.13). This however is not entirely unexpected as 
deoxynucleoside triphosphates and diphosphates both permit the same DNA 
polymerase catalysis with the 3' hydroxyl of the DNA primer attacking the -
phosphate of the incoming deoxynucleotide and the release of inorganic 
pyrophosphate or monophosphate, respectively (Kornberg, 1969). Interestingly, the 
Klenow fragment of Escherichia coli DNA polymerase that showed dGDP utilization 
activity in our assay (Figure 3.11C) has been previously reported inert with 
deoxynucleoside diphosphates (Garforth et al, 2008; Kornberg, 1957). This 
discrepancy is likely due to the lower nucleotide concentration used in previous 
studies.  
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 Under estimated intracellular nucleotide concentrations (Bradshaw & 
Samuels, 2005), telomerase would be efficient for the synthesis of a single repeat, yet 
limited for the processive synthesis of multiple repeats through multiple catalytic 
cycles. Conventional telomerase assays have been performed under exceptionally 
high concentrations of dATP and dTTP in the range of 100 to 1,000 µM, with the 
radiolabeled dGTP in the very low µM range (Greider, 1991; Huard et al, 2003; 
Latrick & Cech, 2010; Wu et al, 2017). These skewed assay conditions lead to 
significant DNA synthesis arrest at the end of catalytic cycle and generated the 
characteristic six-nucleotide ladder banding pattern, a hallmark of telomerase activity. 
Reducing individual nucleotide concentrations below 5 µM results in intermediate 
DNA repeat products accumulation due to the stalling of nucleotide addition before 
reaching the end of the template (Figure 3.7). The incorporation of dG1 is presumably 
slow under the low nucleotide concentrations in vivo, telomerase would 
predominately release DNA products terminating with dG6 prior to the dG1 
incorporation. The analysis of chromosome terminal sequences found a sharp increase 
of the specific dG6 terminal sequence from about 25% in telomerase-null cells to 
about 40% in telomerase-positive cells (Sfeir et al, 2005), which is consistent with our 
hypothesis that telomerase generates DNA products with this terminal sequence. 
 In contrast to the slow dG1 addition, the remaining five nucleotide 
incorporations appear to be efficient without accumulation of any significant 
intermediate products (Figure 3.8A, lane 4). However, in our telomerase product 
release assay, an intermediate DNA product with only three residues, dG1, dG2 and 
dT3, added was observed in the enzyme-bound fraction (Figure 3.8A, lane 1), and not 
in the released product fraction (Figure 3.8A, lane 4). This intermediate DNA product 
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likely resulted from a slightly slower incorporation of dT4. In support of the slower 
rate of the dT4 incorporation, increasing dTTP concentration to above 10 µM indeed 
increases repeat addition rate and generates products with a greater number of repeats 
added (Figure 3.6C, lanes 2 and 3), which is consistent with a previous report 
(Drosopoulos & Prasad, 2010). Together, these results support that the incorporation 
efficiencies of the remaining five residues, dG2, dT3, dT4, dA5 and dG6, minimally 
contribute to the overall repeat addition rate. The dG1 incorporation efficiency is the 
key determinant for both the processivity and the rate of telomerase repeat addition. 
 Elucidating the mechanism by which telomerase undergoes processive 
synthesis of hundreds of telomeric DNA repeats has remained challenging. The 
unique telomerase catalytic cycle relies on a highly-orchestrated arrangement of 
TERT, TR, and accessory proteins to facilitate DNA product retention and effective 
template regeneration for processive repeat addition. Our findings herein redefine the 
telomerase catalytic cycle as three critical and distinct steps: (i) rapid template 
translocation followed by (ii) slow dG1 incorporation and (iii) efficient addition of the 
five remaining residues dG2, dT3, dT4, dA5 and dG6 (Figure 3.10). DNA synthesis 
arrest at the slow dG1 incorporation step promotes product release and limits 
processive repeat synthesis. The intrinsic low processivity of human telomerase is 
beneficial as it affords repeat addition regulation through DNA-protein interactions 
with TERT anchor sites and telomerase accessory proteins to control product release 
(Figure 3.18). Moreover, our findings suggest that telomerase products are released 
mainly from unsuccessful dG1 incorporation, instead of failed template translocation. 
Thus, the slow dG1 incorporation step and the inhibitory effect of the pause-signal 
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limit the processivity and rate of telomerase repeat addition, representing prime 
targets for therapeutic regulation of telomerase function. 
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Figure 3.1. An elevated KM for the dG1 nucleotide incorporation by human 
telomerase. (A). Schematic of the six nucleotide incorporations catalyzed by human 
telomerase. Human telomerase catalyzes incorporations of six deoxynucleotides, dG1, 
dG2, dT3, dT4, dA5 and dG6, directed by the integral hTR template (green box). The 
hTR template contains two regions: an alignment sequence (shaded) for base-pairing 
with the DNA primer and the actual templating sequence for specifying DNA 
polymerization. Numbers below the hTR template region denote the order and 
position of the six deoxynucleotide incorporations. (B). Composition of template-free 
(TF) telomerase. TF telomerase was reconstituted by assembling in vitro expressed 
human TERT protein with the two essential hTR fragments, CR4/5 and the 
pseudoknot (PK) that had the template region excised. Pre-annealed DNA primer 
(blue box) and RNA template (green box) hybrids are used as substrates for the TF 
telomerase activity assay. (C). KM for incorporating nucleotides dG1, dT3, dA5, and 
dG6 by TF telomerase. The dG1 incorporation is located adjacent to the pause site 
(red dashed line) specified by the pause signal (red box), a dT:rA base-pair in the 
DNA/RNA hybrid. For measuring the KM of specific nucleotide incorporations, 
different DNA/RNA hybrid substrates with permuted sequences were used (Figure 
3.4). The KM for incorporating non-telomeric nucleotides (orange) with corresponding 
template mutations are denoted. (D) High dGTP concentrations overcome the pause 
signal mediated DNA synthesis arrest. Primer extension assays performed using the 
TF telomerase and a DNA/RNA hybrid substrate in the presence of 0.165 µM 32P-
dATP (asterisk) with a titration of dGTP (10, 20 and 50 µM). The DNA/RNA hybrid 
substrate allows for the incorporation of four nucleotides: dA5, dG6, dG1, dC2, as 
depicted. The pause signal (red box) and the pause site (red dashed line) in the 
DNA/RNA substrate arrests DNA synthesis after the incorporation of dA5 and dG6 
(blue) reducing the incorporation efficiency for dG1 (red). A radiolabeled DNA 
recovery control (r.c.) was added before product purification and precipitation. 
Nucleotide incorporation beyond the pause site was quantitated by the intensity of 
dG1 and dC2 products (red) over the total intensity of products. (E) Removal of pause 
signal decreases KM for dG1 incorporation. The DNA/RNA hybrid substrates with the 
pause signal dT:rA mutated to dA:rU (orange) were used to determine KM for 
nucleotide incorporation at positions dG1 and dG6 (Figure 3.5). 
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Figure 3.2. Comparison of wild-type and template-free (TF) telomerase 
reconstitution systems. (A) Schematic of the 451 nt full-length hTR. The hTR 
secondary structure comprises three major structural domains: the pseudoknot (PK), 
conserved regions 4/5 (CR4/5) and box H/ACA domain. The template region and the 
two structural domains, PK, and CR4/5 (red), are minimally required for 
reconstituting telomerase activity in vitro. (B) The wild-type telomerase core enzyme 
comprises the full-length hTR (green) and the catalytic TERT protein (grey). The 
substrate for wild-type telomerase is a single-stranded DNA primer (blue). (C) TF 
telomerase comprises the minimally required PK and CR4/5 hTR fragments (green). 
The substrate for TF telomerase is duplex of a single-stranded DNA primer (blue) 
pre-annealed with an RNA template. 
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Figure 3.3. KM measurement for nucleotide incorporations at specific template 
positions. (A) Sequences of the DNA/RNA hybrid substrates and positions of the 
pause site. In vitro reconstituted template-free (TF) telomerase were analyzed with 
specific DNA/RNA hybrid substrates to determine the apparent KM for each 
nucleotide incorporation. Numbers below DNA/RNA duplexes indicate positions 
corresponding to the telomerase template and order of nucleotides incorporated. Non-
telomeric template residues (orange) are indicated. The KM
app values measured for the 
nucleotide incorporation at the indicated position (black arrow) with each hybrid 
substrate are listed to the right. The nucleotides added (black) to the DNA in the 
hybrid are shown, with the first incorporation a 32P-dNTP (circled). (B) 
Representative gels for KM
app measurements. A 32P end-labeled DNA recovery control 
(r.c.) was added before product purification and precipitation. (C) Plots derived from 
the normalized intensity of the +2 or +3 product over the total intensity of products 
for the specified nucleotide concentration. The Michaelis–Menten equation, 
Y=Vmax*X/(KM+X), was used to fit the nonlinear curve to determine the KM
app. Two 
or three replicates were performed for each measurement. 
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Figure 3.4. Time course analysis of telomerase primer-extension assay at 2 and 
200 µM.  (A) Sequence of the DNA/RNA hybrid substrate, position of the pause 
signal and pause site (red). In vitro reconstituted template-free (TF) telomerase were 
analyzed with specific DNA/RNA hybrid substrate to determine linear product 
formation for the KM measurements of nucleotide incorporation over time (0, 20, 40, 
60, and 80 min). Numbers below the DNA/RNA duplex indicate positions 
corresponding to the telomerase template and the order of nucleotides incorporated. 
The nucleotide incorporation KM values measured are indicated (black arrow). The 
DNA products were labeled by incorporating a 32P-dATP (0.166 µM, asterisk) prior 
to the KM measurement. (B) Representative gel for linear product formation for the 
KM measurements of nucleotide incorporation over time. A 
32P end-labeled DNA 
recovery control (r.c.) was added before product purification and precipitation. The 
intensity of total product formation (dA5 and dG6) at various times were normalized 
to the loading control were measured with arbitrary units (a.u.) and were linear. The 
ratio intensity of dG6 over total (dA5 and dG6) was unchanged with time.  (C)  Plots 
derived from the normalized intensity of total product formation (dA5 and dG6) at 
various times revealed a linear relationship between product formation and time. 
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Figure 3.5. KM measurement for nucleotide incorporations in the presence or 
absence of the pause signal.  (A) Sequences of the DNA/RNA hybrid substrates and 
the position of the pause signal mutation. In vitro reconstituted template-free 
telomerase (TF) were analyzed with specific DNA/RNA hybrid substrates to 
determine the apparent KM for each nucleotide incorporation. (B) Representative gels 
for KM
app measurements. An 32P end-labeled DNA recovery control (r.c.) was added 
before product purification and precipitation. (C) Plots derived from the normalized 
intensity of the +2 or +3 product over the total intensity of products for the specified 
nucleotide concentration. The Michaelis–Menten equation, Y=Vmax*X/(KM+X), was 
used to fit the nonlinear curve to determine the KM
app. Two or three replicates were 
performed for each measurement. 
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Figure 3.6. dGTP-dependent repeat addition stimulation of human telomerase. 
(A) Schematic of the dual function of the template-embedded pause signal (red box). 
The pause signal defines the 5’ template boundary (black arrow) by inhibiting non-
telomeric DNA synthesis beyond the template boundary (Brown et al, 2014b). A 
putative additional function of the pause signal is to limit dG1 incorporation post 
template translocation. (B, C) Direct primer extension assays were performed with 
telomerase enzyme reconstituted in vivo and immuno-purified. Telomerase was 
assayed in the presence of either (B) 0.165 µM 32P-dTTP, 10 µM dTTP and a range of 
dGTP or dATP concentrations, or (C) 0.165 µM 32P-dATP, 10 µM dATP and a range 
of dGTP or dTTP concentrations. A radiolabeled DNA recovery control (r.c.) was 
added before product purification and precipitation. Numbers to the left of the gel 
denote the number of repeats added to the telomeric primer. Ratio as a percent for the 
intensity of high over low M.W. DNA products generated relative to the reaction with 
the low nucleotide concentrations. A bar graph of the relative ratio of high/low M.W. 
DNA products are shown below the gel. The error bars represent standard error of the 
mean determined from three independent replicates.  
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Figure 3.7. Effects of dATP concentration on nucleotide incorporation. (A) Direct 
primer extension assays were performed with native telomerase reconstituted in vivo 
and immuno-purified. The DNA primer substrate was extended in the presence of 32P-
dTTP, 10 µM dGTP and a range of dATP concentrations (0.5, 1, 2, 5, 10, 20, 50 and 
100 µM).  (B) Quantitation of intermediate product accumulation from dATP 
insufficiency. Plot of band intensity for the stalling DNA product (+14 nt) with 14 
nucleotides added (two repeats plus 4 nucleotides) over the major product (+2 repeats) 
with two repeats added and normalized for total telomerase activity. 
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Figure 3.8. Effects of dGTP on repeat addition processivity and rate. (A) 
Stimulation of repeat addition processivity with dGTP. In vivo reconstituted 
telomerase enzyme was assayed by the product release analysis in the presence of 
0.165 µM 32P-dTTP, 10 µM dTTP as well as either 10 or 100 µM of dGTP and dATP. 
The enzyme-bound and released DNA products were separated and individually 
analyzed. (B) Quantitation of repeat addition processivity. The intensities of the 
released DNA products with 3-12 repeats added were quantitated and normalized to 
the intensity of the product with 3 repeats added. The relative intensities of major 
bands were plotted against the number of repeats added to determine slopes that 
correspond to the relative processivity from each reaction (see Materials and Methods 
section). (C) Relative repeat addition processivity under different nucleotide 
concentrations. A bar graph indicates the fold change of the relative repeat addition 
processivity under either 10 or 100 µM of dGTP and dATP. The error bars represent 
standard error of the mean determined from two independent replicates. (D) 
Schematic of pulse-chase time course analysis. During the pulse reaction, the DNA 
primer (TTAGGG)3 was labeled with 0.165 µM 
32P-dTTP (asterisk) by the telomerase 
enzyme. During the chase reaction, the enzyme-bound radiolabeled DNA primer was 
extended processively with telomeric repeats under 100 µM cold dTTP as well as 
either 10 or 100 µM of dGTP and dATP for 5, 10, 15 or 20 mins. (E) Repeat addition 
rate measured by the pulse-chase time course analysis under differing nucleotide 
concentrations. The vertical lines on the gel indicate the major bands of telomere 
products synthesized during the chase reactions. Repeat addition rates are expressed 
as repeats per minute (see Materials and Methods) and indicated below the gel. The 
standard error of the mean was determined from two independent replicates. 
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Figure 3.9. The dG1 incorporation and telomerase repeat addition activity.  (A). 
Sequences of hTR mutant templates and DNA primers used in this assay. The wild-
type hTR template specifies for the incorporation of three dG residues, dG1, dG2, and 
dG6. The mutant hTR templates, 51U, 50U and 46/52U, harbor rC-to-rU template 
mutations (orange) that specify incorporations of non-telomeric dA1, dA2 and dA6 
(orange), respectively. The telomerase template mutants were assayed with 
corresponding DNA primers as depicted. (B) Direct primer extension assays of 
telomerase template mutants. Wild-type and mutant telomerases were reconstituted in 
vivo and the immuno-purified enzymes were assayed in the presence of 0.165 µM 32P-
dTTP, 10 µM dTTP as well as either 10 or 100 µM of dGTP and dATP. Ratio as a 
percent for the intensity of high over low M.W. DNA products generated relative to 
the wild-type telomerase reaction with the low nucleotide concentrations. A bar graph 
of the relative ratio of high/low M.W. DNA products are shown below the gel. 
Standard error of the mean was determined from three independent replicates. 
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Figure 3.10. Effects of dATP on repeat addition processivity and rate for the 
telomerase mutant hTR-51U. (A) dATP-dependent stimulation of repeat addition 
processivity with the hTR-51U mutant. In vivo reconstituted telomerase enzyme was 
assayed by the product release analysis in the presence of 0.165 µM 32P-dTTP, 10 µM 
dTTP as well as either 10 or 100 µM of dGTP and dATP. The enzyme-bound and 
released DNA products were separated and individually analyzed. (B) Quantitation of 
repeat addition processivity. The intensities of the released DNA products with 3-12 
repeats added were quantitated and normalized to the intensity of the product with 3 
repeats added. The relative intensities of major bands were plotted against the number 
of repeats added to determine the slopes that correspond to the relative processivity 
from each reaction. (C) Relative repeat addition processivity under different 
nucleotide concentrations. A bar graph indicates the fold change of the relative repeat 
addition processivity under either 10 or 100 µM of dGTP and dATP. The error bars 
represent standard error of the mean determined from two independent replicates. (D) 
Schematic of the pulse-chase time course analysis for the telomerase mutant hTR-
51U. During the pulse reaction, the DNA primer (TTAGGG)2TTAGAG was labeled 
with 0.165 µM 32P-dTTP (asterisk) by the telomerase hTR-51U enzyme. During the 
chase reaction, the enzyme-bound radiolabeled DNA primer was extended 
processively with telomeric repeats under 100 µM cold dTTP as well as either 10 or 
100 µM dGTP and dATP for 5, 10, 15 or 20 mins. (E) Repeat addition rate measured 
by the pulse-chase time course analysis under differing nucleotide concentrations. A 
radiolabeled DNA recovery control (r.c.) was added before product purification and 
precipitation. The vertical lines on the gel indicate the major bands of telomere 
products synthesized during the chase reactions. Repeat addition rates are expressed 
as repeats per minute and indicated below the gel. The standard error of the mean was 
determined from two independent replicates. 
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Figure 3.11. Telomerase utilizes deoxynucleoside diphosphates as substrate. (A) 
Direct primer extension assays were performed with telomerase enzyme reconstituted 
in vivo and immuno-purified. Telomerase was assayed in the presence of 0.165 µM 
32P-dTTP, 10 µM dTTP, 100 µM dATP as well as combinations of either 10 or 100 
µM of dGMP, dGDP or dGTP. (B) Utilization of dGDP by RTs. Specific DNA/RNA 
hybrid substrates depicted harbor a template sequence for the incorporation of a single 
dA and a dG residue. (C) Utilization of dGDP by DNA-dependent DNA polymerases. 
A DNA/DNA hybrid substrate depicted harbor a template sequence to allow for 
incorporation of a single dA and a dG residue. Taq DNA polymerase (pol) and the 
Klenow fragment of DNA polymerases I were assayed in the presence of 0.165 µM 
32P-dATP (asterisk) and either dGMP, dGDP or dGTP. Numbers to the right of the gel 
denote the identity of nucleotides added. 
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Figure 3.12. The utilization of deoxynucleoside diphosphates as substrate for 
telomerase nucleotide addition. (A) Schematic of nucleotide addition with native 
telomerase. The order of the nucleotides, TTAG, added prior to first template 
translocation was depicted. The DNA products were labeled with 32P-dTTP (circled). 
(B) Telomerase was assayed in the presence of 32P-dTTP and 100 µM dGTP with 
either 10 or 100 µM of dAMP, dADP and dATP. An 32P end-labeled DNA recovery 
control (r.c.) was added before product purification and precipitation. (C) Schematic 
of nucleotide addition with a 32P-end-labeled DNA primer and native telomerase. The 
order of the nucleotides, TTAG, added prior to first template translocation was 
depicted. The DNA primer was 32P end-labeled to eliminate the need of including 32P-
dTTP in the dNDP-only reaction. (D) Telomerase was assayed in the presence of 
either 10 or 100 µM deoxynucleoside diphosphates (dGDP, dTDP, dADP) or 
deoxynucleoside triphosphates (dGTP, dTTP, dATP). Direct primer extension assays 
were performed with telomerase enzyme reconstituted in vivo and immuno-purified. 
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Figure 3.13. Utilization of dGDP as substrate by the AMV RT and T4 DNA 
polymerase. Sequences of the DNA/RNA or DNA/DNA hybrid substrates are shown 
above the gels. The templates of the substrates specify incorporation for a dA and a 
dG residue. The enzymes were assayed with 0.166 µM 32P-dATP (asterisk) and either 
dGMP, dGDP or dGTP at 100 µM. 
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Figure 3.14. Effects of pause signal removal on telomerase repeat addition. (A) 
Schematic of wild-type and hTR Δpause template mutant telomerase with 
corresponding DNA primers. The hTR Δpause template mutant harbors rA-to-rU 
mutations (orange) at four residues: 48, 49, 54, and 55 to eliminate the template-
embedded pause signal (red box). (B) Direct primer extension assays for the 
telomerase Δpause template mutant. Wild-type and mutant telomerases were 
reconstituted in vivo and the immuno-purified enzymes were assayed in the presence 
of 0.165 µM 32P-dATP, 10 µM dATP as well as either 10, 20 or 50 µM of dGTP. 
Relative repeat addition activity was presented as the ratio of the intensity of high 
over low M.W. DNA products generated in each reaction normalized to the wild-type 
enzyme reaction with 10 µM dGTP. A bar graph of the relative ratio of high/low 
M.W. DNA products are shown below the gel. Standard error of the mean was 
determined from three independent replicates. 
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Figure 3.15. Effects of dGTP on repeat addition processivity and rate of the 
hTR-Δpause mutant telomerase. (A) Lack of stimulation of repeat addition 
processivity with dGTP for the telomerase mutant hTR-Δpause. In vivo reconstituted 
telomerase enzyme was assayed by the product release analysis in the presence of 
0.165 µM 32P-dATP, 10 µM dATP as well as either 10 or 100 µM of dGTP. The 
enzyme-bound and released DNA products were separated and individually analyzed. 
(B) Quantitation of repeat addition processivity. The intensities of the released DNA 
products with 3-12 repeats added were quantitated and normalized to the intensity of 
the product with 3 repeats added. The relative intensities of major bands were plotted 
against the number of repeats added to determine the slopes that correspond to the 
relative processivity from each reaction. (C) Relative repeat addition processivity 
under different nucleotide concentrations. A bar graph indicates the fold change of the 
relative repeat addition processivity under either 10 or 100 µM of dGTP for wild-type 
and the hTR-Δpause mutant. The error bars represent standard error of the mean 
determined from two independent replicates. (D) Schematic of the pulse-chase time 
course analysis for the telomerase mutant hTR-51U. In the pulse reaction, the DNA 
primer (TTAGGG)2AAAGGG was labeled with 0.165 µM 32P-dATP (asterisk) by the 
telomerase hTR-Δpause enzyme. During the chase reaction, the enzyme-bound 
radiolabeled DNA primer was extended processively with telomeric repeats under 100 
µM cold dATP as well as either 10 or 100 µM dGTP for 5, 10, 15 or 20 mins. (E) 
Repeat addition rate measured by the pulse-chase time course analysis under differing 
nucleotide concentrations. A radiolabeled DNA recovery control (r.c.) was added 
before product purification and precipitation. The vertical lines on the gel indicate the 
major bands of telomere products synthesized during the chase reactions. Repeat 
addition rates are expressed as repeats per minute and indicated below the gel. The 
standard error of the mean was determined from two independent replicates. 
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Figure 3.16. The template immediately-adjacent non-telomeric-encoding 
nucleotide is accessible at the end of telomeric DNA repeat synthesis. (A) 
Schematic of hTR-T6 template permutation shifting the pause site (red hexagon) one 
nucleotide after the physical template boundary (violet triangle). Within the hTR-T6-
45G template mutant, the template immediately-adjacent non-telomeric-encoding 
nucleotide at the 5’-end of the template is mutated from an rU to an rG (orange 
lowercase) to monitor for template bypass in the presence of dCTP in the reaction. (B) 
Direct activity assay with in vivo reconstituted hTR-T6-45G telomerase in the 
presence of 32P-dATP with a range of dCTP concentrations or as a control for mis-
incorporation or terminal transferase activity a range of dTTP concentrations. 
Quantitation of band intensity before (+1, black) and after (+2, red) the physical 
template boundary over total activity. 
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Figure 3.17. The sequence-defined pause, and not template translocation process, 
underlies dGTP-specific processivity stimulation. (A) Uncoupling the sequence-
defined pause site from the physical boundary. In the wild-type hTR template, the 
pre-translocation pause site (red hexagon) and physical boundary boundary (violet 
triangle) coincide at the end of the template. The post-translocation pause site (red 
hexagon) coincides with the position of first nucleotide incorporation. The sequence 
permutation in the hTR-T6 template mutant shifted the pause site one nucleotide 
downstream from the physical boundary and the position of first nucleotide 
incorporation. (B) Schematic of the telomerase catalytic cycle with the hTR-T6 
template mutant. After reaching the physical template boundary, the hTR-T6 mutant 
undergoes template translocation and incorporates a dG residue (+4, violet) as the first 
nucleotide, followed by a second dG residue (+5, red) at the shifted pause site. (C) 
Schematic of hTR-T6 template mutations, T6-U51 and -U50, that alter the first or 
second nucleotide incorporated from dG to dA (shaded) immediately following 
template translocation. The mutated residues in the hTR-T6 template are indicated 
(orange lowercase). The first (violet) and second (red) residues incorporated 
following template translocation are also denoted. (D) Altering the nucleotide 
incorporated following the pause signal—and not the template translocation—shifts 
the nucleotide-specific processivity stimulation. Direct activity assay of the hTR-T6 
telomerase template mutants. The assays were performed in the presence of 32P-dTTP 
with either 10 or 100 µM dGTP and dATP. An end-labeled DNA recovery control 
(r.c.) was added before product purification and precipitation. Relative processivity is 
shown below the gel. (E) The bar graph of fold change compared to the low-
nucleotide-concentration reaction. The error bars represent standard error of the mean 
determined from three replicates. 
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Figure 3.18. A working model of the telomerase catalytic cycle. Following 
telomerase binding the 3’-end of the telomere, nucleotide addition of six residues 
(violet and blue circles) proceeds to the end of the template and is arrested by the 
pause signal (red box) at the pause site. A fast template translocation process 
regenerates the template by realigning the template relative to the 3’-end of the DNA 
primer. Progression to the next catalytic cycle is impeded by the still active pause 
signal from the DNA/RNA hybrid, causing a slow dG1 residue incorporation (violet) 
at the pause site. Failure to incorporate the dG1 residue promotes product release, 
which is counteracted by DNA-protein interactions through the TERT anchor sites 
and telomerase accessory POT1-TPP1 protein complex. Successful dG1 residue 
incorporation is proceeded by the rapid incorporation of five additional residues, dG2, 
dT3, dT4, dA5, and dG6 (blue), completing a telomerase catalytic cycle. The number of 
repeats added corresponds to the number of catalytic cycles completed before 
complete disassociation of the telomeric DNA from the telomerase enzyme. 
Increasing the dGTP concentration increases the rate of the slow dG1 residue 
incorporation, which increases telomerase repeat addition processivity and rate. 
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CHAPTER 4 
THE MOLECULAR MECHANISM UNDERLYING THE TELOMERASE MOTIF 
T K570A MUTATION 
4.1 Abstract 
Linear chromosomal ends in eukaryotes are protected by telomeres, a 
nucleoprotein structure that contains repetitive telomeric DNA sequences and 
associated proteins. Telomerase is an RNA-dependent DNA polymerase that adds 
telomeric DNA repeats to the 3’ ends of chromosomes to offset the loss of terminal 
DNA repeats during DNA replication. It consists of two core components: a telomerase 
reverse transcriptase (TERT) and a telomerase RNA (TR). Even though the crystal 
structures of TERT and TR domains have provided important structural information a 
co-crystal ribonucleoprotein structure is lacking still. The telomerase RNA binding 
domain (TRBD) of TERT contains a unique motif T, which is conserved universally 
among TERTs, but not in conventional reverse transcriptase. Motif T folds into a β-
loop structure and is located facing the binding pocket of the substrate DNA and 
template RNA duplex based on the crystal structure of Tribolium TERT. 
Comprehensive alanine screening mutagenesis identified residue K570 in motif T 
crucial for telomerase enzymatic function. The positive charge as well as the position 
of this residue is indispensable for nucleotide addition in human telomerase. We also 
demonstrated that the K570A mutant shows binding defects with the telomeric DNA 
substrate as well as DNA/RNA duplex in the active site, thus increasing the apparent 
Km
app of the incorporation of nucleotide for DNA synthesis. The results from these 
experiments will add to our current understanding of TERT structure/function 
relationships and the molecular mechanism of telomerase action. 
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4.2 Introduction 
Telomerase is a unique reverse transcriptase crucial for the de novo synthesis 
of telomeric DNA repeats onto chromosomal termini to counter progressive telomere 
shortening resulting from incomplete end replication (Ohki et al, 2001). Highly 
proliferative cells, including germline and stem cells, require telomerase for proper 
telomere length maintenance (Shawi & Autexier, 2008). Telomerase is undetectable 
in human somatic cells, but up-regulated in nearly 90% of cancer cells (Shay & Keith, 
2008). Some inherited human diseases, such as aplastic anemia, dyskeratosis 
congenita and idiopathic pulmonary fibrosis, have been linked to telomerase gene 
mutations that result in telomere shortening and growth defects in stem cells 
(Armanios, 2009; Armanios et al, 2007). The telomerase core enzyme is minimally 
composed of the catalytic telomerase reverse transcriptase (TERT) and the integral 
telomerase RNA (TR) (Collins, 2006). TR varies greatly in size between organisms 
ranging from 159 nt to over 2000 nt (Qi et al, 2013). In contrast, TERT is highly 
conserved among different species. The TERT protein contains four structural 
domains, including the TERT essential N-terminal domain (TEN), the Telomerase 
RNA binding domain (TRBD), the reverse transcriptase domain (RT) and the C-
terminal extension (CTE). Due to the low abundance of telomerase in human cells and 
difficulties in over-expression of soluble full length TERT protein, structural 
determination of the telomerase ribonucleoprotein complex has been limited to 
individual domains of TERT and TR (Miracco et al, 2014). The recently solved 
crystal structure of the TRBD from Takifugu rubripes and Oryzias latipes indicate 
that the structures have mainly alpha helical topology, similar to Tribolium castaneum 
TRBD and Tetrahymena thermophila TRBD (Harkisheimer et al, 2013; Huang et al, 
99 
 
2014; Mitchell et al, 2010; Rouda & Skordalakes, 2007). TRBD contains an 
indentation on its surface formed by two conserved motifs, motif T and CP 
(Harkisheimer et al, 2013; Huang et al, 2014).  
The motif T, which lies within the telomerase RNA binding domain of hTERT 
was recognized as being highly conserved and telomerase specific. Based on the 
crystal structure of Tribolium castaneum TERT (tcTERT) complexed with a synthetic 
RNA/DNA duplex showed that the 5' end of the RNA template is located at the entry 
site of the T-CP pocket (Mitchell et al, 2010). The motif T is the first non-RT motif 
shown to be necessary for telomerase activity (Nakamura et al, 1997). The T motif is 
encoded by amino acids 547–594 in human, within which lies a near-universally 
conserved sequence motif, FYXTE. Mutagenesis of residues within this motif results 
in varying degrees of reduced telomerase activity, as well as significantly increased 
telomere extension rates, without affecting either hTR binding or enzyme processivity 
(Drosopoulos & Prasad, 2010). Use of the telomerase repeat amplification protocol 
(TRAP) to functionally analyze the mutated residue (K570N) demonstrated a drastic 
reduction in telomerase activity, correlating with severely shortened telomere length 
(Xin et al, 2007). Two motif T variants, T567M and K570N, identified in dyskeratosis 
congenita patients have been demonstrated to reduce telomerase repeat addition 
processivity (Gramatges et al, 2013).  
Recently it was found that telomerase with the T-motif loop substitution 
K570A failed to protect a substantial amount of product telomeric DNA from 
exonucleases. It was proposed the T-motif loop cooperates with the thumb loop and 
thumb helix to contribute to a ssDNA retention surface (SRS) that overlaps the 
binding surface of the DNA strand of template duplex (Wu et al, 2017). Our data 
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support the biological importance of K570 residue for the efficiency of nucleotide 
addition by binding to DNA/RNA duplex close to the active site, which is necessary 
for the maintenance of telomeres. The aim of this study is to understand the 
structure/function relationship of how telomerase handles the substrate and how it 
affects telomerase repeat addition processivity. In addition, a cellular limit on active 
telomerase level appears necessary for normal telomere length homeostasis. 
Elucidation of telomerase function could potentially facilitate the development of 
effective treatments for telomerase-related diseases.  
4.3 Material and Methods 
Plasmid construction and mutagenesis.  
Specific mutations in the human TERT genes were introduced into the 
pNFLAG-hTERT by site directed mutagenesis using overlapping PCR strategy (Ge & 
Rudolph, 1997). Intended mutations were confirmed by sequencing. 
In vitro reconstitution of human telomerase.  
Human TERT protein was expressed in rabbit reticulocyte lysate (RRL) from 
the pNFLAG-hTERT plasmid DNA using the TnT T7 Quick Coupled 
transcription/translation kit (Promega) following manufacturer's instructions (Xie et 
al, 2010). For quantitation, hTERT was synthesized in the presence of 35S-Methionine 
(>1000 Ci/mmol, 10.2 mCi/ml, Perkin-Elmer) and analyzed by SDS–PAGE. The hTR 
pseudoknot (residues 32–195) and CR4/5 (residues 239–328) fragments were in vitro 
transcribed, gel purified, and assembled together with the TERT protein in RRL for 
30 min at 30°C at a final concentration of 1.0 μM (Brown et al, 2014; Qi et al, 2012). 
For template free human telomerase, the hTR pseudoknot (residues 64–184) and 
CR4/5 (residues 239–328) fragments were in vitro transcribed, gel purified, and 
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assembled together with the TERT protein in RRL for 30 min at 30°C at a final 
concentration of 1.0 μM (Brown et al, 2014; Qi et al, 2012). 
In vivo reconstitution of human telomerase.  
HEK 293FT cells were grown in DMEM medium (Corning) supplemented 
with 10% FBS (Atlanta Biological), 1x Penicillin-Streptomycin-Amphotericin B mix 
(Lonza) and 5% CO2 at 37°C to 80–90% confluency. Cells in a 6-well plate were 
transfected with 0.4 μg of pcDNA-nFLAG-hTERT wild type or K570A mutant, 1.6 
μg of pBS-U1-hTR wildtype or template mutants using 6 μL of Fugene HD 
transfection reagent (Promega) following manufacturer’s instruction. Cells were 
harvested 48 hours post transfection, homogenized in HEPES lysis buffer (20 mM 
HEPES-KOH, pH 7.9, 400 mM NaCl, 0.2 mM EGTA, 2 mM MgCl2, 10% glycerol, 5 
mM -mercaptoethanol and 1x complete protease inhibitor cocktail (Roche), 1 mM 
PMSF), incubated on ice for 30 min and the lysate clarified by centrifugation. Two 
hundred microliters of cell lysate were combined with 30 μL Anti-FLAG® M2 Beads 
(Sigma) pre-washed with 1X TBS buffer (50 mM Tris-HCl, pH 7.4 and 150 mM 
NaCl) and incubated at 4°C with gentle rotation for 1 hour. The beads were washed 
three times with 100 μL of 1x TBS buffer and once with 50 μL 1x telomerase reaction 
buffer (50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 50 mM KCl, 2 mM DTT and 1 mM 
spermidine), followed by activity assay. 
Telomerase direct primer-extension assay.  
Two microliters in vitro reconstituted telomerase enzyme or 20 μL of 
immuno-purified in vivo reconstituted telomerase enzyme on beads was assayed in a 
10 μL reaction containing 1x telomerase reaction buffer, 1 μM DNA primer, specified 
dNTPs and 0.165 μM of the denoted α-32P-dNTP. Reactions were incubated at 30°C 
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for 60 min and terminated by phenol/chloroform extraction, followed by ethanol 
precipitation. The DNA products were resolved on a 10% (wt/vol) polyacrylamide/8 
M Urea denaturing gel, dried, exposed to a phosphorstorage screen and imaged on a 
Bio-Rad FX-Pro phosphorimager.  
KM
app measurement using native telomerase.  
Twenty microliters of immuno-purified in vivo reconstituted telomerase 
enzyme on beads was assayed in a 10 μL reaction containing 1x telomerase reaction 
buffer, 1 μM DNA primer, specified dNTP or ddNTPs and 0.165 μM of the denoted 
α-32P-dNTP. For measuring the KMapp values, the activity assays were performed with 
deoxynucleotide or dideoxynucleotide concentrations varying from 0 to 200 µM, or 
up to 1 mM for high KM measurement. Reactions were incubated at 30°C for 60 min 
and terminated by phenol/chloroform extraction, followed by ethanol precipitation. 
The DNA products were resolved on a 10% (wt/vol) polyacrylamide/8 M urea 
denaturing gel, dried, exposed to a phosphorstorage screen and imaged on a Bio-Rad 
FX-Pro phosphorimager. The intensities of specific products were normalized to the 
total product intensity and plotted against the nucleotide concentrations with the 
Michaelis-Menten equation, Y=Vmax*X/(Km+X), used to fit the nonlinear curve to 
determine the KM
app (Prism 5, Graphpad Software). 
Duplex KM measurement using TF telomerase.  
One microliter of RRL reconstituted TF telomerase enzyme was assayed in a 
10 μL reaction containing 1X telomerase reaction buffer, specified dNTPs and 0.165 
μM of the denoted α-32P-dNTP. For measuring the KM values of the duplex, the 
activity assays were performed with DNA/RNA duplex concentrations varying from 0 
to 200 µM. Reactions were incubated at 30°C for 60 min and terminated by 
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phenol/chloroform extraction, followed by ethanol precipitation. The DNA products 
were resolved on a 15% (wt/vol) polyacrylamide/8 M urea denaturing gel, dried, 
exposed to a phosphorstorage screen and imaged on a Bio-Rad FX-Pro 
phosphorimager. The quantification is same as described above. 
N. crassa telomerase and T. brucei in vitro reconstitution and telomerase activity 
assay.   
The N. crassa and T. brucei telomerases were in vitro reconstituted as 
previously described (Bley et al, 2011; Podlevsky et al, 2016; Qi et al, 2013). 
Recombinant ncTERT and tbrTERT protein were synthesized from pCITE-NFLAG-
N.crassa and pCITE-NFLAG-T.brucei in a 10 µL reaction of TnT Quick-coupled 
transcription/translation kit (Promega) at 30°C for 60 min, following the 
manufacturer’s instructions. N. crassa TERT was assembled with N. crassa TR RNA 
fragments T/PK (nt 225- 1515, Δ463-1288/GGAC, Δ256-433/GAAA) and TWJ (nt 
1813-1877); and T.brucei TERT was assembled with T.brucei TR RNA fragments 
template core (nt 279-414) and eCR4/5 (nt 781-819). RNA fragments were in vitro 
transcribed, gel purified, and added at a final concentration of 1 µM to assemble with 
tbrTERT in RRL. 
The telomerase assay was carried out with 2 μl of in vitro reconstituted 
telomerase in a 10 μl of reaction. For N. crassa and T.brucei telomerase assays, the 
reaction contained 1x reaction buffer (50 mM Tris- HCl (pH 8.0), 0.5 mM MgCl2, 1 
mM spermidine, 2 mM DTT), 100 μM dATP, 1 μM dTTP, 5 μM dGTP, 0.165 μM α-
32P-dGTP (3000 Ci/mmol, 10 mCi/ml, PerkinElmer) and 1 μM DNA primer 5’-
(TTAGGG)3-3’. The reactions were incubated at 30°C for 60 min and terminated by 
phenol/chloroform extraction, followed by ethanol precipitation. Telomerase extended 
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products were resolved on a denaturing 8M urea/10% polyacrylamide gel. The dried 
gel was exposed to a phosphor storage screen and analyzed with a Bio-Rad FX Pro 
Molecular Imager. 
 Koff measurements using native telomerase.  
Twenty microliters of immuno-purified in vivo reconstituted telomerase 
enzyme on beads was assayed in an 8 μL reaction containing 1x telomerase reaction 
buffer, 0.1 μM DNA primer (TAGGGT)3 for 10 min at 30 °C. Then addition of the 1 
µL (TAGGGT)4 challenge primer (10 µM). At times denoted added to 1 µL 0.165 μM 
α-32P-dTTP (3000 Ci/mmol, 10 mCi/ml, PerkinElmer) and labeled for 10 min at 
30 °C. Reactions were terminated by phenol/chloroform extraction, followed by 
ethanol precipitation. The DNA products were resolved on a 10% (wt/vol) 
polyacrylamide/8 M urea denaturing gel, dried, exposed to a phosphorstorage screen 
and imaged on a Bio-Rad FX-Pro phosphorimager. The intensities of initial primer 
products were normalized to the total product intensity. The rate constants were 
determined by fitting the data to the equation y=Aexp(-kt) (where A represents the 
amount of primer in complex at time zero, k is the rate constant, and t is the time in 
minutes), using the Prism software package (Prism 5, Graphpad Software). 
4.4 Results 
Alanine mutagenesis of motif T residue K570 displays defects in telomerase function.  
The telomerase specific motif T, located in the TRBD domain of TERT was 
previously found to contain a universally conserved sequence “FYXTE” within a β-
loop structure in many species (Figure 4.1A). Two disease mutations were discovered 
in the motif T region of human TRBD: T567M and K570N (Gramatges et al, 2013). 
The defects of these mutants were consistent with previous results that have shown a 
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conserved region inside motif T affect repeat addition rate (Drosopoulos & Prasad, 
2010). To experimentally determine the function of motif T, comprehensive alanine 
screening mutagenesis on each residue of motif T was performed. Coding sequence 
mutations were created by overlap extension PCR (from residue 561- 577). These 
motif T mutants were expressed and reconstituted in RRL with in vitro transcribed 
hTR for activity and processivity assays. The activity of each mutant was normalized 
by 35S-labeled hTERTs. While various mutations showed different levels of 
telomerase activity, the K570A mutant, like the K570N disease mutant previously 
described, had dramatically decreased repeat addition processivity. (Figure 4.1B) 
These differences could not be accounted for by differences in hTERT expression 
levels. A similar processivity defect of K570A mutant was observed using telomerase 
reconstituted in vivo (Figure 4.2). The telomeric DNA substrate can be extended to 
reach the end of the template (+4) by K570A mutant, but the activity significantly 
decreases after the first repeat. The intermediate bands before reaching the end of the 
template (+4) means more product release during the nucleotide addition. It suggests 
that K570 residue in hTERT plays an important role for telomerase catalytic function. 
Different substitutions or position of K570 affects telomerase activity and 
processivity.  
To further investigate the possible roles of the motif T regulate telomerase 
enzymatic function, based on a homology threading model made of Takifugu rubripes 
TERT using Tribolium TERT DNA/RNA duplex co-crystal and Takifugu rubripes 
TRBD crystal structure.  Motif T is located close to a substrate duplex in the active 
site (Harkisheimer et al, 2013). The position of motif T in this model makes it 
possible to directly interact with the duplex in the active site or with the single 
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stranded DNA to facilitate template translocation. It is also easy to imagine that motif 
T may interact with the 5’ region of the single stranded RNA template. According to 
the threading model of hTRBD through trTRBD with DNA/RNA duplex, K570 is 
located in the middle of the β-loop and is very close to the 3' end of the DNA 
substrate or 5’ end of the RNA template. (Figure 4.3A)  
To investigate a possible role of K570 interacting with DNA/RNA duplex 
within the active site, we created various substitutions of K570 and assayed 
telomerase function. The mutants were reconstituted in RRL with hTR for activity 
assays and normalized by 35S-labeled hTERTs. The wild type hTERT as well as 
mutants of flanking residues of K570 was used as a control. The substitutions of K570 
to neutral residues (glutamine or asparagine) showed the same phenomenon as 
K570A, which decreased processivity significantly to only completing one repeat 
addition (+4). (Figure 4.3B) The K570D and K570E mutants showed worst defects in 
nucleotide addition with neither of them unable to reach the end of the template. 
Intriguingly, K570R mutant showed nearly native telomerase activity. The arginine is 
the only substitution which can rescue the telomerase processivity while histidine 
failed (Figure 4.3B).  Both arginine and lysine are positively charged amino acids 
with a linear side chain, this suggests that the positively charged linear side chain of 
this residue is required for telomerase activity, which may interact with the negatively 
charged DNA/RNA duplex in the active site. Additionally, the insertion or deletion of 
residues flanking K570, drastically reduced telomerase processivity similar to the 
K570A mutant (Figure 4.3B). This indicates that the position of K570 residue is vital 
for telomerase activity. Altered position of K570 residue could disrupt the local 
structure near the active site, thus hindering the interaction of K570 residue with the 
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hybrid duplex. Furthermore, motif T mutants in N. crassa and T. brucei were tested 
via alanine screening mutagenesis as well. Residues corresponding to K570 (hTERT) 
based on amino acid sequence alignments, also showed processivity defects (Figure 
4.4). This indicates evolutionarily conservation of the charge and position of the 
residue is critical for telomerase enzymatic function. 
K570A mutants are defective in utilizing short DNA primers. 
The K570A mutant that disrupted telomerase processivity, presumably 
affected either the template realignment or product release during template 
translocation. Collectively, the information from the crystal structure and functional 
assays suggest that K570 may interact with DNA/RNA duplex close to the catalytic 
active site to regulate template translocation. To test this, various short primers that 
can base pair with RNA template, but leave no single stranded overhang for the TEN 
domain anchor site to bind have been analyzed. This assay eliminates discounts the 
effect of the TEN domain on substrate binding (Lue et al, 2003). To study the specific 
function of K570, other TERT mutants were used as controls: mutations N95A in the 
TEN domain and L980A in CTE have been previously shown to reduce telomerase 
processivity (Huard et al, 2003; Lue et al, 2003; Moriarty et al, 2005). Mutations 
D682A and D684A in motif 3 have been demonstrated to respectively decrease and 
increase processivity by interacting with DNA/RNA duplex (Xie et al, 2010). Upon 
feeding a short 8 mer telomeric DNA substrate, the K570A mutant completely fails to 
synthesize a single repeat (Figure 4.5). While wild type telomerase can utilize all 
primers and exhibit similar activity. The K570A as well as D682A and L980A 
mutations cannot use the short primer as substrate. D682A and L980A have been 
shown to compromise the ability of TERT in promoting DNA/RNA duplex formation 
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or positioning the duplex to the active site for the first repeat synthesis. While the 
N95A mutant, having low processivity, can extend the short primer efficiently shows 
that TEN domain does not play a role in facilitating primer/template realignment but 
in preventing product release during template translocation. This indicates K570 may 
act together with any other residues of motif 3 and CTE to interact with the 
DNA/RNA duplex for template translocation.  
The K570A mutants retain stimulation by elevated dGTP concentration 
It has been previously reported that elevated dGTP concentrations positively 
correlate with a repeat addition processivity for human telomerase. To investigate 
whether K570A mutant telomerase activity could be affected by nucleotide 
concentration, I performed telomerase primer extension assays in the presence of 32P-
dGTP with increasing concentrations (10, 50 and 200 µM) of the individual dTTP or 
dATP nucleotides or unlabeled dGTP (5, 10 and 20 µM) (Figure 4.6). Since K570A 
mutant is not processive, we use the intensity of product released after second repeat 
(+10) / intensity of the product released after the first repeat (+4) to evaluate the 
repeat addition efficiency. In the wild type human telomerase, it is consistent with 
previous results that the elevation of dGTP concentration increased the band intensity 
ratio +10: +4, while the concentration of dATP and dTTP had no significant effect on 
repeat addition efficiency. Meanwhile, elevated dGTP concentrations at 10 and 20 
µM significantly increased the ratio of +10 over +4 of K570A mutant by 
approximately 2 and 3 folds compared to 5 µM dGTP. This indicates that the motif T 
mutant, K570A, does not abrogate the stimulation in processive repeat synthesis with 
elevated dGTP concentration. 
Position specific deficiency of K570A mutant for nucleotide incorporation. 
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During the extension of telomeric DNA substrate, the reaction with in vivo 
reconstituted K570A mutant showed much stronger intermediate bands compared to 
wild type before reaching the end of the template (Figure 4.7). This indicates that the 
mutant may have nucleotide incorporation defects. To investigate the nucleotide 
addition efficiency of K570A mutants we measured the apparent KM (KM
app) value of 
nucleotide incorporation. I reconstituted human telomerases in vivo in human 
HEK293 cells, following by assays on immuno-purified enzyme with (TAGGGT)3 
DNA primers in the presence of 32P-dTTP and titration of dATP. KM
app for dATP 
incorporation was approximately 0.5 µM for native wild type enzyme, compared to 
the remarkably high 8.5 µM in K570A mutant (Figure 4.8A). The extra band shown 
from wild type telomerase at high concentration of the dATP could be due to mis-
incorporation or terminal transferase activity (Lue et al, 2005) (Figure 4.9). To 
eliminate the extra-band and test the KM
app at other positions, permutated telomeric 
DNA primers are employed in the presence of varying 32P-dNTP and titration of 
ddNTP for KM
app measurement. KM
app for ddATP incorporation was about 0.76 µM 
for wild type enzyme, compared to 11 µM in K570A mutant (Figure 4.8A). The 
mutant still has much higher KM
app compared to the wild type enzyme, and both 
values are close to that of dATP. It suggests that ddNTP could be used to estimate the 
incorporation nucleotide at other positions of the template, where KM
app 
measurements with dNTP titration is technically challenging. The result demonstrates 
that KM
app for ddGTP at the end of the template (hTR 46) is 0.3 µM for the wild type 
telomerase and 9 µM for K570A. Interestingly, the KM
app for the first dT (hTR 49) is 
comparable between wild type and mutant enzymes, which is 2.5 µM and 3 µM 
respectively (Figure 4.8A). However, the hTR 49U mutant shows the same 
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phenomenon. The KM
app for wild type TERT with hTR 49U mutation is 1.1 µM and 
0.7 µM for K570A with hTR 49U mutation (Figure 4.8B). It indicates that K570A 
mutant has position specific nucleotide incorporation defects, instead of bias on 
purine over pyrimidine. Particularly, the middle position of the template, the apparent 
KM is less affected in the mutant. It suggests that the K570A mutant may play a role 
for type I template translocation for nucleotide repeat addition when reaching the end 
of the hTR template by handling DNA/RNA duplex. This is further verified by the 
comparison of KM
app value between the wild type hTERT and K570A with hTR 46A 
mutant (Figure 4.8B).  
The K570A mutant shows substrate binding affinity deficiency. 
It has been shown the motif T mutant K570A failed to protect the DNA 
substrate from exonuclease digestion (Wu et al, 2017). The defect of binding affinity 
of K570A to DNA substrate could contribute to the higher KM
app value. To determine 
the binding affinity, we measured the Koff value of telomeric DNA for wild type 
telomerase and K570A mutant. Initially, a saturating concentration of the 18 mer 
(TAGGGT)3 was incubated with in vivo reconstituted immuno-purified enzymes. 
After reaching equilibrium, the enzyme-primer complex was challenged with a large 
excess of a competitive 24 mer (TAGGGT)4 primer, having a different length than the 
original one. Aliquots were removed at different time points and labeled with 32P-
dTTP, which resulted in either the original primer or the competitive primer 
producing a discrete end-labeled product (Figure 4.10A). The intensity of the lower 
band (18+1) representing the product of the initial enzyme-primer complex decreases 
as a function of time. A concomitant increase in the upper band representing the 
product of the competitive primer can also be observed (Figure 4.10B). The ratio of 
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product resulting from the initial enzyme-primer complex over total is assigned the 
value of 100% bound (time zero). Remaining complexes at subsequent times is 
expressed as a fraction of that initial amount (Figure 4.10C). It is noteworthy that a 
major increase of the Koff value of K570A mutant is observed at 0.23 min
-1 (t1/2 ~3 
min) compared with the wild type enzyme which has 0.03 min-1 (t1/2 ~22 min). This 
affinity difference may be attributed to its defects in the ability to incorporate 
incoming nucleotide. 
In template free system K570A mutant shows deficiency to use DNA/RNA duplex in 
the active site. 
The active site of telomerase intrinsically binds the DNA/RNA duplex. The 
binding affinity of DNA/RNA duplex has been shown to correlate with repeat 
addition processivity and template translocation efficiency. To further study the 
interaction of K570 residue with DNA/RNA hybrid in active site, we measured the 
apparent Michaelis constant (KM) value of the DNA/RNA duplex in the template-free 
human telomerase system which lacks the template sequence in the hTR component. 
The wild type human telomerase and K570A mutant were reconstituted in RRL with 
in vitro transcribed template free hTR fragments. The K570A mutant compared to the 
wild type enzyme showed generally lower activity. The activities were normalized by 
35S-labeled hTERTs (Figure 4.11). The mutant had an apparent KM value of 50 M, 
which was considerably higher than the 13 M for the wild-type enzyme (Figure 
4.11).  A lower affinity for the hybrid substrate is expected to result in nucleotide 
addition processivity deficiency. This data is consistent with the Koff value of the 
K570A mutant which shows defects in binding to the DNA substrate in the catalytic 
site. 
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4.5 Discussion 
Repeat addition processivity is a unique property of telomerase, which 
requires repetitive regeneration of the short hTR template. The telomerase catalytic-
cycle transitions through states with many specializations of substrate handling 
required for processive repeat synthesis. Specific interactions between hTERT and 
hTR define the template region, allowing stable active site engagement of the short 
duplex formed in the realignment region, dissociate duplex at the template 5’ end, and 
retain ssDNA during template translocation. Based on the high-resolution structure of 
Tribolium castaneum TERT bound to a model DNA–RNA duplex (Mitchell et al, 
2010), some TERT specific motifs could potentially contact either template strand on 
hTR or telomeric DNA substrate. Including telomerase specific motif T in TRBD, 
motif 3 in RT domain, the thumb helix region in CTE and thumb loop linking the RT 
and CTE domains (Figure 4.12). With mutagenesis studies, substitution of some of 
residues led to decrease in repeat addition processivity for human telomerase, such as 
N666A, L681A, G682A, I686A on motif 3 (Xie et al, 2010); L859, L980A, K981A 
on CTE (Huard et al, 2003); and K570A on motif T. It has also been shown TERT-
mutant enzymes with substitutions in the T-motif loop, thumb loop, and thumb helix 
all failed to unpair protected product from the template 3’ end (Wu et al, 2017). The 
T-motif loop, thumb loop, and thumb helix are deep within the active-site cleft where 
they could potentially discriminate the sequence of the final base-pairs of template 5’ 
end duplex to execute sequences-specified template 5’ boundary definition (Brown et 
al, 2014). It has been proposed that these residues in hTERT may interact with ssDNA 
as well as the DNA/RNA duplex to create a large surface for ssDNA retention during 
template translocation (Wu et al, 2017). The conformation of the motif T β-loop is not 
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determined at atomic resolution, but its general location suggests that it may clamp 
around the DNA 3’ end on the face opposite the thumb helix to stabilize bound 
duplex. 
The T motif was the first conserved element to be described that is unique to 
TERTs, identified via the nearly universal conserved the “FYXTE” telomerase 
signature sequence to the N terminal of the beta-sheet (Nakamura et al, 1997). Within 
this telomerase signature sequence, it also has a remarkable influence of telomerase 
repeat extension rate. Data from primer direct extension assays indicates that mutants 
of this sequence fail to alter repeat addition processivity (Figure 4.1). It is consistent 
with previous targeted mutagenesis of this region showing only significant alteration 
of extension rate but not processivity. It could be achieved via the repeat translocation 
rate by interaction with the template region of the TR at its 5’ end (Drosopoulos & 
Prasad, 2010). The loop of motif T is conserved among species, according to 
sequence alignments and secondary structure prediction, even with various residues. 
The K570A mutant in human hTERT as well as the corresponding mutants in N. 
crassa and T. brucei showed significant decrease in repeat addition processivity 
(Figure 4.4). Defects are rescued by K570R mutant in human telomerase for 
processivity supports that a positively charged residue is critical for repeat addition 
processivity via interactions with negatively charged DNA/RNA duplex in the 
catalytic active site. The position of the K570 residue is also important since 
modifying the location of this residue by insertion or deletion abolished repeat 
addition processivity. The relatively weak processivity of N571A mutant could also 
be due to the larger side chain of asparagine than alanine that help to position K570 
(Figure 4.3).  
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Additionally, K570A failed to utilize a short primer (8mer) as substrate 
indicating the deficiency of the mutant in interacting with the duplex in the active site. 
It shows a similar phenomenon like the D682A and L980A on motif 3 and CTE 
respectively, both of which have been demonstrated to have defects for duplex 
handling in the active site (Huard et al, 2003; Xie et al, 2010). It is solely the 
contribution of mutants in facilitating formation, or recognition, of the short 
DNA/RNA duplex inside the active site. This assay thus discounts the effect of the 
TEN domain on substrate binding, since the TEN domain N95A mutant can extend 
both the short 8 mer or 12 mer DNA substrate efficiently (Figure 4.5). This 
phenomenon is consistent with previous reports that TEN domain binding to the 
longer DNA primer facilitates template translocation (Moriarty et al, 2005). 
Meanwhile, the short 5’ end of the DNA overhang may interact with hTERT protein 
or hTR via a yet unclear mechanism to facilitate telomerase extension, which 
evidenced by alleviating the template embedded pause signal in template free system 
(Brown et al, 2014). The short 5’ end DNA overhang is indispensable for nucleotide 
incorporation of the K570A mutant since it is unable to bind the DNA/RNA duplex in 
the active site.  
Telomerase has to interact with both of its substrate, the telomeric DNA and 
the incoming nucleotide for nucleotide incorporation. Interestingly, the K570A 
showed significantly higher KM
app for the incorporation of ddATP and ddGTP, but not 
ddTTP. This suggests that the mutant may disrupt a specific conformation of the 
protein structure proximal to the active site at a certain stage of nucleotide addition, 
which is required for type I translocation, thus failing to bind the duplex at certain 
positions. According to the accordion model of template positioning by telomerase, 
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the TR contributes to the template positioning within the active site, it requires 
unknown specific interaction with TERT when reaching the 5’ end of the template 
(Berman et al, 2011). K570 could be part of the surface area of hTERT to handle the 
DNA/RNA duplex for type I template translocation during each round of nucleotide 
extension.  
K570A mutant has similar KM
app value compared with the wild type enzyme 
for the incorporation of 1st T (or A after mutate 49rA to rU on hTR template), which 
ruled out the binding deficiency of the mutant to the nucleotide (Figure 4.8). The 
binding affinity of telomerase with its DNA substrate can be assessed from the 
dissociation constant (KD). The KD for a given substrate can be determined by 
titration its concentration and measuring the quantity bound to enzyme as a function 
of its concentration. Alternatively, the dissociation rate (Koff) of enzyme bound 
substrates can be used to determine relative affinities of the substrates for the enzyme. 
Measuring the Koff is often a much more experimentally tractable approach, especially 
when it is hard to get a large amount of telomerase enzyme. Koff was chosen when 
determining primer affinities for telomerase. The higher Koff and lower t1/2 of K570A 
provided direct evidence that the binding deficiency of K570A to the telomeric DNA 
substrate and consistent with the result of exonuclease protection assays (Wu et al, 
2017). The higher KM
app of nucleotide could because of the weak binding affinity of 
the mutant to DNA substrate. For the phenotype, it could be the mechanism of the 
K570N mutant, which have been found in patients with aplastic anemia and 
dyskeratosis congenital, for the shorten of telomere. With deeper understanding the 
mechanism of the mutants could be helpful for the diagnose and therapy strategy for 
the disease (Gramatges et al, 2013; Xin et al, 2007). 
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Figure 4.1. Alanine substitution screening of motif T. (A) Schematic of domain 
and motif organization of human TERT protein. Telomerase specific motif T is 
colored (red). (B) Sequence alignment of TERT motif T from vertebrates, 
invertebrates, fungi, plants and ciliates. Darker shading indicates greater identity 
conservation with the human sequence (<30% light, 30–60% medium and >60% 
dark). (C) Activity assay of the motif T mutants. Human telomerases with alanine 
substitutions in motif T were reconstituted in vitro and assayed for activity. 
(TTAGGG)3 was used as DNA substrate and 32P-dGTP for labeling with unlabeled 
other nucleotides. Numbers on the left (+4, +10, +16, etc.) of the gel indicate the 
number of nucleotides added to the primer in each major band. r.c.: recovery control, 
a 32P-end-labeled 18-nt DNA oligonucleotide. Below the gel, the [35S] methionine 
labeled TERTs analyzed by SDS–PAGE for quantitation are shown. 
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Figure 4.2. Both in vitro as well as in vivo reconstituted K570A mutant showed 
defect of repeat addition processivity. Wild type or K570A mutant TERT was 
reconstituted in RRL or HEK293FT cell with hTR for activity assay. (TTAGGG)3 is 
used as DNA substrate and 32P-dGTP for labeling with unlabeled other nucleotides. 
Numbers on the left (+4, +10, +16) of the gel indicate the number of nucleotides 
added to the primer in each major band. r.c.: recovery control, a 32P-end-labeled 18-nt 
DNA oligonucleotide. 
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Figure 4.3. Substitutions, deletion and insertion mutants of motif T. (A) Structural 
model of motif T β-loop interacting with an RNA/DNA duplex. A model derived 
from Takifugu rubripes TRBD crystal structure (PDB: 4MLO) and Tribolium 
castaneum TERT RNA/DNA duplex co-crystal structure (PDB: 3KYL). (B) Left: the 
list of different mutants of K570 and flanking residues in motif T. Right: Activity 
assays of the motif T mutants. Human telomerases with substitutions of K570 as well 
as insertion or/and deletion next to K570 in motif T were reconstituted in vitro and 
assayed for activity. Numbers on the left (+4, +10, +16, etc.) of the gel indicate the 
number of nucleotides added to the primer in each major band. r.c.: recovery control, 
a 32P-end-labeled 18-nt DNA oligonucleotide. Below the gel, the [35S] methionine 
labeled TERTs analyzed by SDS–PAGE for quantitation are shown. 
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Figure 4.4. Evolutionary conservation of the hTERT K570 residue function. 
Alanine substitution screening of the motif T β-loop in N. crassa (A) and T. brucei 
(B). (GTTAGG)3 was used as substrates for activity assay with 
32P-dGTP and other 
unlabeled dNTPs. The DNA primers (GTTAGG)3 extended by one 
32P-dGTP with 
terminal deoxynucleotidyl transferase (TdT) were included as size markers. Human 
telomerase reconstituted in RRL used as control. r.c.: recovery control, a 32P-end-
labeled 18-nt DNA oligonucleotide. Below the gel, the [35S] methionine labeled 
TERTs analyzed by SDS–PAGE for quantitation are shown. 
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Figure 4.5. Activity assay of telomerase mutants using primers with various 
lengths. (A) The 3 different primers are aligned with hTR template sequence. (B) 
Telomerases with specific mutations in TERT indicated were assayed for activity 
using telomere primers, tel8, tel10 or tel12, with length ranging from 8 to 12 nt. The 
numbers (8+2, 10+2, 12+2, etc.) labeled on the left of the gel indicate the length of 
the primer plus the number of nucleotides added. r.c.: recovery control, a 32P-end-
labeled 7-nt DNA oligonucleotide. Below the gel, the [35S] methionine labeled TERTs 
analyzed by SDS–PAGE for quantitation are shown. 
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Figure 4.6. Effects of nucleotide concentration on telomerase repeat addition 
activity for K570A mutant and wild type enzyme. Direct primer extension assays 
were performed with telomerase enzyme reconstituted in vitro. Top: Sequences of the 
DNA primer and the hTR template for telomerase direct assay. Middle: Telomerase 
was assayed in the presence of either 32P-dGTP with a range of dGTP, dATP and 
dTTP concentrations. A radiolabeled DNA 18 mer recovery control (r.c.) was added 
before product purification and precipitation. Numbers to the left of the gel denote the 
number of nucleotide added to the telomeric primer. Ratio as a percent of the intensity 
of +10 over +4 DNA products. Bottom: A bar graph of the relative ratio of +10/+4 
DNA products are shown below the gel.  
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Figure 4.7. Nucleotide addition defect of K570A mutant. Wild type or K570A 
mutant hTERT was in vivo reconstituted and immune-purified for activity assay. 
(TTAGGG)3 or (GTTAGG)3 is used as DNA substrate respectively and labeled with 
denoted 32P-dNTP with unlabeled other nucleotides. Numbers on the right (+1, +4, +5 
etc.) of the gel indicate the number of nucleotides added to the primer in each major 
band. r.c.: recovery control, a 32P-end-labeled 18-nt DNA oligonucleotide. 
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Figure 4.8. K570A deficiency on nucleotide incorporation kinetics. (A). The KM
app 
for nucleotide addition at positions 46,47, and 49 were measured using wild type and 
K570A mutant telomerases reconstituted in vivo and the immuno-purified and various 
DNA substrates (Figure 4.8 & Figure 4.13). Position 47 of hTR was incorporating 
dATP as well as ddATP (marked with *). The 46 and 49 was incorporate with ddGTP 
or ddTTP (marked with *). The KM
app for incorporating nucleotides are denoted. (B). 
Mutation at position 46 and 49 of hTR, rC mutated rA and rA mutated to rU 
respectively (orange), keep the same trend for the nucleotide incorporation efficiency 
between wild type and K570A mutant (Figure 4.14). 
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Figure 4.9. Defect of K570A mutant on KMapp for dATP incorporation. In vivo 
reconstituted telomerases were immune-purified and analyzed with (TAGGGT)3 
substrates and labeled with 32P-dTTP to determine the apparent KM for dATP. 
Numbers on the left (+1, +2) of the gel indicate the number of nucleotides added to 
the primer. A 32P end-labeled DNA recovery control (r.c.) was added before product 
purification and precipitation. At the bottom of the gel is the quantification of the 
intensity of the +2 and +3 products over the total intensity of products for the 
specified nucleotide concentration. The Michaelis–Menten equation, 
Y=Vmax*X/(KM+X), was used to fit the nonlinear curve to determine the KM
app.  
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Figure 4.10. Dissociation rates of K570A mutants and wild type. (A) Schematic of 
the process for measuring Koff. Wild type or K570A mutant telomerases were in vivo 
reconstituted and then immuno-purified. The initial DNA primer (TAGGGT)3 was 
incubated with an enzyme on beads for 10 min at 30 °C. Following the addition of the 
competitor primer (TAGGGT)4, aliquots were removed at 2, 5, 10, 15, 20, 40, or 80 
mins and 1 µL 0.165 μM α-32P-dTTP was added for isotopic labeling for 10 min at 30 
°C. (B) Representative gels for Koff measurements for wild type telomerase and 
K570A mutant. A 32P-end-labeled 18-mer was used as a recovery control (r.c.). (C) 
Bands depicted in panel B were quantitated by PhosphorImager analysis. Plots 
derived from the normalized intensity of the 18+1 initial product over the total 
intensity of products (18+1 and 24+1) for the specified time points and normalize to 
start point. The rate constants were determined by fitting the data to the equation 
y=Aexp(-kt), using the Prism software package to determine the Koff and t1/2. 
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Figure 4.11. KM comparison for DNA/RNA duplex of wild type and K570A 
mutant enzyme. (A) In vitro reconstituted template-free (TF) telomerase were 
analyzed with titration of DNA/RNA hybrid substrates to determine the apparent KM. 
The nucleotides added (black) to the DNA in the hybrid are shown, with the first 
incorporation a 32P-dATP (circled). (B) Representative gels for KM
app measurements. 
A 32P end-labeled DNA recovery control (r.c.) was added prior to product purification 
and precipitation. (C) The [35S] methionine labeled TERTs analyzed by SDS–PAGE 
for quantitation are shown. (D) Plots derived from the normalized intensity of the +1 
and +2 products for the specified DNA/RNA duplex concentration. The Michaelis–
Menten equation, Y=Vmax*X/(KM+X), was used to fit the nonlinear curve to 
determine the KM
app.  
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Figure 4.12. Motifs proximal to the TERT active-site cavity. TERT active-site 
motifs are colored within the overall ribbon diagram of Tribolium TERT crystallized 
in complex with a model DNA–RNA duplex (PBD accession code 3KYL). The 
product DNA strand is in blue, and RNA template strand is in green. Red: motif T; 
Purple: motif 3; Orange: thumb loop and thumb helix. 
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Figure 4.13.  Defect of K570A mutant on KMapp for ddNTP incorporation. In vivo 
reconstituted wild type telomerases and K570A mutant were immune-purified and 
analyzed with various denoted DNA substrates and labeled with 32P-dNTP to 
determine the apparent KM for ddNTP. Numbers on the left (+1, +2) of the gel 
indicate the number of nucleotides added to the primer. A 32P end-labeled DNA 
recovery control (r.c.) was added before product purification and precipitation. At the 
bottom of the gel is the quantification of the intensity of the +2 products over the total 
intensity of products for the specified nucleotide concentration. The Michaelis–
Menten equation, Y=Vmax*X/(KM+X), was used to fit the nonlinear curve to 
determine the KM
app.  
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Figure 4.14.  Defect of K570A mutant on KMapp for ddNTP incorporation at 
specific position. In vivo reconstituted wild type telomerases and K570A mutant with 
different hTR mutant were immune-purified and analyzed with various denoted DNA 
substrates and labeled with 32P-dNTP to determine the apparent KM for ddNTP. 
Numbers on the left (+1, +2) of the gel indicate the number of nucleotides added to 
the primer. A 32P end-labeled DNA recovery control (r.c.) was added before product 
purification and precipitation. At the bottom of the gel is the quantification of the 
intensity of the +2 products over the total intensity of products for the specified 
nucleotide concentration. The Michaelis–Menten equation, Y=Vmax*X/(KM+X), was 
used to fit the nonlinear curve to determine the KM
app.  
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CHAPTER 5 
EXPLORATION OF THE MOLECULAR MECHANISM OF TELOMERASE 
INHIBITOR BIBR1532 
5.1 Abstract 
 Telomerase is a ribonucleoprotein with reverse transcriptase activity that has 
long been identified as a potential target for cancer therapy. The non-nucleoside, 
synthetic compound BIBR1532 is a potent and selective telomerase inhibitor capable 
of inducing senescence in human cancer cells. Although BIBR1532 has been 
extensively applied in both in vivo and in vitro studies, the molecular basis of 
inhibition is unclear. To characterize the function of the telomerase inhibitor BIBR 
1532, we use the in vitro reconstituted telomerase from RRL (rabbit reticulocyte 
lysate) in direct primer extension assays. We confirmed the ability of BIBR 1532 to 
inhibit telomerase activity in a concentration dependent manner. Additionally, we 
found BIBR 1532 to specifically repress human telomerase catalytic activity, but not 
telomerases from other species. The apparent KM for nucleotide incorporation is not 
affected in the presence of the inhibitor. This study provides crucial information to 
understand the molecular mechanism of BIBR 1532 inhibition of telomerase catalytic 
function. Further investigation is required to uncover the exact and detailed role of the 
inhibitor for each step of the catalytic cycle of human telomerase.  
5.2 Introduction 
 Telomerase is a highly specialized reverse transcriptase that adds DNA repeats 
to the ends of chromosomes to offset the loss of telomeric DNA during each DNA 
replication cycle (Greider & Blackburn, 1987). The core components of telomerase 
include the catalytic telomerase reverse transcriptase (TERT) and telomerase RNA 
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(TR). Since the discovery of telomerase, progress has been made in the identification 
of the core components of representative organisms of various evolutionary groups 
across eukaryotes (Greider & Blackburn, 1989; Shippen-Lentz & Blackburn, 1990). A 
variety of accessory proteins, while dispensable for enzyme activity in vitro, play 
important roles in regulation, biogenesis, and localization in vivo (Egan & Collins, 
2010; Podlevsky et al, 2008). 
 Recently we have reviewed telomerase as a promising target in oncogenesis 
and summarize recent advances in potential telomerase inhibitors for antitumor 
therapy (Chen & Zhang, 2016). Telomerase, and specifically its catalytic subunit 
TERT, is over-expressed in 85–90% of cancers and has become a widely accepted 
tumor marker and a compelling target for anticancer therapeutics (Ruden & Puri, 
2013). Telomere maintenance by telomerase is a key requisite for human cancer cells 
to gain unlimited proliferation potential and is regarded as an essential alteration in 
the physiology of the tumor cell to acquire malignant growth (Hanahan & Weinberg, 
2011). Constitutive overexpression of the telomerase in various pre-senescent and 
normal cells conveyed an unlimited growth potential onto these cells, further 
confirming the role of telomerase in the immortalization process (Bodnar et al, 1998). 
In contrast, inhibition of telomerase results in telomere-shortening, subsequent growth 
arrest, and senescence in cancer cells (Xi et al, 2015).  
In the growing list of promising telomerase inhibitors, BIBR1532 (2-[(E)-3-
naphtalen-2-yl-but-2-enoylamino]-benzoic acid) is one of the most potent non-
peptidic, non-nucleosidic small molecule inhibitor of the telomerase catalytic subunit 
(hTERT) (Figure 5.1A). The anticancer value of BIBR 1532 has been evaluated in 
numerous studies, suggesting the strong ability to suppress tumor cell growth in 
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several types of cancers (Bashash et al, 2012; Bashash et al, 2017; Brassat et al, 2011; 
Liu et al, 2017). There is also evidence showing that BIBR1532 may find potential 
application as an adjunctive agent in cancer chemotherapy. For instance, BIBR1532 
in combination with carboplatin demonstrates the synergistic effect in eliminating 
ovarian cancer spheroid-forming cells by inhibition of telomerase activity (Meng et al, 
2012). Despite extensive use of BIBR1532 in biochemical, as well as in vivo studies, 
its precise mechanism of inhibition of telomerase remains unclear. The co-crystal 
structure of BIBR1532 bound to a conserved hydrophobic pocket in Tribolium 
castaneum catalytic subunit of telomerase (tcTERT) provides useful information to 
explore the molecular function of BIBR 1532 inhibiting the telomerase activity 
(Bryan et al, 2015). In this project, we showed BIBR 1532 to specifically inhibit 
human telomerase activity during catalytic action in a concentration dependent 
manner. The preliminary data are useful to further study the inhibition mechanism of 
this promising telomerase inhibitor. 
5.3 Material and Methods 
In vitro reconstitution of telomerase from representative species.  
Human TERT, purple sea urchin TERT, filamentous fungi (Neurospora) 
TERT, medaka fish TERT, and ciliate (Tetrahymena) TERT proteins were expressed 
in rabbit reticulocyte lysate (RRL) from the pNFLAG-TERT plasmid DNA using the 
TnT T7 Quick Coupled transcription/translation kit (Promega) following 
manufacturer's instructions. The hTR pseudoknot (residues 32–195) and CR4/5 
(residues 239–328) fragments, the SpuTR (residues 63–154), NcrTR (residues 457–
1501/Δ463–1288/insGGAC) pseudoknots, P4.2 (residues 288–446) and three-way 
junction (residues 1813–1877) fragments, and medaka TR fragments PK (1-150) and 
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CR4/5 (170-220) were in vitro transcribed, gel purified, and assembled together with 
the TERT proteins in RRL for 30 min at 30°C at a final concentration of 1.0 μM. 
Tetrahymena thermophila telomerase was reconstituted as previously described 
(Hong et al, 2013). 
Telomerase direct primer-extension assay.  
 Two microliters in vitro reconstituted telomerase enzyme was assayed in a 10 
μL reaction containing 1x telomerase reaction buffer, 1 μM DNA primer, specified 
dNTPs and 0.165 μM of the α-32P-dGTP in the presence of denoted concentrations of 
BIBR 1532 (ApexBio). Reactions were incubated at 30°C for 60 min and terminated 
by phenol/chloroform extraction, followed by ethanol precipitation. The DNA 
products were resolved on a 10% (wt/vol) polyacrylamide/8 M urea denaturing gel, 
dried, exposed to a phosphor storage screen and imaged on a Bio-Rad FX-Pro 
phosphorimager.  
KM measurement using template free (TF) telomerase.  
 Two microliters of RRL reconstituted TF telomerase enzyme was assayed in a 
10 μL reaction containing 1X telomerase reaction buffer, 40 μM pre-annealed 
DNA/RNA duplex, 0.165 μM of the α-32P-dATP with or without BIBR 1532 (5 μM). 
For KM
app measurements, the activity assays were performed with nucleotide 
concentrations ranging from 0 to 1 mM. Reactions were incubated at 30°C for 60 min 
and terminated by phenol/chloroform extraction, followed by ethanol precipitation. 
The DNA products were resolved on a 15% (wt/vol) polyacrylamide/8 M urea 
denaturing gel, dried, exposed to a phosphor storage screen and imaged on a Bio-Rad 
FX-Pro phosphorimager. The intensities of specific products were normalized to the 
total product intensity and plotted against the nucleotide concentrations with the 
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Michaelis-Menten equation, Y=Vmax*X/(KM+X), used to fit the nonlinear curve to 
determine the KM
app (Prism 5, Graphpad Software). 
5.4 Results 
BIBR1532 is an inhibitor of recombinant Telomerase 
 BIBR1532 has been identified as a potent and selective inhibitor of human 
telomerase instead of other RTs or polymerases (Damm et al, 2001). To obtain a 
better understanding of the mechanism of action exerted by this compound, we use in 
vitro reconstituted hTERT from RRL assembled with hTR and telomerase direct 
primer extension assay to quantify the effect of BIBR 1532 on telomerase activity. 
The native enzyme synthesized long extension products in the conventional assay 
similar to the vector, 1% DMSO which did not affect the activity (Figure 5.1B). The 
telomerase inhibitor, BIBR1532, inhibits the accumulation of telomeric DNA in a 
dose-dependent manner, which is consistent with previous results from TRAP assays 
as well as direct assays. Noticeably, at low concentrations of the inhibitor, the 
synthesis of long extension products appears to be more affected than the synthesis of 
shorter products. It suggests that the BIBR 1532 may impede the repeat addition 
processivity during the extension of the telomeric DNA substrate by human 
telomerase.  
 
BIBR1532 inhibits telomerase catalytic activity but not enzyme assembly 
 To determine whether BIBR1532 would directly interfere with telomerase 
catalytic activity, 2 μM of inhibitor was added at various stages of enzyme 
reconstitution: before hTERT expression in RRL, following hTERT expression but 
prior to the addition of in vitro transcribed hTR and just before the primer direct 
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extension assay to assembled telomerase (Figure 5.2A). The BIBR 1532 had a similar 
influence on the telomeric DNA synthesis for each reaction. The earlier treatments 
with inhibitor, before hTERT expression or reconstitution failed to repress telomerase 
function (Figure 5.2B). Meanwhile, it also means the longer incubation with 
telomerase is dispensable for the inhibitory function of BIBR 1532. The result 
indicates the inhibitor does not further inhibit telomerase activity with pre-incubation, 
thus it is only functional during the telomerase catalytic cycle. 
BIBR 1532 does not affect apparent KM for the first nucleotide incorporation in 
human telomerase.  
 Previously, we discovered that the human telomerase template is uniquely 
embedded with a single-nucleotide pause signal that arrests DNA synthesis at the 
template boundary (Brown et al, 2014). And the pause signal mediates high KM for 
nucleotide incorporation. To investigate the effect of telomerase inhibitor BIBR 1532 
on nucleotide incorporation, we measured the apparent KM (KM
app) value of 
nucleotide incorporation with or without BIBR 1532 (5 µM) using DNA/RNA hybrid 
substrates and template-free (TF) human telomerase that lacks the template sequence 
in the integral hTR component (Qi et al, 2012). Human TF telomerase was 
reconstituted by assembling in vitro expressed human TERT protein in rabbit 
reticulocyte lysate with the two essential hTR fragments, CR4/5 and pseudoknot 
lacking the template region. The KM
app for incorporating first nucleotide after template 
translocation is very similar in the presence or absence of BIBR 1532, even though 
the total activity decreased after treatment (Figure 5.3).  It suggests that the BIBR 
1532 did not act as a competitive inhibitor for nucleotide addition, which is consistent 
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with previous results reporting BIBR 1532 as a non-competitive inhibitor of 
telomerase activity (Pascolo et al, 2002).  
BIBR 1532 specifically inhibits human telomerase activity but not in other species. 
 BIBR 1532 has been previously shown to inhibit telomerase but does not 
affect conventional reverse transcriptase or DNA polymerase activity (Damm et al, 
2001). It has also been shown to bind a conserved hydrophobic pocket (FVYL motif) 
on the outer surface of the thumb domain in Tribolium co-crystal structure. For 
comprehensive studies on the species-specific telomerase inhibition of BIBR 1532, 
we incubate the inhibitor with in vitro reconstituted telomerase from representative 
organisms covering ciliates, fungi, invertebrates and vertebrates. Interestingly, BIBR 
1532 demonstrated inhibition of only human telomerase instead of other species.  
5.5 Discussion  
 A number of genetic validation experiments indicated telomere maintenance 
by telomerase is an important process of human cancers (Arndt & MacKenzie, 2016). 
The pharmacological studies showed cancer cells treated with the non-nucleosidic 
small telomerase inhibitor BIBR1532 leads to progressive telomere shortening, cell 
proliferation arrest and senescence (Barma et al, 2003; El-Daly et al, 2005). 
Understanding the mechanism of telomerase inhibition by small-molecule inhibitors 
such as BIBR1532 will assist to identify and develop useful telomerase inhibitors as 
potential therapeutics. Structural data show that BIBR1532 binds to a hydrophobic 
pocket on the outer surface of the thumb domain in Tribolium castaneum (Bryan et al, 
2015). The key residues in the structural organization of the FVYL motif are 
conserved across species, and the pocket is solvent-accessible for substrate binding. 
However, according to the results of telomerase functional assays in the presence of 
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BIBR 1532, it failed to show significant inhibition of telomerase activity in other 
species except human. Further studies as well as functional assay are required for the 
solid conclusion for the binding site of the inhibitor with TERT protein. Since BIBR 
1532 has been shown to neither inhibit other polymerases nor reverse transcriptase, 
this suggests the high specificity of these small molecules to be a potent human 
telomerase inhibitor (Damm et al, 2001). More detailed understanding of the 
molecular basis of BIBR1532 inhibition will require the crystal structure analysis of 
the human telomerase-inhibitor complex. 
 BIBR 1532 anticancer value has been evaluated in numerous preclinical 
studies, it suggested capability of this inhibitor to suppress tumor cell growth in 
several types of cancers (Bashash et al, 2012; Liu et al, 2017). There is also evidence 
showing the potential application of BIBR1532 as an adjunctive agent in cancer 
chemotherapy (Ward & Autexier, 2005). Previous pharmacology studies 
demonstrated that BIBR 1532 inhibits telomerase activity, which result in sensitizing 
drug-resistant cell lines to several DNA damaging agents, and preventing the 
additional activation of telomerase in response to these drugs (Bashash et al, 2017; 
Meng et al, 2012). However, the prevalently inhibitory mechanism of BIBR 1532 
ranging from the biogenesis of the enzyme to its catalytic activity remains unclear. To 
dissect the question, it is added at each stage of the reconstitution process in vitro: 
protein expression, enzyme reconstitution as well as immediately before the 
functional assay. There are no significant differences in repression of enzymatic 
activities regardless of the various stages of addition. It indicates the compound only 
play the role in the inhibition telomerase catalytic function instead protein expression 
or RNP assembly. More studies are required to answer whether high-dose BIBR1532 
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could repress the biogenesis of the telomerase as well as binding of protein partners of 
the telomerase resulting in telomere dysfunction in vivo.  
 To further investigate how BIBR 1532 repress human telomerase catalytic 
function, we measure the apparent KM of the first nucleotide incorporation after 
template translocation, which is the rate limiting step for template translocation. In the 
presence of 5 µM BIBR 1532, the total activity is decreased, but the apparent KM for 
nucleotide incorporation is close to the negative control group. This is consistent with 
the conclusion of an earlier study that BIBR 1532 inhibits telomerase function in a 
non-competitive manner (Pascolo et al, 2002). Moreover, the inhibitor leads to an 
overall reduction in the number of added TTAGGG repeats. To sum up, BIBR1532 
does not block the basic catalytic steps involved in template copying, but specifically 
suppress elongation of the DNA substrate following primer extension to the 5’-end of 
the template.  
 All results are supporting the hypothesis that the binding site of the drug and 
the binding site of the deoxyribonucleotides is in close proximity or overlap, creating 
a steric reciprocal interference for the binding efficiency (Pascolo et al, 2002). 
BIBR1532 is involved in template translocation of the enzyme-substrate complex or 
dissociation between the DNA substrate and the enzyme upon completion of template 
copying, unique to telomerase.  That could be the reason of the compound’s 
specificity. During the catalytic cycle of the telomerase including the nucleotide 
addition and template translocation, BIBR 1532 could either act as non-competitor for 
the nucleotide incorporation or suppress the template translocation for regenerating 
hTR template. However, more information is required to uncover the effect of 
inhibitor on each step of human telomerase catalytic. 
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Figure 5.1. BIBR1532 inhibits the recombinant telomerase activity. (A) Chemical 
structure of the BIBR 1532. (B). Telomerase was reconstituted in vitro in RRL and 
incubated with (TTAGGG)3, dATP, dTTP, and 
32-P-dGTP with various 
concentrations of BIBR1532. Telomerase products were separated on a sequencing 
gel. The inhibitor was dissolved in dimethyl sulfoxide (DMSO) and diluted with 
water before adding to the reaction mix prior to the addition of telomerase. The gel 
shows a control with or without dimethyl sulfoxide and reactions in the presence of 
different concentrations of inhibitor. A radiolabeled DNA recovery control (r.c.) was 
added prior to product purification and precipitation. Numbers on the left (+4, +10, 
+16, etc.) of the gel indicate the number of nucleotides added to the primer in each 
major band. Quantitation of telomerase activity in relation to control are shown below 
the gel.  
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Figure 5.2. BIBR1532 inhibits recombinant telomerase activity not reconstitution 
process. (A) Schematic of the stages in which BIBR1532 was introduced during the 
human telomerase in vitro reconstitution: Human TERT protein was expressed in 
RRL using pNFLAG-hTERT vector ①; In vitro assembly of telomerase with the two 
essential hTR fragments, CR4/5 and the pseudoknot (PK) ②; The telomeric DNA 
primer is the substrate used for the telomerase activity assay ③. Telomerase inhibitor 
BIBR 1532 was added to each step respectively. (B). Telomerase was reconstituted in 
vitro by RRL and incubated with (TTAGGG)3, dATP, dTTP and 
32-P-dGTP in the 
absence or presence of 2µM of BIBR1532 added at each step. A radiolabeled DNA 
recovery control (r.c.) was added before product purification and precipitation. 
Numbers on the left (+4, +10, +16, etc.) of the gel indicate the number of nucleotides 
added to the primer in each major band. Quantitation of telomerase activity in relation 
to control are shown below the gel.  
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Figure 5.3. BIBR 1532 does not affect nucleotide incorporation kinetics. (A) In 
vitro assembly of template-free (TF) telomerase. TF telomerase was reconstituted by 
assembling in vitro expressed human TERT protein with the two essential hTR 
fragments, CR4/5 and the pseudoknot (PK) that had the template region excised. (B) 
The pre-annealed DNA primer and RNA template are the substrate used for the TF 
telomerase activity assay. The nucleotides added (black) to the DNA in the hybrid are 
shown, with the first incorporation a 32P-dATP (circled) to determine the apparent KM 
for the 1st nucleotide incorporation with or without telomerase inhibitor BIBR 1532 (5 
µM). (C) Representative gels for KM
app measurements. Numbers on the left (+1, +2, 
+3.) of the gel indicate the number of nucleotides added to the primer. A 32P end-
labeled DNA recovery control (r.c.) was added before product purification and 
precipitation. At the bottom of the gel is the quantification of the intensity of the +3 
products over the total intensity of products for the specified nucleotide concentration. 
The Michaelis–Menten equation, Y=Vmax*X/(KM+X), was used to fit the nonlinear 
curve to determine the KM
app.  
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Figure 5.4. BIBR 1532 specifically inhibits human telomerase activity but not 
other species. In vitro reconstituted telomerases of human, purple sea urchin, N. 
crassa, Tetrahymena and medaka were analyzed with specific DNA substrates, dATP, 
dTTP and labeled with 32P-dGTP in the presence (+) or absence (−) of 2 µM BIBR 
1532 as denoted above the gel. Numbers on the left (+4, +10, +16 etc.) of the gel 
indicate the number of nucleotides added to the substrate primer. A 32P end-labeled 
18-mer oligonucleotide was used as a recovery control (r.c.). At the bottom of the gel 
is the quantification of the relative total intensity normalized by recovery control. 
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CHAPTER 6 
 
EXPLORATION OF HTERT DOMAIN AND HTR TEMPLATE REGIOIN FOR 
TELOMEASE ACTIVITY AND PROCESSIVITY 
6.1 Abstract 
Telomerase is a ribonucleoprotein (RNP) enzyme requiring the catalytic 
subunit telomerase reverse transcriptase (TERT) protein and the integral telomerase 
RNA (TR) component. The featured ability of TERT to precisely utilize the short 
template region within TR for telomeric DNA synthesis is different from all known 
DNA polymerases or reverse transcriptase. The template sequence of the TR not only 
determines the sequence of the substrate, but also play an important role in 
determining telomerase enzymatic function, including repeat addition processivity 
and rate. Previously we have discovered the embedding the pause signal in human TR 
sequence to arrest nucleotide incorporation when reaching the end of the template. 
This self-regulating system is crucial for the fidelity of telomeric DNA synthesis. To 
determine the detailed mechanism for sequence-dependent pausing of telomerase 
enzymatic activity, we investigate on the motif E of hTERT, which close to the active 
site of the telomerase. Meanwhile, we also tried to elucidate the role of the hTR 
template region for its role in the template translocation process. In sum, we use the 
mutagenesis of the hTERT and hTR subunits to explore motif E residues and hTR 
nucleotide sequence for their role in the telomerase enzymatic function. 
6.2 Introduction 
Telomerase is a ribonucleoprotein complex, including a catalytic protein 
subunit, and an integral RNA subunit. The telomerase reverse transcriptase (TERT) 
contains the polymerase activity to utilize a short region within the telomerase RNA 
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(TR) as the template for the telomeric DNA synthesis. In addition to servings as a 
template for DNA synthesis, the hTR assists in the realignment of substrate at the end 
of each round product synthesis. The base-pairing interaction with the alignment 
region allows proper positioning of the telomeric DNA for the next round of 
polymerization. Previous studies have been shown the hTR temple sequence play an 
important role for the telomerase enzymatic function, including repeat addition rate 
(Drosopoulos et al, 2005; Drosopoulos & Prasad, 2010). The sequences in the RNA 
provide the pausing signal together with template boundary elements defined the 
boundary for high-fidelity synthesis of telomeric DNA repeats (Brown et al, 2014).  
The catalytic subunit of human telomerase, hTERT, contains conserved motifs 
common to retroviral reverse transcriptase and telomerase. The initial identification of 
the TERT protein was facilitated from the homology model to the traditional reverse 
transcriptase (Lingner et al, 1997). The sequence analysis of hTERT revealed the 
presence of conserved motifs important for enzymatic function. The hTERT RT motif 
consist of two subdomains, which resemble the finger and palm subdomains of the 
reverse transcriptase (Wyatt et al, 2010). These domains are connected by the 
conserved motif E, which include the primer grip region (Gillis et al, 2008). The 
treading molecular model indicates the loop of the motif E may direct interaction with 
DNA/RNA duplex in the active site. Previously we have discovered that telomerase 
recognizes a dT:rA base-pair in the DNA/RNA duplex as the pausing signal to 
terminate telomerase nucleotide addition activity (Brown et al, 2014). To further 
determine the detailed mechanism for sequence-dependent pausing on telomerase 
enzymatic activity, we did the alanine screen test the function of the residues of the 
motif E for the telomerase activity as well as a repeat addition processivity. 
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6.3 Material and Methods 
Plasmid construction and mutagenesis.  
Specific mutations in the human TERT genes were introduced into the 
pNFLAG-hTERT by site directed mutagenesis using overlapping PCR strategy (Ge & 
Rudolph, 1997). Intended mutations were confirmed by sequencing. 
In vitro reconstitution of human telomerase.  
Human TERT protein was expressed in rabbit reticulocyte lysate (RRL) from 
the pNFLAG-hTERT plasmid DNA using the TnT T7 Quick Coupled 
transcription/translation kit (Promega) following manufacturer's instructions (Xie et 
al, 2010). The hTR pseudoknot (residues 32–195) and CR4/5 (residues 239–328) 
fragments were in vitro transcribed, gel purified, and assembled together with the 
TERT protein in RRL for 30 min at 30°C at a final concentration of 1.0 μM (Brown et 
al, 2014; Qi et al, 2012). For template free human telomerase, the hTR pseudoknot 
(residues 64–184) and CR4/5 (residues 239–328) fragments were in vitro transcribed, 
gel purified, and assembled together with the TERT protein in RRL for 30 min at 
30°C at a final concentration of 1.0 μM (Brown et al, 2014; Qi et al, 2012). 
Telomerase direct primer-extension assay.  
One microliters in vitro reconstituted telomerase enzyme was assayed in a 10 
μL reaction containing 1x telomerase reaction buffer, 1 μM DNA primer, denoted 
dNTP, and 0.165 μM of denoted α-32P-dGGP. Reactions were incubated at 30°C for 
60 min and terminated by phenol/chloroform extraction, followed by ethanol 
precipitation. The DNA products were resolved on a 10% (wt/vol) polyacrylamide/8 
M urea denaturing gel, dried, exposed to a phosphorstorage screen and imaged on a 
Bio-Rad FX-Pro phosphorimager. For template free telomerase, 1μL of RRL 
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reconstituted enzyme was assayed in a 10 μL reaction containing 1X telomerase 
reaction buffer, specified dNTPs and 0.165 μM of the denoted α-32P-dNTP. Reactions 
were incubated at 30°C for 60 min and terminated by phenol/chloroform extraction, 
followed by ethanol precipitation. The DNA products were resolved on a 15% 
(wt/vol) polyacrylamide/8 M urea denaturing gel, dried, exposed to a phosphor 
rstorage screen and imaged on a Bio-Rad FX-Pro phosphorimager. The quantification 
is same as described above. 
6.4 Results 
Some residue mutants of motif E displays defects in telomerase enzymatic function.  
Motif E located in the RT domain of the TERT, which includes a conserved 
loop region for primer grip in many species. (Figure 6.1) The structure model predicts 
the loop may interact with the DNA/RNA duplex directly at the 3’ end close to the 
active site of the enzyme (Gillis et al, 2008). To experimentally explore the function 
of each residue of motif E, comprehensive alanine as well as tyrosine screening 
mutagenesis were performed. Coding sequence mutations were generated by overlap 
PCR. The mutants of motif E were expressed reconstituted in RRL with in vitro 
transcribed two hTR fragments for the activity assay. Certain residues in motif E 
appear to be essential for telomerase enzymatic functions. The mutants F928Y, 
F928A, W930A, G932Y, D936A, D936Y, R938A, V942Y, D945Y, I954A, G963A, 
A966Y, G967A abolished the telomerase activity, which behave like the catalytically 
inactive hTERT mutant K868N. (Figure 6.2) Some other mutants including G932Y, 
G932A, L933Y, Y946A, Y949A, T952Y, I954Y, S957Y, L958A, L958Y, G967Y 
significantly decreased telomerase repeat addition processivity, which show similar 
patterns like the motif T mutant K570A. (Figure 6.2) 
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We have identified an embedding pausing previously (see chapter 2). To test if 
the residues from motif E contribute to the arrest of the nucleotide addition, we 
investigated mutants function in template free system. The template free telomerase 
mutants were assayed with DNA/RNA duplex. (Figure 6.3) In presence of 32P-dATP 
and dGTP, the avian myeloblastosis virus (AMV) RT extended the DNA primers to 
the RNA template. DNA primer was extended by one or two nucleotides by the wild 
type enzyme with or without the presence of dGTP, because of the pausing signal. 
(Figure 6.3) The mutant S948Y shows the +3 band in the presence of dGTP, which 
indicates reaching the end of the template. However, compare with AMV RT, the 
intensity of the +3 band is relatively weaker than +2 bands. The last nucleotide 
incorporation could because of the higher total activity instead of the deficiency of the 
pausing signal. (Figure 6.3) Further test or structural information required to elucidate 
the mechanism of how human telomerase arrest nucleotide addition at the end of the 
template region. 
Human telomerase RNA template sequence plays an important role for enzymatic 
function. 
Human telomerase utilizes the short RNA template within the hTR for 
telomease DNA repeats synthesis. In vitro telomerase activity assay, the product 
observed as six nucleotide ladder patterns, each band of the ladder representing 
telomerase stalling or dissociation of product. To test the sequence of hTR template 
affect telomerase function, a series of mutants were created and tested. (Figure 6.4) 
The mechanistic model for human telomerase repeat synthesis, including extension of 
the DNA substrate to the end of the template sequence followed by template 
translocation and repositioning of the 3’ end product with the 3’ end of the template 
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region of hTR. The alignment region which contains partial repeats of the template 
sequence played an important role for the repeat addition processivity. The previous 
study has shown the alignment regions contribute to the repeat addition processivity 
(Drosopoulos et al, 2005). In our test, the mutants 48U49U and 47A significant 
reduced repeat addition processivity compared with 48U49U54U55U and 47A53A 
mutants. This indicates the base-pair at the alignment regions after template 
translocation is crucial for the telomerase repeat addition processivity. (Figure 6.5) 
Some of the mutants including 48C54C and 48C49C54C55C increased the higher 
weigh molecular product accumulation comparison with the wild type enzyme. 
(Figure 6.6) The 48C54C mutant has been tested previously showed a higher repeat 
addition rate (Drosopoulos et al, 2005). This mutant showed relative higher 
processivity with 32P-dGTP or 32P-dTTP labeling. The mutant 48C49C54C55C shows 
near inactive for 32P-dTTP labeling because of unable to incorporate dTTP according 
to the template sequence. (Figure 6.6) Interestingly, the 47C48C53C54C mutant, 
which shows less processive than wild type with 32P-dGTP labeling but more 
processive with 32P-dTTP labeling. One explanation could be the concentration of 
cold dGTP affect the enzymatic function. The total concentration of dGTP is much 
higher with 32P-dTTP labeling. The other mutants 46U52U and 46U51U52U both 
showed deficiency for the repeat addition processivity. (Figure 6.6) In chapter 3, we 
have shown the Δpause mutant is much more processive than the wild type enzyme 
and it lack the stimulation by higher concentrations of dGTP. Compare with the 
Δpause mutant, the mutants 48U54U and 49U55U, which only convert one of the T-A 
base-pair to A-U base-pair, both showed accumulation of higher molecular weight 
product. (Figure 6.7) Importantly, the processivity of both 48U54U and 49U55U 
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mutants can be stimulated by the higher concentration of the dGTP. Since the existing 
of the pause signal within the mutants, it further to demonstrate that the incorporation 
of the first nucleotide after the pause signal is essential for the catalytic cycle of 
human telomerase. (Figure 6.7) 
6.5 Discussion 
Even though with increasing knowledge of the telomerase enzyme, there are 
still many questions about the unique mechanism of human telomerase remain 
unclear. This project aims to characterizing the role of the hTERT and TR residues by 
mutational analysis. The catalytic domain of hTERT contains evolutionarily 
conserved RT motifs crucial for telomerase function. (Figure 6.1) The RT domain of 
the hTERT can be organized into two subdomains that resemble the ‘fingers’ and 
‘palm’ in the conventional reverse transcriptase (Gillis et al, 2008). The motif E 
contains a conserved primer grip region connect the subdomains. According to the 
molecular model, the motif E loop may directly interact with the DNA/RNA duplex. 
Previously we have identified telomerase has the ability of recognizing a single base-
pair (bp) signal in the DNA primer/RNA template duplex to terminate nucleotide 
addition in template free telomerase system (Brown et al, 2014). (Chapter 2) The 
sequence-dependent pause signal could be recognized by TERT protein residues close 
to the DNA/RNA duplex near the active site. The amino acid residues in hTERT near 
the DNA/RNA duplex are possibly making physical contact with the dT-rA base pair. 
The comprehensive mutagenesis studies by alanine and tyrosine screening of the 
motif E failed to find a residue responsible for the pause signal by allowing TF 
telomerase incorporate nucleotide after the pause site. (Figure 6.3) However, some of 
the residues have played an important role for the repeat addition processivity of 
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human telomerase. (Figure 6.3) Further studies could be focused on exploring the 
mechanism of those residues for human telomerase enzymatic functions. 
In addition to providing the template for telomeric DNA repeat synthesis, hTR 
contains motifs necessary for the reconstitution and catalytic function (Podlevsky & 
Chen, 2012).  The mutations on the hTR template, both the alignment and templating 
region, have been shown directly influenced overall repeat addition rate and 
processivity (Drosopoulos et al, 2005). It has been demonstrated the complementarity 
of TR templating and alignment region is required for the processive enzymatic 
function (Chen & Greider, 2003; Gavory et al, 2002). Our date consistent with this 
conclusion: the mutants 48U49U as well as 47A show obvious deficiency for the 
repeat addition processivity compares with 48U49U54U55U and 47A53A. (Figure 
6.5) Previously, we have shown that the pause signal responsible for the low 
processivity and rate of human telomerase. (Chapter 3) The mutants 48U54U and 
49U55U, which are only mutated one rA residue in the hTR template and the pause 
signal is not completely depleted, showed accumulation of the higher molecular 
weight product comparison with the wild type enzyme. (Figure 6.7) More 
importantly, a contrast to the Δpause mutant that independent of dGTP stimulation of 
repeat addition activity, higher concentration of dGTP increased the higher molecular 
weight product by 48U54U and 49U55U mutants. (Figure 6.7) This indicates the first 
nucleotide incorporation after the pause signal still limited catalytic cycle of the 
mutant. Taken together, these results provided more information for the protein and 
RNA subunits of their role in human telomerase.  
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Figure 6.1.  Schematic of domain and motif organization of human TERT 
protein. Sequence alignment of TERT motif E from vertebrates, invertebrates, fungi, 
plants and ciliates. Darker shading indicates greater identity conservation with the 
human sequence (<30% light, 30–60% medium and >60% dark). 
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Figure 6.2.  Alanine substitution screening of motif E. Activity assays of the motif 
E mutants. Human telomerases with alanine substitutions in motif E were 
reconstituted in vitro and assayed for activity. (TTAGGG)3 is used as DNA substrate 
and 32P-dGTP for labeling with unlabeled other nucleotides. Wild type human 
telomerase as well as catalytical inactive mutant enzyme used as control for each 
panel. Numbers on the left (+4, +10, +16.) of the gel indicate the number of 
nucleotides added to the primer in each major band. r.c.: recovery control, a 32P-end-
labeled 18-nt DNA oligonucleotide.  
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Figure 6.3.  Alanine substitution screening of motif E with TF telomerase. Human 
TF telomerases with alanine substitutions in motif E were reconstituted in vitro and 
assayed for activity. Wild type human telomerase as well as AMV RT used as control 
for each panel. DNA/RNA duplex is used as substrate and 32P-dATP for labeling with 
unlabeled dGTP. Numbers on the left (+1) of the gel indicate the number of 
nucleotides added to the primer in each major band. r.c.: recovery control, a 32P-end-
labeled 18-nt DNA oligonucleotide. The DNA primers TTAGGGTT extended by one 
α-32P-dATP with terminal deoxynucleotidyl transferase (TdT) were included as size 
markers. 
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Figure 6.4.  Schematic representation of human telomerase template region and 
its mutants. Sequences of the hTR mutants (bottom). Changes from wild type 
telomerase sequence are underlined. Predicted product is shown on the right of the 
bottom. * stand for the non-processive product. 
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Figure 6.5.  Primer extension by human telomerase template mutants.  Sequences 
of hTR mutant templates used in this assay. Direct primer extension assays of 
telomerase template mutants. (Left) Wild-type and mutant telomerases were 
reconstituted in vitro were assayed in the presence of 0.165 μM 32P-dGTP, 100 μM 
dATP and dTTP. Numbers to the left of the gel denote the number of nucleotide 
added to the telomeric primer. An 32P end-labeled DNA recovery control (r.c.) was 
added before product purification and precipitation. The DNA primers (TTAGGG)3 
extended by one α-32P-dTTP with terminal deoxynucleotidyl transferase (TdT) were 
included as size markers. (Right) 
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Figure 6.6.  Primer extension by human telomerase template mutants.  Sequences 
of hTR mutant templates and the DNA primers used in this assay. Direct primer 
extension assays of telomerase template mutants. (Left) Wild-type and mutant 
telomerases were reconstituted in vitro were assayed in the presence of 0.165 μM 32P-
dGTP, 100 μM dATP and dTTP or 0.165 μM 32P-dTTP, 100 μM dATP and dGTP. 
Numbers to the left of the gel denote the number of nucleotide added to the telomeric 
primer. An 32P end-labeled DNA recovery control (r.c.) was added before product 
purification and precipitation. The DNA primers (TTAGGG)3 extended by one α-32P-
dTTP with terminal deoxynucleotidyl transferase (TdT) were included as size 
markers. (Right) 
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Figure 6.7.  dGTP-dependent repeat addition stimulation of human telomerase. 
Sequences of hTR mutant templates and the DNA primers used in this assay. Direct 
primer extension assays of telomerase template mutants. (Left) Wild-type and mutant 
telomerases were reconstituted in vitro were assayed in the presence of 0.165 μM 32P-
dATP, 100 μM dTTP and 10 or 100 μM dGTP. Numbers to the left of the gel denote 
the number of repeat added to the telomeric primer. An 32P end-labeled DNA 
recovery control (r.c.) was added before product purification and precipitation. Ratio 
as a percent for the intensity of high over low M.W. DNA products generated relative 
to the reaction with the low nucleotide concentrations. (Right) 
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